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POSTULATIONS 
1. In the model of ultrasound-induced “emotional stress”, brain over-
expression of GSK-3 isoforms is accompanied by markers of 
microglia activation and oxidative stress (this thesis); 
2. Expression of GSK-3α and GSK-3β is differentially altered both in 
the model of ultrasound stress and in the model of enhanced learning 
of adverse context (this thesis); 
3. In the examined models, GSK-3β overexpression correlates with 
depressive-like behavior, cytokine production, and oxidative stress 
markers, suggesting overlapping molecular mechanisms underlying 
the depressive syndrome (this thesis); 
4. Brain upregulation of the GSK-3 cascade in a mouse model of 
enhanced learning of adverse memories is associated with increased 
production of pro-inflammatory cytokines, c-Fos and markers of 
oxidative stress (this thesis);  
5. These changes are prevented by a pre-treatment with antidepressant 
compounds, as well as anti-oxidant vitamin B1 (thiamine) that is 
useful for fundamental and pre-clinical studies (valorization);  
6. Contextual learning occurs in the presence of background stimuli; 
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7. Stress-linked inflammation is a coherent mechanism to enhance 
animal survival; 
8. The majority of currently used antidepressants are discovered 
around half a century ago; 
9. "Not everything that is faced can be changed, but nothing can be 
changed until it is faced" (James Baldwin) 
10. “I take vitamins” (Hillary Clinton) 
11. “To attain any assured knowledge about the soul is one of the most 
difficult things in the world” (Aristotle) 
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CHAPTER 1. INTRODUCTION 
 
1. Aetiology of major depression and the role of emotional stress 
in its pathogenesis 
Ebers Papyrus, an Egyptian medical papyrus dated about 1500 BC, 
describes the first knowledge of mental disorders similar to depression; in 
those times term “melancholy” was used to indicate this state (Okasha, 
1978). This term almost uncheangeably had been used until 19th century, 
when “depression” came into use in physiology and psychiatry (Berrios, 
1988). The modern concept of depression covers a wide range of mental 
health problems characterized by low mood, negative thoughts, fatigue, 
indecisiveness and a broad constellation of associated symptoms (Kessler 
et al., 2003). One of the core symptoms of depression is anhedonia, or 
decreased ability to experience pleasure, that is a clinical presentation of 
reward circuit dysregulation that can be detected in humans, apes and 
rodents (Gong et al., 2015). Depression is often associated with cognitive 
and motivational decline, aberrations of exploratory behavior and memory 
loss (Ramponi et al., 2004) due to disruption of neurogenic processes and 
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deficient neuroplasticity in the main limbic brain structures (Kheirbek et al., 
2012; Boku et a., 2018). 
Clinical depression, also referred to as major depressive disorder  (MDD), 
is characterized by at least 5 of these criteria that should be persistent during 
2 consecutive weeks, according to the 5th edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-V) (APA., 2013). 
Today, depressive disorders are recognized as a group of severe and 
debilitating diseases that affect more than 300 million people all over the 
globe (http://www.who.int/healthinfo/global_burden_disease/ estimates).  
Depressive disorders are often roughly classified into bipolar depressions 
(manic-depressive conditions; the presence of an episode of mania is 
crucial), and unipolar (no oscillation between depression and mania)  
(Cuellar et al., 2005). Major depressive disorder is an example of unipolar 
depression along with minor depressive disorder (at least two depressive 
criteria are present for two consecutive weeks) and atypical depression 
(with mood reactivity, hyperphagia and hypersomnia) (Benazzi et al., 
2006). These disorders are also classified into reactive subtype of 
depression (situational, stress-related) and endogenous depression (caused 
by genetic or other internal factors) based on the occurrence of the 
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pathology following the presence or absence of stress in their etiology 
(Showraki, 2019). 
It is known that depression may not only diminish emotional state of 
affected individuals but also somatic health (Lopez et al., 1998; Evans et 
al., 2005). Indeed, patients with depression more often have 
cerebrovascular, cardiovascular, and other somatic disorders compared with 
general population (Uzun et al., 2008). Interestingly, depression may 
supercede cardiovascular disease as the leading cause of disability in the 
year 2020 according to the report of World Health Organization (Robinson, 
2018). 
Taking together, depression decreases the daily productivity and motivation 
of individuals that potentially may lead to losing a job that can further 
deepen depression and put individuals at risk of suicidal thoughts (Meltzer 
et al., 2011; Jesulola et al., 2018). In fact, clinical studies have documented 
strong association of depressive disorders with suicide ideation and suicide 
attempts (Ribeiro et al., 2018).   
Emotional (psychosocial) stress is regarded as one of the main 
environmental risk factors for the genesis of a depressive-like state. Animal 
models of social stress are valuable tools to study the phenomenon and one 
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of the most extensively used translational paradigms is the social defeat 
stress paradigm (Bjorkqvist, 2001; Rygula et al., 2006). The stressful 
condition here is based on circumstances that lead to intermale 
confrontation and fighting, whereby a dominant male attacks a subdominant 
male (Golden et al., 2011). Repeated negative experience in this model 
leads to the development of a depressive-like state in a subdominant male: 
it is accompanied by anhedonic states, suppressed locomotion and 
exploratory behavior, and cognitive declines (Kudryavtseva et al., 1991; 
Krishnan et al., 2007). These behavioral manifestations are often paralleled 
by disturbance in monoamine systems in the central nervous system (Goto 
et al., 2015).   
There are also a variety of models that make use of the concept of isolation 
as another environmental factor implicated in depression, for example 
social isolation. These are widely used to model depressive syndromes 
(Zanier-Gomes et al., 2015; Ieraci et al., 2016). Maternal separation is 
another way to induce depressive syndrome in rodent models, where 
littermates are separated from their mothers (Gardner et al., 2005; Fabricius 
et al., 2008; Roque et al., 2014). There is growing concern that this kind of 
stress can increase the vulnerability to develop emotional abnormalities, 
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psychopatologies and social behavioral deficits (Huot et al., 2001; Roque et 
al., 2014). 
Environmental stress is one of the most crucial set of factors that can trigger 
depression. The famous Canadian scientist Hans Selye is a pioneer in stress 
research and has shown the deleterious effects of stress in somatic health.  
He postulated three distinct stages of a stress response that are triggered by 
an unspecific stress hit: general anxiety, resistance and general exhaustion 
of all adaptative mechanisms (Selye, 1936). Harmful effects of a stress 
reaction can be detected at the very first instance, and they are generally 
referred to in the literature as acute stress effects. Mobilisation of an 
organism’s internal capacities to overcome this acute stress often leads to 
resistance of an organism to the applied disturbance (see Fig. 1). 
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Figure 1. Stress models associated with two distinct patterns of HPA 
axis activation. Purple and Blue lines respectively represent modern and 
Selye’s views on susceptibility to stress-associated diseases depending on 
HPA axis activation. Adapted from Kim et al., 2015. 
 
In the organism there is a pathway that amplificates the stress response – 
the hypothalamic-pituitary-adrenal pathway. The hypothalamus is 
particularly sensitive to a stress hit and initiates boostered production of 
major stress hormones – glucocorticoids. An important region for 
glucocorticoid production is the PVN nucleus of the hypothalamus, that 
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secrets CRH (corticotropin-releasing factor), in turn triggering biochemical 
changes in the pituitary gland (Jiang et al., 2018). Receptors for 
glucocorticoids are widely expressed throughout the nervous system and 
through negative feedback mechanisms respond to an excess of 
glucocorticoids by decreasing the upstream synthesis of CRH (Herman et 
al., 2016).  It was shown that injections of CRH induce robust pro-
depressant changes in rodents and lead to altered locomotor activity, 
decreased food intake and disturbed sleep (Holsboer, 2001). 
Depression can manifest as a number of various symptoms, including low 
mood, anhedonia, feelings of helplessness, irritability and sleep changes, 
making it a complex disease to treat (Kendler et al., 2016). There are many 
types of mood stabilizers, such as antidepressants (imipramine, fluoxetine), 
antipsychotics (olanzapine), anticonvulsants (lamotrigine) and lithium 
(Baldessarini et al., 2013). Among these drugs lithium gained a unique 
position as it has both antimanic and antidepressant activity and is used to 
treat bipolar disorder (Can et al., 2014). Lithium is a potent suppressor of 
glycogen synthase kinase 3 (GSK-3), a marker of a distress and depression, 
the functions of which are discussed below (Freland et al., 2012). Being the 
most potent drug therapying the treatment of depression, lithium is effective 
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for a third of depressed patients and upregulates neurotrophins and their 
cognate receptors (see below; Gideons et al., 2017). 
2. Enhanced cognitive processing as a pathological mechanism in major 
depressive disorder  
Mechanisms of depression are poorly understood (Kessler et al., 2015). Of 
particular significance is to study what molecular cascades underpin the 
enhanced conditioning of environmental adversities as they constitute an 
important vulnerability factor for the development of a depressive 
syndrome (Clark et al., 2009). Identification of the mechanisms or 
molecular targets involved in this phenomenon may be of particular 
significance to find novel approaches to treat depressive disorders 
associated with enhanced conditioning of adversities. Up to now, a very 
limited amount of data are available to describe these mechanisms and in 
the present work we addressed these phenomena. We used a relevant model 
of a modified forced swim test that was established recently (Strekalova et 
al., 2016). We believe that widening of the current knowledge of molecular 
mechanisms implicated in these conditions can potentially facilitate 
management of these conditions associated with augmented acquisition to 
adverse experiences. It is known that a faster ability to acquire negative 
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memories and their inappropriate recall can provoke deleterious effects on 
the health and trigger cognitive and emotional aberrations (Strekalova et al., 
2016). These conditions can decrease quality of life as they interfere with 
normal daily functioning and may be manifested as signs of behavioral 
despair, inability to experience pleasure and other traits of depressive 
syndrome. Enhanced memorizing of negative experiences can be a factor of 
additional stress by its own and further worsen mental and physical health 
conditions (Yehuda et al., 2010) (Fig. 2). In patients with phobias and post 
traumatic stress disorder (PTSD) the high incidence of inappropriate 
retention of adverse memories is prevalent (Chrousos and Gold, 1992). 
To model augmented memorizing of adversities we employed a modified 
forced swim test paradigm (modFST). 
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Figure 2. Augmented learning of adverse memories in the symptoms of 
depression and post-traumatic stress disorder (PTSD). Abnormal 
memorizing and retention of adversities can result in the development of 
depression and PTSD (adapted from Yehuda et al., 2010). 
 
In comparison to the classical two-day protocol of Porsolt’s test (Porsolt et 
al., 1977), the modFST test consists of three swimming sessions on days 1, 
2 and 5. During  delayed swimming session animals typically demonstrate 
increased duration of floating behavior in the first two minutes of the test 
that suggests that these rodents are prone to float. In this regard the 
parameter of duration of floating can be regarded as a parameter of learned 
Augmented learning of adversities
Enhanced memorizing of
adverse experiences and
inappropriate retention
of negative memories
PTSDDepression
Flash back memories and
severe nightmares
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immobility and can be a measure of enhanced cognitive processing. At the 
same time, modFST similarly to the classical Porsolt’s paradigm triggers 
alterations relevant to a depressive syndrome, that makes modFST to be a 
useful tool to model these conditions.  
3. Brain regions involved in the pathogenesis of depressive syndrome 
Various signals including danger and emotional stressors are transduced by 
sensory afferents to the central nervous system where this information is 
processed by limbic brain circuits (Human et al., 2007). Despite the fact that 
there is still no clear understanding of specific neuroanatomical connections 
that underlie different types of depression, many brain regions can be 
implicated (Drevets, 1998). From research dedicated to uncovering 
anatomical features of depression, disturbances in monoaminergic regions 
were considered key to the development of the depressive syndrome 
(Delgado, 2000). Nowadays pivotal roles of serotonergic, noradrenergic 
and dopaminergic neurons in diverse neural circuits in a depressive 
syndrome are widely accepted and have been proven in pharmacological 
and genetic animal models of depression (Hasler, 2010). 
The most important constellation of serotonergic neurons in the midbrain 
are located in the regions of medial, dorsal and caudal raphe nuclei and 
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lateral medullary reticular formation (Muller and Jacobs, 2009). These 
nuclei send projections to cortex areas, brainstem, cerebellum, 
hippocampus and other brain structures that regulate depression, sickness 
behavior and comorbid chronic pain conditions such as fibromyalgia (Fig. 
3). The noradrenergic system constitutes nuclei that are located in the locus 
coeruleus (in the pons) and sympathetic ganglia of the autonomic nervous 
system; main brain projections are to the cerebral cortex (coeruleo-cortical 
pathway), thalamus, amygdala and basal forebrain (Moore and Bloom, 
1979) (Fig. 3). As for the clustering of dopaminergic neurons, the most 
important are identified in the substantia nigra, periventricular and arcuate 
nuclei, ventral tegmental area and zona incerta (Saltiel and Silvershein, 
2015). The most important group of dopaminergic neurons projects to the 
prefrontal cortex (mesocortical pathway) and nucleus accumbens 
(mesolimbic pathway) (Bjorklund and Dunnett, 2007). 
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Figure 3. Schematic representation of brain regions involved in the 
pathogenesis of depression. (Saltiel et al., 2015). 
Legend: A - tonsil; BF - basal forebrain; C is the cerebellum; H - 
hypothalamus; NA - nucleus accumbens; NT - neurotransmitter centers; 
PFC - prefrontal cortex; S - striatum; SC - spinal cord; T - thalamus. 
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The extensively reported data about neuroanatomic substrates of depression 
obtained by imaging technologies are dedicated to dramatic volumetric 
changes in two main brain areas – the prefrontal cortex and hippocampus 
(Krishnan et al., 2008).  
In the prefrontal cortex, the degeneration of astrocytes (Domin et al., 2014), 
microglial pro-apoptotic changes (Banasr et al., 2008) and long-term 
depression (Vialou et al., 2014) are commonly reported to be associated 
with pro-depressant behavioral changes. Clinical data demonstrate atrophy 
of hippocampal neurons (Schmidt et al., 2007) and volumetric changes 
(Sheline et al., 1996) in postmortem brains of depressed patients. 
Depression is often accompanied by reduced hippocampal volume 
(Campbell et al., 2004), deficient neurogenesis (Henn et al., 2004) and 
downregulated expression of neuroplasticity factors (Shafia et al., 2017). 
4. Disrupted plasticity and oxidative stress in the brain as 
pathophysiological factors of depressive disorder 
An important hypothesis of mechanisms involved in the vulnerability to 
depression is aberrant neuroplasticity in the brain as this mechanism of 
neuronal adaptation is disrupted in depression (Wainwright et al., 2013). 
Neurotrophic factors, related molecules and signaling kinases associated 
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with structural neuroplasticity and synaptoplasticity are among the crucial 
factors that are involved in the pathophysiology of depressive disorders 
(Schmidt et al., 2006). Stressors, e.g. emotional stressors, can diminish their 
expression, affecting neuronal survival, plasticity, cell migration and 
neurogenesis (Duman et al., 2012; Phillips, 2017). 
Prominent neurotrophins include BDNF, GDNF, FGF, VEGF, FGF-2, 
NGF, NT-3 and NT-4; they are implicated in an animal emotionality and 
cognition (Jansson, 2011). In particular, signaling via BDNF and its 
receptor tropomyosin receptor kinase B TrkB plays an important role in the 
pathophysiology of depression and in the therapeutic mechanisms of 
antidepressants as BDNF-TrkB signaling is an integral part of learning, 
memory and long-term potentiation processes (Harrisberger et al., 2015) . 
BDNF is a protein that promotes survival of neurons and widely expressed 
in the developing and adult central nervous system acting as a regulator of 
neuroplasticity, neurogenesis and synapse development (Choo et al., 2017). 
Considerable research has proven an important role of BDNF dysregulation, 
such as peripheral reduction in serum BDNF, in the development of 
depressive-like traits (Erickson et al., 2012; Yoshida et al., 2012). In 
consistency, postmortem studies of persons with clinical depression have 
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revealed decreased protein BDNF content in the hippocampus (Duman and 
Monteggia, 2006). Importantly, altered BDNF signaling may affect 
homeostasis of microglia and astrocytes in the key depression-associated 
brain areas that can be reversed following abtidepressant treatment (Rial et 
al., 2015). Notably, following antidepressant treatment BDNF content is 
upregulated (Russo-Neustadt et al., 1999); subcutaneous or 
intrahippocampal injections of BDNF produce robust antidepressant and 
anxiolytic-like effects accompanied by increased cell survival in the 
hippocampus (Hoshaw et al., 2005; Schmidt and Duman, 2010). It is 
interesting to note, that injection of BDNF in the ventral tegmental area 
provokes depressive syndrome (Eisch et al., 2003). BDNF binding to its 
cognate receptor TrkB triggers downstream cascades, and among them 
phosphatidyl inositol-3 kinase (PI3K) - protein kinase B (Akt) cascade is 
the most extensively studied in depression research (Duman et al., 2012). 
Consistent with BDNF content reduction in the brain limbic regions 
following stress exposure, PI3K-Akt pathway activity is lowered in 
depressed individuals (Dwiwedi et al., 2006). Interestingly, there is a notion 
that genetic ablation of genes encoding BDNF is insufficient to cause 
depressive syndrome (Duman et al., 2012). This notion leads us to speculate 
that BDNF cannot be a major factor for the development of a susceptibility 
31 
 
to a depressive syndrome by itself and some downstream elements of 
BDNF-related cascades can be better targets for understanding the role of 
BDNF in the development of depressive disorders (Duman et al., 2012).  
Besides BDNF’s role in depressive disorders, other neurotrophins may also 
contribute to neuroplasticity changes associated with depression 
(Naumenko  et al.,  2013). For instance, glial cell-line derived neurotrophic 
factor GDNF is an important factor for survival of serotonergic and 
dopaminergic neurons (Naumenko  et al.,  2013) and is downregulated 
following chronic stress paradigms of depressive syndrome (Liu et al., 
2012). For the involvement of GDNF it was shown that stress-susceptible 
BALB/c mice are characterized by reduced expression of this factor, while 
resilient animals of the C57 strain are characterized by upregulated basal 
level of GDNF (Palumbo et al., 2009). 
VEGF is traditionally associated with the formation of new blood vessels 
while its overexpression is regarded as a marker of antidepressant-like 
changes (Warner-Schmidt and Duman, 2007). The relevance of VEGF as a 
marker of depression has also been highlighted through clinical research 
indicating the strong comorbidity between cardiovascular disorders and 
depression (Musselman et al., 1998; Salaycik et al., 2007; Newton et al., 
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2013). Interestingly, astrocytes and microglia have direct interactions with 
blood vessels (Mulligan et al., 2004) and overexpression of VEGF by these 
cells is associated with increased permeability of the blood brain barrier 
(Argaw et al., 2012) that potentially may lead to increased infiltration of 
monocytes from systemic circulation thus exacerbating pro-inflammatory 
changes that typically accompany a stress response.  
There is emerging concern about the role of oxidative stress in the 
pathogenesis of depression (Liu et al., 2015). Naturally, low levels of 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) are 
produced by mitochondria (Cadenas et al., 2000) and play important roles 
in cell homeostasis (Cheignon et al., 2018). But ROS/RNS are high risk 
factors to damage brain tissue as brain contains relatively high levels of 
redox-active metals (Garbarino et al., 2015). 
 It is speculated that inconsistency of ameliorative results following 
antidepressant treatments can be related to differences in the brain contents 
of oxidative stress markers (Lindqvist et al., 2018) as disturbance in the ratio 
of pro-oxidants/anti-oxidants leads to the development of oxidative stress 
(Birben et al., 2012), a condition that is regarded as one of the fundamental 
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vulnerability factors for the development of depressive syndrome (Michel 
et al., 2012). 
A process of lipid peroxidation triggered by excessive ROS generation is an 
especially relevant marker of oxidative stress as the brain contains a high 
content of polyunsaturated lipids (Patel et al., 2016). A prominent marker 
of oxidative stress related to lipid peroxidation is malondialdehyde (MDA), 
that was shown to be upregulated in depressed individuals (Bajpai et al., 
2014). Excessive production of ROS can also damage proteins generating 
irreversible protein carbonylation that is often accompanied  by depressive 
syndrome and deficient hippocampal neuroplasticity (Vignisse et al., 2017). 
5. Rodent models of depression 
To model human disorders in animals is an important and challenging task 
as multiple psychological, emotional and physiological symptoms have 
subjective nature and can be affected by unique environmental conditions 
in human society (Nestler et al., 2010). It is important to notice that none of 
currently used animal models of depressive syndrome may perfectly 
replicate human depression and multiple limitations still exist (Berton et al., 
2006). However, overlapping mechanisms and brain alterations between 
clinical data, post-mortem research, and animal models have resulted in the 
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discoveryof effective treatment strategies that were elaborated in the first 
instance in animal models of depressive syndrome (Nestler et al., 2010). To 
establish a relevant animal model that can recapitulate and mimic some of 
the human disorder manifestations, certain validity criterion should be met 
(Strekalova et al., 2011), such as face validity, construct validity, and 
predictive validity (Willner, 1984). Face validity displays symptomatic 
traits of the disease; construct validity reflects interspecies similarity of the 
biochemical pathways (McKinney et al., 1969); and predictive validity 
confirms common effects upon pharmaceutical treatment (Willner, 1984).  
Currently used translational models of depression can be divided into 
several groups, such as invasive models (e.g. bulbectomy based), genetic 
models (e.g. knock-out of genes important for serotonergic 
neurotransmission), stress models (e.g. intermale confrontation, maternal 
separation) and others (Fuchs et al., 2006; Valvassori et al., 2013). Below I 
will briefly review some of the established animal models of depressive 
syndrome that are especially frequently used.   
Olfactory bulbectomy is an important invasive model of depression (Jarosic 
et al., 2007). Bulbectomy provokes profound biochemical changes that 
mimic a profile of human depression, and are also paralleled by behavioral 
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alterations such as anhedonic state and despair behavior (Slattery et al., 
2014). 
Among depressive models that use physical stimuli a concept of repeated 
social defeats has gained extensive attention (Strekalova et al., 2008; 
Hammels et al., 2015) as it implicates excessive competition behavior and 
provokes development of depressive syndrome (Berton et al., 2006). In this 
model there is a situation of intermale confrontation, where one animal 
ascertains dominance and aggression whilst the other becomes submissive 
with depressive-like features (Krishnan et al., 2007). Following repeated 
experience of social defeat an animal displays a submissive phenotype 
reminiscent of depressive syndrome in humans, as well as anhedonia and 
motivational deficits (Kudryavtseva et al., 1991) that are reversible by 
antidepressant treatment (Rygula et al., 2006).  
Stress models of depression are of particular significance (Duman, 2010). 
A learned helplessness model is a classical one (Bali et al., 2015) in this 
regard. In this model an animal is placed in a situation where it cannot 
escape from the dangerous environment that results in the formation of a 
state of helplessness, that is manifested as an absence of any attempts to 
struggle (Vollmayr et al., 2013). This model of coping deficit was initially 
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elaborated in dogs and consisted of foot shock applications (Overmier et al., 
1967) that was subsequently recapitulated in rodents (Maier et al., 1990). 
Additional ways to model designated conditions is to use a paradigm of 
unpredictable mild stress of prolonged duration (Strekalova et al., 2004; 
Willner, 2005; Strekalova et al., 2006; Strekalova et al., 2011). Under these 
conditions the development of a depressive syndrome can be initiated 
following at least 14 days of stress exposure (Willner, 2005) and this model 
triggers a wide range of behavioral abnormalities, including depressive 
syndrome, aggression, cognitive deficits and fatigue, prevented by 
antidepressant treatments (Mutlu et al., 2014).  As a stressor here can be 
employed random alteration of different conditions such as frequent change 
of the bedding, watering of bedding, disrupted day/night cycle, deprivation 
of food, water or social contacts. An important limitation of this model is 
great inter-strain differences in response to an applied hit: C57 mouse strain 
is a particularly vulnerable to this model while CD-1 strain has a higher 
proportion of resilient animals (Jung et al., 2014). 
While these experimental models are widely applied in the preclinical study 
of depression, there is a certain need in experimental models that employs 
naturalistic approaches instead of artificial situations. Naturalistic 
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challenges are of particular significance for depression research as they 
mimic risk factors typical for human society that we encounter in our daily 
life. Emotional stress is one of the most important risk factors for 
developing depressive syndrome in human society and their respective 
animal models are of a great use to overcome current limitations that 
invasive animal models or models of artificial challenges have. In this 
regard in chapter 4 we discuss our model of ultrasound of alternating 
frequencies. 
To sum up it can be concluded that there is a lack of valid depression models 
based on naturalistic stimuli. In our daily life we encounter mostly 
emotional challenges that are associated with our social sphere. This notion 
makes methods and approaches based on emotional stress the most relevant 
when conducting translational research on predisposing factors of 
depression that we face in human society. Emotional stress does not 
implement any physical elements or elements of organic nature and it is 
based purely on cognitive processes of evaluation of information.  
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6. Changes in glycogen synthase kinase-3 (GSK-3)-related cascades 
during depression 
GSK-3 is a serine-threonine kinase that is activated and upregulated under 
various stress conditions that are extensively used to induce depressive 
syndrome (Pavlov et al., 2017). GSK-3 refers to two separate isoforms – 
alpha and beta that have a high rate of homology and structural similarity, 
though structural differences determine the distinct functions between these 
molecules (Pavlov et al., 2017). While functions of beta isoform is well 
documented for its role in apoptosis, distress, and affective disorders,  
functions of alpha isoform remain largely unaddressed. Functional 
similarity of both isoforms have been suggested, but some regulatory 
activities of alpha isoform cannot be substituted by its beta isoform and vice 
versa. For example, genetic knock-out of the GSK-3α isoform is not a  lethal 
mutation, but result in deficient cognitive functions, whereas ablation of 
genes that encode the beta isoform is lethal, revealed by mouse studies 
(Sayas et al., 2012; Maurin et al., 2013).  
Neuronal alpha isoform knock-out models generate mice that tend to be 
more anxious and with lowered explorative behavior (Kaidanovich-Beilin 
et al., 2009). Partial knock-out of beta isoform is not a lethal mutation but 
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besides heightened anxiety these mice have severe cognitive impairments, 
memory deficiencies and lowered vertical activity. Knock-in GSK-3β 
models that produce mice with increased expression of beta isoform with 
replacement of Serine 9 to Alanine and thus resistant to inhibitory 
phosphorylation, provoke hyperactive behavioral phenotype that mimic 
traits of bipolar disorder (Prickaerts et al., 2006).  
Emotional stress-induced activation of GSK-3 in wild type animals is 
underpinned by decreased pro-inhibitory serine phosphorylations that takes 
place in conjunction with increased corticosterone (CORT) release 
(Dobarro et al., 2013). This activation is closely linked to upstream pro-
inflammatory changes (Fig. 5), as antagonists of TLR4 receptors prevent 
GSK-3 upregulation following stress exposure (Cheng et al., 2016).  
Activated GSK-3 is a potent suppressor of neuroplasticity and neurogenesis 
that can lead to deleterious effects on brain tissue (Beurel et al., 2015). 
Interestingly, GSK-3 underpins regulation of neuroplasticity and 
neurogenic processes during the embryonic stages of development, 
including cell migration and neuronal maturation (Sayas et al., 2012). While 
it was traditionally assumed that only the beta isoform was important for 
neural developmental processes, genetic methods of interference of 
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regulatory RNAs display key role of alpha isoform as well (Gartido et al., 
2006). 
Regulation of GSK-3 activity consists of both regulation of expression and 
regulation of activity of these kinases. Functional antagonism of protein 
kinase B (Akt) and GSK-3 (Fig. 4) makes these two kinases to be 
convenient markers of depressive syndrome (Karege et al., 2011). In various 
paradigms of despair behavior elevated content of active GSK-3β isoforms 
is paralleled with decreased content of functionally inactive, 
phosphorylated, GSK-3 isoforms (Polter et al., 2010); pharmacological 
agents with antidepressant properties such as imipramine of fluoxetine also 
increase content of inactive forms of GSK-3. 
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Figure 4. Schematic representation of top-to-bottom stress-induced 
molecular alterations related to GSK-3 cascade. 
Severe stress disrupts brain neuroplasticity and especially neuroplasticity of 
limbic structures that is often associated with changes in glutamatergic 
neurons (Calabrese et al., 2012) that largely affects synaptic plasticity, an 
important component of learning processes and memory retention. GSK-3 
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was shown to affect these processes leading to reduction of formation of 
new synapses and subsequently to long-term depression. GSK-3β 
antagonists prevent these stress-induced effects and increase NMDA-
dependent neurotransmission (Peineau et al., 2007).  
7. The role of vitamin B1 (thiamine) in the mechanisms of 
neuropsychiatric disorders 
Vitamin B1 (thiamine) is a crucial vitamin to maintain normal animal 
physiology (Liu et al., 2017). Lack of thiamine can provoke profound 
metabolic disturbances, apoptotic changes, neurodegeneration and 
diminished neuroplasticity and neurogenesis (Liu et al., 2017).  These data 
make thiamine supplementation an important approach to counteract these 
changes. Recently it was shown that thiamine pre-treatment prior to 
predation stress prevented stress-evoked suppression of hippocampal 
neurogenesis, manifesting in reduced densities of BrdU-positive and Ki67-
positive cells (Vignisse et al., 2017). Importantly, thiamine supplementation 
rescued stress-induced upregulation of protein carbonyl content, a marker 
of irreversible protein damage by oxidative stress (Vignisse et al., 2017). 
Thiamine deficiency affects brain functioning in many ways and impaired 
oxidative glucose metabolism is thought to underlie many of these changes 
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(Gibson, 2007).  Some studies have shown that thiamine is implicated in 
depression and affective disorders through modulation of GSK-3 activity as 
thiamine-based supplementations can exert anti-depressant-like effects and 
counteract stress-induced GSK-3 overexpression (Markova et al., 2016; 
Vignisse et al., 2017). 
It is known that thiamine can display neuroprotective roles by affecting the 
activity of several regulatory proteins, such as cofactors of synthesis of 
adenosine triphosphoric acid (ATP) (thiamine phosphate and pyridoxal 
phosphate; Bettendorff et al., 2014). Additionally, thiamine is involved in 
regulation of mitochondrial metabolism thus affecting production of ROS 
(Abdou et al., 2015). Deficiency in thiamine content can provoke 
development of Gaie - Wernicke encephalopathy, polyneuropathy and other 
serious conditions, e.g. neurodegenerations, that affect normal functioning 
of the central nervous system and limbic structures (Abdou et al., 2015). 
Thiamine deficiency can be provoked by disbalanced diet or perturbations 
in the digestive tract, such as malabsorption syndrome; all these conditions 
are comorbid with major depression as suggested by clinical data (Torshin, 
2009). Vitamin B1 deficiency was shown to aggravate the effect of ethanol 
toxicity on the nervous system, thus provoking alcoholic polyneuropathy 
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with 10% prevalence rate among 40 to 70 y.o. cohort of people with 
alcoholism (Torshin, 2009).   
Neuroprotective mechanisms of thiamine are of particular significance as 
long-lasting daily thiamine supplementation compared to standard selective 
serotonin reuptake inhibitors treatment exerted better Hamilton Depression 
Rating Scores in a clinical study (Ghaleiha et al., 2016). Interestingly, 
vitamin B1 has not only neuroprotective effects but also analgesic activity 
(Onk et al., 2018). Employment of thiamine as a supplement treatment to 
counteract these disabling conditions is advantageous for several reasons: 
thiamine is a nontoxic and has no side effects, can moderate pain and 
increase hippocampal neurogenesis thus also affecting cognitive skills 
(Vignisse et al., 2017; Onk et al., 2018). Nowadays there are treatment 
strategies that include combined application of thiamine and prominent 
antidepressants, glucocorticosteroids and other drugs that substantially 
increase effectiveness of the employed treatments (Johnson et al., 2018).  
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HYPOTHESIS AND AIMS 
 
We hypothesized that depressive syndromes of various aetiologies might 
have overlapping molecular mechanisms. Upregulation of GSK-3, 
functionally related pro-inflammatory mechanisms and oxidative stress 
likely underlie these disorders.  To study these conditions, we used two 
mouse models of depressive syndrome of distinct aetiologies: an ultrasound 
model of “emotional stress” and modified forced swim test that models 
enhanced learning of adverse memories.  
In the ultrasound stress study part mice were chronically exposed to 
randomly alternated ultrasound frequencies that mimicked signals of 
distress that are naturally emitted by rodents. We studied depressive-like 
behavioral changes as well as hippocampal gene and protein expression of 
both GSK-3β and GSK-3α and associated molecules FOXO3a, PTEN and 
AktpSer473. We also aimed to study the relationships between expression 
of neuroplasticity factors and expression of pro-inflammatory cytokines, 
microglial activation and parameters of oxidative stress in animals with 
depressive syndrome.  
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In the modified forced swim test we aimed to investigate whether or not 
overexpression of GSK-3 isoforms have distinct profiles. Correlation 
analysis between pro-inflammatory cytokine expression and GSK-3 
isoforms was performed. Concentration of stress hormone corticosterone, 
brain content of oxidative stress markers and c-Fos activation was assessed 
as well. Furthermore, we investigated whether these changes can be 
prevented by thiamine and imipramine supplementations.  
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Abstract  
Glycogen synthase kinase 3 (GSK3) has been linked to the mechanisms of 
stress, mood regulation, and the effects of antidepressants. The functions of 
the GSK3β isoform have been extensively investigated, but little is known 
about the α-isoform, although they may functionally related. In a recently 
established modified swim test with a third delayed swim exposure, brain 
GSK3β mRNA expression positively correlated with floating behavior on 
the third test. A two-week-long pretreatment regime with imipramine (7.5 
mg/kg/day) or thiamine (200 mg/kg/day), which is known to have 
antidepressant properties, reduced the GSK3β over-expression and 
decreased floating behavior on day 5. GSK3α mRNA levels were measured 
in the hippocampus and prefrontal cortex on Days 1, 2 and 5. GSK3α 
expression was decreased in the prefrontal cortex on day 2 and increased on 
day 5. In this model, GSK3α mRNA changes were prevented by imipramine 
or thiamine treatment. There was a significant correlation between the 
expression of the two isoforms in the prefrontal cortex on day 2 in untreated 
group. These results provide the first evidence for the potential involvement 
of GSK3α in depressive-like behaviours and as a target of anti-depressant 
therapy. Furthermore, the correlations suggest some cross-talk may exist 
between the two GSK3 isoforms.  
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Key words: GSK3α, depression, prefrontal cortex, imipramine, thiamine, 
mice. 
Glycogen synthase kinase-3 (GSK3) is a multifunctional serine/threonine 
kinase with numerous regulatory roles, whose functions have been well 
studied for its beta isoform (GSK3β) [1,2], but not for its alpha isoform 
(GSK3α). Recent data suggest that both GSK3 isoforms are independently 
implicated in the regulation of similar molecular and cellular functions, and 
that there is also cross-talk between them, thereby regulating their activities 
[3,4]. Given that GSK3β is well documented to play critical roles in cell 
development, apoptosis, and the mechanisms of distress and depression [1-
4], similar functions have been suggested for GSK3α.  
While the functions of GSK3α and GSKβ in a cell may overlap, GSK3α 
determines a number of processes that are specific for this kinase and may 
be not substituted by its beta isoform [5]. In particular, there are difference 
in the contribution of the two isoforms in the formation, elongation and 
branching of hippocampal neuronal axons during different periods of 
neuronal growth [6]. Knock out of GSK3α was shown to result in 
impaired cognition and reduced LTP in mice, suggesting that GSKβ cannot 
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compensate [7]. GSK3α, but not GSKβ, has been implicated in fast (short-
term) spine shape remodeling and plasticity in the hippocampal formation 
[8]. Clock protein phosphorylation was found to differ for the two GSK3 
isoforms [9]. Moreover, pharmacological manipulation of GSK3α function 
alters the rate of apoptosis and has greater therapeutic effects than the 
GSK3β-targeting treatments [10]. Biochemical evidence has shown that 
GSK3α is generally involved in fast and relatively short-lasting cellular 
events, whereas GSKβ activities tend to be associated with delayed and 
longer-lasting changes [2]. 
While several studies have addressed a potential involvement of GSK3α in 
stress response and depression, no direct evidence for such role for GSK3α 
has been reported to date. Based on above-mentioned functional links 
between two isoforms of GSK3, we hypothesized that changes in brain 
GSK3α might be brought on by a depressive-like state associated with 
altered GSKβ activities. Therefore, we studied GSK3α expression in a 
modified swim test with repeated testing, in which the over-expression of 
brain GSK3β plays a critical role [16,17]. In this new modification of the 
classic two-day protocol of Porsolt test, an additional swimming session is 
performed on day 5 following the initial exposure, at a time when there is 
increased floating behaviour and GSK3β expression for both mRNA and 
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protein in the prefrontal cortex and hippocampus. These increases are not 
observed during the classic Porsolt test. Moreover, over-expression of 
GSK3βmRNA in prefrontal cortex during the delayed testing session was 
previously shown to correlate with other parameters of behaviour despair in 
this model that are not observed in other swim test protocols [16].  
In this study, the expression of both isoforms of GSK3 was studied in the 
hippocampus and prefrontal cortex in pharmacologically naïve mice. 
Furthermore, after the administration of two antidepressant treatments from 
different classes, imipramine and thiamine (vitamin B1), which were shown 
to normalize GSK3β expression in this and other paradigms [17,18],  was 
applied. 
 3-month-old male C57BL6 mice were obtained from Stolbovaja-RAS, 
Moscow region (http://www.spf-animals.ru/about/providers/animals) and 
housed individually under standard conditions (light on 9.00; see 
Supplementary Data). Experimental protocols conformed to directive 
2010/63/EU, and were approved by the local veterinarian committee. Using 
a modified swim test in mice [16,17] (see below), we studied their floating 
behaviour on Day 1, Day 2 and Day 5. The levels of GSK3αmRNA and 
GSK3βmRNA in the hippocampus and prefrontal cortex were investigated 
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on each day of the test in pharmacologically naïve mice (Study 1, Fig.1A), 
and on Day 5 in mice that were non-treated or pre-treated with imipramine 
(7.5 mg/kg/day) or thiamine, (200 mg/kg/day) for two weeks, via drinking 
water (Study 2, Fig.1B, see Supplementary Data). In Study 2, half of the 
samples was used for GSK3βmRNA gene expression analysis and results 
were reported elsewhere [17]. Both treatments were applied as described 
elsewhere [17,18] and were previously shown to preclude stress-related 
changes in this model. Control naïve for swimming mice were sacrificed 
simultaneously with the experimental animals, which were killed 10 min 
after swimming; group sized are indicated in Figure legends.  
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Figure 1. Schematic timeline of the modified swim test and culling. (A) 
In Study 1, pharmacologically naïve mice were tested for their floating 
behaviour and culled on Day 1, Day 2 or Day 5. (B) In Study 2, non-treated 
or pre-treated with imipramine or thiamine mice were studied for their 
floating behavior and culled on Day 5.  
 
 Mice were subjected to two 6-min swimming sessions, with intervals of 24 
h on Days 1 and 2 and 48h thereafter (Day 5 following the initial test), as 
described elsewhere [16,17] (see Supplementary Data). The duration of 
floating behaviour was defined by the absence of any directed movements 
of the animals’ bodies and was scored using previously validated the 
criteria, as described elsewhere [16-19]. 
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Mice were sacrificed by cervical dislocation. The prefrontal cortex and 
hippocampi were then isolated and stored at -80oC. Extraction of mRNA, 
cDNA synthesis and quantitative RT-PCR (qRT-PCR) of GSK3α and 
GSK3β gene expression were performed; the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was selected as the 
reference gene based on previous studies [16]. Data were normalized to 
GAPDHmRNA and calculated as relative-fold changes compared to the 
control mice, as well as in percent from mean control values (see 
Supplementary Data and Table 1).  
Data were analyzed with GraphPad Prism v.5.0 (San Diego, CA, USA). 
Wilcoxon, Mann-Whitney and Kruskall-Wallis tests were used to perform 
repeated measures, two- and multiple-group comparisons, respectively. 
Spearman correlation was used for correlation analysis. The level of 
confidence was set at 95% (p<0.05), all data are mean±SEM. Statistical 
values of group comparisons are in Supplementary Tables 2-5. 
In Study 1, mice floated for a significantly longer duration from Day 1 to 
Day 2 (p=0.0001, Wilcoxon test), and from Day 2 to Day 5 (p=0.0002, 
Fig.2A). On Day 1, brain GSK3αmRNA and GSK3βmRNA were unaltered 
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(p>0.05 vs.control, Mann-Whitney test; Fig.2B-C, Table 1, Supplementary 
Table 2).  
Table 1 
Normalized brain GSK3β mRNA levels in the modified swim experiments 
on untreated and pharmacologically treated mice.  
 
Data for groups from Study 1 and Study 2 are expressed in percent from 
means of control groups and presented as Mean ± SEM. Significant 
differences vs. control group are indicated in bold, arrows indicates a 
direction of changes vs. control group. FST-imi: imipramine-treated mice 
subjected to forced swim test; FST-Thi: thiamine-treated mice subjected to 
forced swim test. 
 
 
 
On Day 2, hippocampal GSK3αmRNA levels were unchanged (p>0.05, 
vs.control). There was a significant decrease of this measure in the 
prefrontal cortex (p<0.05, vs.control), whereas GSK3βmRNA brain 
concentrations were unchanged (p>0.05 vs.control, Fig.2D-E, 
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Supplementary Table 2). Significant positive correlation between GSK3α 
mRNA and GSK3βmRNA was found in the prefrontal cortex of non-treated 
mice on Day 2 (p=0.0016, r=0.8754, Spearman correlation, Fig.2E). On 
Day 5, there were no changes in hippocampal levels of GSK3αmRNA 
(p>0.05 vs.control) and a significant increase of its expression in the 
prefrontal cortex (p<0.05 vs.control); GSK3βmRNA levels were 
significantly increased in both brain areas (p<0.05 vs.control, Fig.2E-F, 
Supplementary Table 2). No significant correlations between 
GSK3αmRNA and floating behavior were revealed (p>0.05, Spearman 
correlation). 
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Figure 2. Brain GSK3αmRNA levels and duration of floating behaviour 
in pharmacologically naïve mice subjected to the modified swim test. 
(A) Duration of floating on Day 1, Day 2, and Day 5 (*p<0.05, Day 1 vs. 
Day 2; #p<0.05, Day 2 vs. Day 5; n=14). The levels of GSK3αmRNA in 
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the hippocampus (n=9-13) and prefrontal cortex (n=6-9) and correlations 
with GSK3βmRNA levels after swimming sessions on Day 1 (B,C), Day 2 
(D,E) and Day 5 (F,G) (§p<0.05, vs. control, n=). Line: p<0.05, Spearman 
correlation for linear trend. FST: modified forced swim test. Data in the 
bars are mean±SEM normalized to control.  
 
In Study 2, there was a significant group difference in floating behaviour 
(Kruskal-Wallis statistic 29.16, p<0.001); non-treated mice floated 
significantly longer from Day 2 to Day 5 (p=0.005). This increase was not 
found in the imipramine-treated mice (p=0.252), nor in the thiamine-treated 
group (p=0.18, Fig.3A). On Day 5, there was significant group difference 
in hippocampal GSK3αmRNA levels (p<0.5, Kruskal-Wallis). This 
parameter was unchanged in non-treated and imipramine-treated groups 
were unchanged (p>0.05, vs.control, Mann-Whitney test), thiamine-treated 
mice displayed a significant increase in this measure (p<0.05, vs.control, 
Fig.3B, Table 1 and Supplementary Table 4). Hippocampal GSK3β mRNA 
levels were significantly different between the groups (p<0.05, Kruskal-
Wallis) and increased in non-treated mice (p<0.05, vs. control). In 
comparison to the latter group and to naïve mice, GSK3βmRNA 
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concentrations were significantly decreased in imipramine- and thiamine-
treated animals (p<0.05). 
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Figure 3. Brain GSK3αmRNA levels and duration of floating behaviour 
in mice subjected to the antidepressant treatment and modified swim 
test. (A) Duration of floating on day 2 and day 5 in non-treated, imipramine-
treated or thiamine-treated mice (#p<0.05, vs. day 2,). The levels of 
GSK3αmRNA in the hippocampus (B) and prefrontal cortex (C) and 
correlations with GSK3βmRNA after swimming sessions on day 5 in mice 
pre-treated with imipramine or thiamine (§p<0.05, vs.control, &p<0.05, 
vs.non-treated mice n=13-18). Line: p<0.05, Spearman correlation for 
linear trend. FST: modified forced swim test. Data in the bars are 
mean±SEM normalized to control.  
 
In the prefrontal cortex, the levels of both GSK3αmRNA and 
GSK3βmRNA were significantly between the groups (Kruskall Wallis 
statistic 10.31 and 17.48, p=0.0161 and p=0.0006, respectively). Both 
parameters were elevated in non-treated animals and unaltered in 
imipramine-and thiamine-treated mice in comparison to controls, (p<0.05, 
vs.control, Mann-Whitney tests, Fig.3C, Table 1, Supplementary Table 3). 
In comparison to non-treated mice, dosed animals showed significantly 
reduced expression of both isoforms of GSK3 in this brain area (p<0.05). 
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No significant correlations between GSK3αmRNA and floating behavior 
were revealed across this study (p>0.05, Spearman correlation). A positive 
correlation between GSK3αmRNA level and GSK3βmRNA were found in 
the prefrontal cortex of imipramine–treated mice on Day 5 (p=0.0498, r=-
0.5143, Fig.3D). 
To summarize, we found significant changes in GSK3αmRNA expression 
in the prefrontal cortex and hippocampus in mice subjected to the modified 
swim test, and also during antidepressant treatments with imipramine or 
thiamine. These findings provide the first evidence for the involvement of 
GSK3α in depressive-like phenotype and the effects of antidepressant 
treatments in an animal model of depression. Our results reveal certain 
similarities in the direction of expression change of GSK3α and GSK3β and 
a role of the prefrontal cortex in their neuroanatomic localization during 
depressive-like state in the modified swim test. Furthermore, the present 
data demonstrate a dynamic expression profile for the two molecules 
throughout the repeated swim tests.   
Analysis of the behavioural changes and effects of pre-treatment with 
imipramine or thiamine revealed similar results to those previously reported 
[16,17]. Behavioural effects of the treatments were in accordance with 
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previously demonstrated anti-stress effects of employed here dosing with 
imipramine and thiamine in a rat exposure stress. These ameliorative effects 
concern stress-related anxiety-like behaviours [16], hippocampal 
neurogenesis and elevated serum corticosterone levels [18].  
No change in the GSK3αmRNA was found after the first exposure to 
swimming, when GSK3β expression on gene and protein levels was 
unaltered too [16]. Notably, the concentration of GSK3αmRNA in the 
prefrontal cortex was reduced when GSK3β expression was unchanged at 
the gene level and GSK3β activities were increased at the protein level (day 
2) [16]. These data suggest differences in the dynamics of the expression 
changes in response to external challenges for GSK3α and GSK3β that 
could be accounted, as for instance, for unique interactions with several 
major regulators of cellular functions, such as Akt, protein kinase C, protein 
phosphatase-1 (PP1), IL-1, mTOR and other regulatory factors [2,4,21,22]. 
As mentioned above, besides differences in the signaling mechanisms, there 
is also evidence of distinct functional effects exerted by GSK3α and 
GSK3β. The regulation of hippocampal plasticity [7,8] is likely to be 
contributor to the requirement for dynamic expression of the GSK3 
isoforms. Of note, the present study revealed that GSK3α brain expression 
changes do not occur after a single swim, but after repeated swimming, 
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accompanied by altered GSK3β protein/gene activities, even though 
biochemical studies suggest faster reaction of GSK3α mechanism in 
response to various challenges [2]. In a similar manner to the results 
presented here, no changes in brain GSK3β was found after a single 
swimming session in a previous study [16]. Together, current results 
indirectly suggest a link between functional activation of both isoforms of 
GSK3. 
In this study we found that GSK3α was over-expressed in the prefrontal 
cortex of untreated, swim exposed mice on the last day of testing that 
paralleled the increase in GSK3βmRNA levels. The latter measure was 
previously reported to correlate with floating behavior at this stage of 
repeated testing in the paradigm employed here [16]. No over-expression of 
GSK3α was found in the prefrontal cortex of imipramine- or thiamine-
treated groups. Similar findings were obtained with GSK3β expression in 
imipramine- and thiamine-treated animals in current and previous studies 
[16,17]. Remarkably, there were no significant changes in hippocampal 
GSK3αmRNA in our experiments, with the exception of the effects of 
administration of thiamine, whose stimulating effects of this measure can 
be associated with its memory-enhancing properties [17,23,24]. Of note, a 
particular link between molecular changes with the development of a 
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depressive-like behavior in the modified swim test was previously shown 
for the prefrontal cortex and not the hippocampus [16,17].  
Our data showed similar suppressive effects of two antidepressant 
treatments, imipramine and thiamine, on GSK3α and GSK3β expression. 
This observation supports the view that GSK3α as plays an analogues role 
to that of GSK3β during depression and may be considered as an additional 
target in the pharmacotherapy of depression. Together, the present results 
demonstrate that GSK3α can be an important factor in depression and a 
mediator of antidepressant therapy, where GSK3α possibly indirectly 
regulates GSK-3β activities. Further identification of mechanisms and 
functions associated with GSK3α and GSK3β that are differentially 
regulated during depression may lead the way towards the development of 
therapeutic interventions that can predominantly affect one isoform more 
than the other that hopefully could improve pharmacological management 
of depressed patients. A modified swim test with an additional testing 
session might be a suitable model for further investigation into these 
functions of GSK3α and potential drug development.  
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SUPPLEMENTARY DATA  
 
Animals and housing conditions 
 
Experiments were performed on male C57BL6 mice that were 12 weeks 
old. All animals were provided by Stolbovaja, RAS, Moscow region, a 
provider licensed by Charles River (http://www.spf-
animals.ru/about/providers/animals). Mice were housed individually in 
standard plastic  cages (27x22x15 cm for mice) and maintained on a 12-
hour light/dark cycle, under controllable laboratory conditions (22±1°C, 
55% humidity, room temperature 22ºC), food and water were available ad 
libitum. Housing conditions and all experimental procedures were set up 
and maintained in accordance with a Directive 2010/63/EU of 22 September 
2010 and carried out under approval of the local veterinarian committee. All 
efforts were undertaken to minimize the potential discomfort of 
experimental animals.  
 
Modified swim tests with additional delayed testing  
Mice were subjected to one or two swimming sessions with an interval of 
24 h, or, to three session, where after the first two tests the third test was 
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carried out on Day 5 following the initial test on Day 1 as described 
elsewhere (Strekalova et al., 2016; Markova et al., 2016). All sessions were 
6-min long and were performed by placing a mouse in a transparent cylinder 
(Ø 17 cm) filled with water (+23 °C, water height 13 cm, height of cylinder 
20 cm). The duration of floating behavior that was defined by the absence 
of any directed movements of the animals’ head and body, was scored 
manually using criteria, which were previously validated by automated 
scoring with Noldus EthoVision XT 8.5 (Noldus Information Technology, 
Wageningen, The Netherlands) and CleverSys (CleverSys, Reston, VA, 
USA) as described elsewhere (Malatynska et al., 2012; Strekalova et al., 
2015). Time spent with floating was evaluated for the entire duration of the 
test. In all assays mice were sacrificed ten minutes after swimming. 
Imipramine- and thiamine-treated mice were tested in all three session and 
sacrificed after the last session, alone with respective non-treated control 
mice. With all tests, naïve control groups that were not exposed to a 
swimming were sacrificed simultaneously with experimental groups of 
mice. 
Drug delivery 
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Experimental solutions replaced normal drinking water. Thiamine and 
imipramine were obtained from Sigma-Aldrich, St. Louis, MO, USA. All 
agents were dissolved in tap water and were changed every 4-5 days 
(Strekalova et al., 2016, Vignnisse et al., 2017). Drinking behaviour of mice 
was monitored by evaluating a 24-h liquid intake during the first three days 
of dosing. The dose of imipramine dose (7.5 mg/kg/day), was based on 
previous results showing that this dose had no effect on general locomotor 
behaviour (Strekalova et al., 2015; Costa-Nunes et al., 2015). 
Brain dissection, RNA extraction and qRT-PCR 
Mice were sacrificed by cervical dislocation a 10 min after the last 
swimming, brains were  dissected and the prefrontal cortex and hippocampi 
were isolated as previously reported (Couch et al., 2013; Markova et al., 
2016) and stored at -80oC until use. mRNA was extracted by using TRI 
Reagent (MRC, Cincinnati, OH, USA). First-strand cDNA synthesis was 
performed using random primers and Superscript III transcriptase 
(Invitrogen, Darmstadt, Germany); 1 μg total RNA was converted into 
cDNA. Quantitative RT-PCR (qRT-PCR) of the GSK-3beta gene and the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
was performed using the SYBR Green master mix (Bio-Rad Laboratories, 
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Philadelphia, PA, USA) and the CFX96 Real-time System (Bio-Rad 
Laboratories, Philadelphia, PA, USA). A reference gene was selected in 
previous experiments that demonstrated relatively low variability in 
GAPDH expression in the limbic structures under employed (Strekalova et 
al., 2016; Markova et al., 2016). Data were normalized to GAPDH mRNA 
expression and calculated as relative-fold changes compared to control mice 
that were not exposed to swimming, as described elsewhere (Strekalova et 
al., 2016; Markova et al., 2016); data were additionally calculated as percent 
from the mean of control groups. Further details, sequences of primers used 
are listed below (Supplementary Table 1). Data are given as expression-
folds compared to the mean expression values in non-stressed control mice 
and in percent expressed from the means of control groups that were not 
exposed to swimming. 
Table 1. Sequences of primers used  
 
 
RNA isolation and RT PCR 
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The qRT-PCR was performed in a 25 μl reaction volume containing a 
10хPCR Buffer (2.5l), 25 mmol MgCl2 (4 l), 10 mmol dNTPs (2l), 
specific forward and reverse primers at 20 pmol/l concentration (1 l), 
cDNA (2l), 5 u/l Taq DNA polymerase (1 l) (Beagle, st. Petersburg, 
Russia), and ddH2O (10 l). All samples were run in duplicate. Cycling was 
performed at 95 C° for 5 min followed by a 45-cycle amplification at 95°C 
for 10s, then at the annealing temperature defined previously for 15 s and at 
the temperature 72°C for 20 s.  
Results of the qPCR measurements were expressed as Ct values, where Ct 
is defined as the threshold cycle of PCR at which amplified product was 
0.05 % of normalized maximal signal. We used the comparative Ct method 
and computed the difference between the expression of the gene of interest 
and GAPDH expression in each cDNA sample (2−ΔΔ Ct method). Results 
are expressed as folds of expression compared to the mean values of 
expression in non-stressed control animals (Couch et al., adapted from 
Livak and Schmittgen, 2001). 
Statistical values of data comparison  
Table 2. Summary of comparisons between naïve control mice and mice 
that underwent swim testing on Days 1, Day 2 and Day 5, in the duration 
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of floating (Wilcoxon test for repeated group comparisons) and levels of 
GSK3αmRNA and GSK3βmRNA (Mann-Whitney test, for two-group 
comparison); significant differences are in bold. The values of GSK3α 
mRNA expression in the hippocampus were not significantly different 
between the groups (Kruskal-Wallis statistic 7.920, p=0.1607), but in the 
prefrontal cortex (Kruskal-Wallis statistic=15.06, p=0.0101). There was a 
significant group difference in the expression of GSK3β mRNA in the 
hippocampus (Kruskal-Wallis statistic 17.034, p=0.0036) and in the 
prefronal cortex (Kruskal-Wallis statistic 11.284, p=0.0462). 
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Table 3. Summary of comparisons between mice that underwent swim 
testing and were not treated with drugs (FST), or received imipramine 
(FST imipramine) or thiamine (FST thiamine), on Day 5, in duration 
of floating. Wilcoxon tests was used for repeated measures and Kruskall-
Wallis followed by Mann-Whitney tests were used for group comparisons 
(significant differences are in bold). There was no significant difference 
between the groups in floating behavior on Day 1 (Kruskal-Wallis statistic 
0.2771, p = 0.8706), Day 2 (Kruskal-Wallis statistic 0.09189, p=0.9551), 
but Day 5 (Kruskal-Wallis statistic 9.754, p=0.0076). 
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Table 4. Summary of comparisons between naïve control mice (Con), 
and mice that underwent swim testing and were not treated (FST), or 
received imipramine (FST imipramine) or thiamine (FST thiamine), on 
Day 5, in the GSK3αmRNA and GSK3βmRNA (Kruskall-Wallis and 
Mann-Whitney tests; significant differences are in bold). There was 
significant group difference in hippocampal GSK3αmRNA levels (Kruskal-
Wallis statistic 22.24, p<0.0001) and GSK3β mRNA levels (Kruskal-Wallis 
statistic 26.93, p<0.0001), as well as in the levels of both GSK3αmRNA 
and GSK3βmRNA in the prefrontal cortex (Kruskall Wallis statistic 10.31 
and 17.48, p=0.0161 and p=0.0006, respectively). 
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Chapter 3 
 
Enhanced conditioning of adverse memories in the mouse modified 
swim test is associated with neuroinflammatory changes: effects of 
treatments with antidepressant properties 
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Abstract  
Deficient learning and memory are well-established pathophysiologic 
features of depression, however, mechanisms of the enhanced learning of 
aversive experiences associated with this disorder are poorly understood. 
Currently, neurobiological mechanisms of enhanced retention of aversive 
memories during depression, and, in particular, their relation to 
neuroinflammation are unclear. As the association between major 
depressive disorder and inflammation has been recognized for some time, 
we aimed to address whether neuroinflammatory changes are involved in 
enhanced learning of adversities during depressive state. To study this 
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question, we used a recently proposed mouse model of enhanced contextual 
conditioning of aversive memories, the modified forced swim model 
(modFST). In this model, the classic two-day forced swim is followed by 
an additional delayed session on Day 5, where increased floating behaviour 
and upregulated glycogen synthase kinase-3 (GSK-3) are context-
dependent. Here, increased time spent floating on Day 5, a parameter of 
enhanced learning of the adverse context, was accompanied by 
hypercorticosteronemia, increased gene expression of GSK-3α, GSK-3β, c-
Fos, cyclooxygenase-1 (COX-1) and pro-inflammatory cytokines 
interleukin-1 beta (IL-1β), tumor necrosis factor (TNF), and elevated 
concentrations of protein carbonyl, a marker of oxidative stress in the 
prefrontal cortex and hippocampus. There were significant correlations 
between cytokine levels and GSK-3β gene expression. Two-week 
administration of drugs with antidepressant properties, imipramine 
(7.5mg/kg/day) or thiamine (vitamin B1; 200mg/kg/day) counteracted most 
of our reported alterations. Thus, enhanced learning of adverse memories is 
associated with pro-inflammatory changes that should be considered for 
optimizing pharmacotherapy of depression associated with enhanced 
learning of aversive memories.   
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Key words: major depression, enhanced learning of adverse memories, 
cytokines, glycogen synthase kinase-3 (GSK-3), oxidative stress, mice.  
 
Abbreviations:  GSK-3 glycogen synthase kinase; TNF - tumor necrosis 
factor, IL – interleukin,  
 modFST - modified forced swim test, ROS - reactive oxygen species, NF-
κB  - nuclear factor-κB,  COX-1 - cyclooxigenase-1, GAPDH - 
glyceraldehyde 3-phosphate dehydrogenase,  PTSD - post-traumatic stress 
disorder, HPA – hypothalamic-pituitary-adrenal axis, D - Day. 
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Introduction 
 
While impaired brain plasticity is a well-established pathophysiologic 
feature of depression, little is known about disorder-associated enhanced 
cognitive processing. Enhanced cognitive processing of adverse events is 
one of the most critical elements in the pathology of major depression that 
can contribute to the development of stress-related depressive symptoms 
(Clark et al., 2009; Gold and Korol, 2012; Gold et al., 2012; de Bitencourt 
et al., 2013). However, its neurobiological mechanisms are currently 
unclear. At the same time, the association between depressive disorders and 
inflammation has been recognized for some time (Dantzer, 2009; Leonard 
and Maes, 2012; Anthony and Patossi, 2014). However, it remains elusive 
to which aspects of this highly heterogeneous disorder inflammation may 
specifically contribute (Michopoulos et al., 2017; Harro, 2018).  
Enhanced acquisition and retention of aversive memories is characteristic 
of melancholic and anxiety-associated depression (Monzon et al., 2010) and 
depression comorbid with post-traumatic stress disorder (PTSD) (Flory and 
Yehyda, 2015). Positive correlations between blood levels of C-reactive 
protein, pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), 
interleukin-6 (IL-6), tumor necrosis factor (TNF), as well as 
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cyclooxygenase-1 (COX-1) and augmented learning of aversive memories 
has been demonstrated in patients with PTSD (Lindqvist  et al., 2017; Miller 
et al, 2018; Toft et al., 2019). This condition is well known to share many 
symptoms with depression and is highly comorbid with this disease, as well 
as with generalized anxiety disorder and panic disorder (Michopoulos et al., 
2016). Central overexpression of pro-inflammatory cytokines functionally 
interferes with increased activities of glycogen synthase kinase-3 (GSK-3) 
and is associated with treatment resistance in depressed patients with 
comorbidity for PTSD (Cortes-Vieyra et al., 2012; Bailey et al., 2013; 
Costemale-Lacoste et al., 2016). Up-regulation of GSK-3 was shown to be 
implicated in the processing of aversive memories during PTSD (Lopresto 
et al., 2016), and emotional and cognitive dysregulation during depressive 
syndrome (Jope and Roh et al., 2006). 
Up to now, very few mechanistic studies have explored the role of 
neuroinflammation in the enhanced processing of aversive memories. 
While translational approach was extensively used to study depression-
related pro-inflammatory changes in models of stress (Couch et al., 2013, 
2016; Patel et al., 2019), helplessness (Chover-Gonzalez et al., 2000) and 
other depression paradigms (Mesquita et al., 2008, Dudek et al., 2019), to 
date, limited literature described neuroinflammatory mechanisms 
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associated with inappropriate learning of aversive memories in animals. 
Recently, we established a mouse paradigm of enhanced contextual 
conditioning of adverse memories, in which the classic two-day swimming 
test is followed by an additional swimming testing on Day 5 (Strekalova et 
al., 2016; Markova et al., 2017; Pavlov et al., 2017).  
In this modified forced swim model (modFST), increased floating 
behaviour and GSK-3β activities during the delayed swimming session 
were found to be context-dependent and reversible by a pre-treatment with 
antidepressant compounds (Strekalova et al., 2016; Markova et al., 2017). 
In the modFST, the increase of floating behavior during delayed testing on 
Day 5 correlates with brain over-expression of GSK-3β and was validated 
as a parameter of enhanced learning of adverse context. Both changes were 
associated with an exposure of animals to a context alone and are reversible 
by a pre-treatment of a low dose of tricyclic antidepressant imipramine 
(Strekalova et al., 2016). While imipramine can ameliorate behavioural 
despair in the classic Porsolt test, lower doses are often unable to affect 
behavioural parameters. Here, in the modFST model, low doses of 
imipramine were found to prevent an increase in floating behavior and over-
expression of GSK-3β associated with swimming on Day 5 in the modFST 
(Strekalova et al., 2016; Markova et al., 2016). As forced swimming on day 
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5 was shown to provoke similar molecular changes with the experience of 
swimming itself, this suggests the presence of classical Pavlovian 
contextual conditioning in our model. 
We hypothesized that augmented contextual conditioning in the modFST is 
accompanied by central pro-inflammatory changes. Therefore, we sought to 
explore whether expression of interleukin-1 beta IL-1β, TNF and COX-1 is 
altered in the hippocampus and prefrontal cortex of mice exposed to the 
modFST. As elevated expression of pro-inflammatory cytokines is 
accompanied by an increased corticosterone secretion and activation of 
hypothalamic-pituitary-adrenal axis (HPA) axis (Uchoa et al., 2014), 
leading to oxidative stress in the CNS (Sato et al., 2010), we also studied 
blood corticosterone concentrations and c-Fos expression, where over-
expression is associated with increased production of GSK3 and cytokines 
(Kadry  et al., 2018), as well as oxidative stress marker, protein carbonyl 
content (Vignisse et al., 2017; Frijhoff et al., 2015). We administered a two-
week pre-treatment regime with a low dose of imipramine or thiamine 
(vitamin B1), an important metabolism regulator with antioxidant, anti-
stress and anti-inflammatory properties (Pan et al., 2010; Bettendorff et al., 
2014; Mkrtchyan et al., 2015; Gorlova et al., 2019), whose chronic 
administration to mice prevented increases in floating behaviour and GSK-
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3 functions in mice subjected to the modFST (Markova et al., 2017; Pavlov 
et al., 2017).  
Methods 
2.1 Animals  
3-month-old male C57BL6/J mice were obtained from Stolbovaja-RAS, 
Moscow region (http://www.spf-animals.ru/about/providers/animals) and 
housed individually under standard conditions (light on 9.00-21.00). 
Experimental protocols conformed to directive 2010/63/EU, and were 
approved by the local veterinarian committee (MSMU #11-18-2018; see 
Supplementary file).  
2.2 Experimental outline  
Animals were studied for their floating behaviour in 6-min sessions split by 
three 2-min intervals on Day 1, Day 2 and Day 5 and had tap water (FST 
group) or were pre-treated with imipramine or thiamine (Imi-FST and Thi-
FST groups) for two weeks, via drinking water; dosing of selected drug 
concentrations was controlled as described in Supplementary file (see also 
Pavlov et al., 2017). Floating behaviour was defined by the absence of any 
directed movements of mice and was scored using validated method with 
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CleverSys (Clever Sys Inc, Reston, VA, USA; Malatynska et al., 2012). 
Mice subjected modFST were killed 10 min after swimming on Day 5 at the 
same time as naïve controls that were not subjected to swimming but 
handled on the respective days of testing. Mice were terminally 
anaesthetized with an intraperitoneal injection of Nembutal (Bayer, 
Wiesbaden, Germany) and then were transcardially perfused with 10 ml of 
the ice-cold 0.9% NaCl. Their brains were dissected, and prefrontal cortex 
and the whole hippocampus were isolated as described elsewhere (Gorlova 
et al., 2019). Blood serum was collected as described elsewhere (Couch et 
al., 2016; Pavlov et al., 2019) and stored at −80 °C for subsequent in vitro 
assays; each group had 6-7 animals per experimental run (Fig.1A). Data 
from one run were used for all assays except the correlation analysis 
between floating behavior and gene expression, for which cDNA from three 
experimental runs were used, including previously obtained material 
(Pavlov et al., 2017). Both vehicle- and drug-treated mice exposed to the 
modFST were included in the correlation analysis. 
2.3 Biochemical assays 
CORT ELISA was performed using ab108821 kit (Abcam, Cambridge, 
UK) as previously described (Vignisse et al., 2017; Gorlova et al., 2019), 
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for details see Supplementary file. For protein carbonyl assay, OxiSelect™ 
Protein Carbonyl Fluorometric Assay kit (Cell Biolabs, Inc., San Diego, 
CA, USA) kit was used as described elsewhere (Vignisse et al., 2017; 
Gorlova et al., 2019, see Supplementary file). Extraction of mRNA, cDNA 
synthesis and quantitative RT-PCR were performed to study brain 
concentrations of GSK3α/β, IL-1β, TNF, COX-1 and c-Fos mRNA as 
described elsewhere (Couch et al., 2013; Markova et al., 2016; Pavlov et 
al., 2017, 2019; Gorlova et al., 2019). Mice were sacrificed 10 min after the 
last swimming, brains were dissected and the prefrontal cortex and 
hippocampi were isolated as previously reported (Couch et al., 2013; 
Markova et al., 2016) and stored at -80° C until use. Expression data were 
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), used 
as housekeeping gene. Sequences for primers are listed in the 
Supplementary Table 1. mRNA was extracted by using TRI Reagent (MRC, 
Cincinnati, OH, USA). First-strand cDNA synthesis was performed using 
random primers and Superscript III transcriptase (Invitrogen, Darmstadt, 
Germany); 1 μg total RNA was converted into cDNA. Quantitative RT-PCR 
(qRT-PCR) was performed using the SYBR Green master mix (Bio-Rad 
Laboratories, Philadelphia, PA, USA) and the CFX96 Real-time System 
(Bio-Rad Laboratories, Philadelphia, PA, USA). The qRT-PCR was 
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performed in a 25 μl reaction volume containing a 10хPCR Buffer (2.5l), 
25 mmol MgCl2 (4 l), 10 mmol dNTPs (2l), specific forward and reverse 
primers at 20 pmol/l concentration (1 l), cDNA (2l), 5 u/l Taq DNA 
polymerase (1 l) (Beagle, st. Petersburg, Russia), and ddH2O (10 l). All 
samples were run in duplicate. Cycling was performed at 95°C for 5 min 
followed by a 45-cycle amplification at 95°C for 10s, then at the annealing 
temperature defined previously for 15 s and at the temperature 72°C for 20 
s.  
Results are expressed as folds of expression compared to the mean values 
of expression in non-stressed control animals (Couch et al., adapted from 
Livak and Schmittgen, 2001). To calculate ΔCt for each sample, Ct of 
GAPDH was subtracted from respective Ct of gene of interest. Mean control 
ΔCt value was subsequently calculated and subtracted from every other ΔCt 
values to get ΔΔCt value for each particular sample. Afterwards these data 
were processed  (2^(-ΔΔCt)) and normalized to control group; data were 
additionally calculated as percent from the mean of control group 
(unpresented results) to facilitate discussion and literature search where 
applicable.   
2.4 Statistics 
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Data were analyzed with GraphPad Prism v.6.0 (San Diego, CA, USA). 
Repeated measures ANOVA and two-way ANOVA were used to treat 
behavioral and the corticosterone data, one-way ANOVA was applied to 
analyze results of PCR and ELISA assays. Tukey’s test was used for post 
hoc analysis. Spearman correlation was employed for correlation analysis. 
The level of confidence was set at 95% (p < 0.05), all data are mean and 
SEM. 
Results 
3.1 Overproduction of brain protein carbonyl and blood CORT 
accompany behavioral despair during delayed swim session: effects of 
imipramine and thiamine 
In the modified forced swim test, repeated two-way ANOVA with session 
and treatment as factors revealed significant effects of sessions (F2,48=14.57, 
p<0.0001) and treatment (F2,48=4.218, p=0.0114) on total duration of 
floating (Fig.1B). A significant effect of sessions, but not treatment, on 
duration of floating was found in minutes 1-2 (F2,48=10.66, p=0.0001 and 
F2,48=1.21, p=0.307, respectively). For minutes 3-4, a significant effect on 
duration of floating of both sessions (F2,48=7.27, p=0.0017) and treatment 
(F2,48=10.66, p=0.0001) was revealed. No significant effect of sessions and 
108 
 
treatment on duration of floating was revealed in minutes 5-6 (F2,48=0.38, 
p=0.68 and F2,48=2.64, p=0.08, respectively); there was no significant 
interaction between these factors (F2,48=0.36, p=0.83). In all groups, 
duration of floating was significantly elevated during the first two time 
intervals on Day 2 in comparison to Day 1, that was not shown for the last 
time interval of the test (p<0.05 and p>0.05, respectively; repeated 
measures ANOVA and Tukey’s test¸ Supplementary Table 2). On Day 5, 
total duration of floating and duration of floating for 1-2 min interval were 
significantly increased in comparison with values registered on Day 2 in the 
FST group (p<0.05; repeated measures ANOVA and Tukey’s test; Fig.1B, 
Supplementary Table 2), but not Imi- or Thi-FST groups (p>0.05). No 
significant group differences were found in each time interval of testing, 
except significantly shortened duration of total floating in Thi-FST group 
in comparison with FST mice (Supplementary Table 2). Together, analysis 
of floating behavior by 2-min intervals indicate that treatment could 
significantly affect the expression of floating behavior at the first two period 
of the test, but not during the last 2 min of the swimming session. This may 
be interpreted as possible sign of effects of drugs on cognitive factors in this 
test, rather than on despair behavior caused by prolonged unescapable 
swimming. The overall analysis showed significantly elevated total 
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duration of floating during delayed session on Day 5, a measure of enhanced 
contextual conditioning in this test was observed in pharmacologically 
naïve mice, but not in groups treated with thiamine or imipramine. 
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Figure 1. Experimental outline, potentiated behavioral despair and 
accompanying brain oxidation and systemic CORT upregulation 
during delayed swimming session.  
(A) After pre-treatment with imipramine or thiamine mice were subjected 
to 5-day modified swim paradigm and killed; their brains were dissected for 
in vitro assays, including quantitative reverse transcription polymerase 
chain reaction (qRT-PCR) and measurement of carbonyl protein content; 
blood was collected for measurement of corticosterone levels. (B) On 
testing Day 2 and 5, total floating behavior was increased in comparison to 
the one at Day 1. Total duration of floating on Day 5 was also significantly 
increased in comparison with Day 2. This parameter was decreased in Thi-
FST group in comparison with FST group on Day 5. (C) FST mice on Day 
5 displayed increased systemic CORT level in comparison with controls. 
Thiamine or imipramine counteracted this effect. (D) FST mice on Day 5 
displayed increased protein carbonyl content in the hippocampus and (E) in 
the prefrontal cortex in comparison with controls. Mice treated with 
thiamine, but not imipramine, did not differ from controls in protein 
carbonyl content in the hippocampus and displayed significant decrease of 
this measure in comparison with non-treated group. *p<0.05 vs. testing Day 
1, #p<0.05 vs. testing Day 2, &p<0.05 vs. testing Day 5 of FST group, 
repeated measures and two-way ANOVA, post hoc Tukey’s test. D1: Day 
1; D2: Day 2; D5: Day 5 of modified swim test paradigm. 
 
There were significant group differences in CORT levels in blood 
(F3,38=5.48, p=0.003, one-way ANOVA). Specifically, this measure was 
increased in FST mice in comparison with controls (p=0.04; Tukey’s test; 
Fig.1C). In contrast, CORT levels in Thi-FST and Imi-FST mice were not 
different from control values (p=0.56 and p=0.27, respectively) and were 
significantly decreased in comparison with FST group (p=0.006 and 
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p=0.01, respectively). We found significant group differences in protein 
carbonyl contents in the prefrontal cortex (F3,38=6.58, p=0.002, one-way 
ANOVA; Fig.1D) and hippocampus (F3,38=6.209, p=0.003, Fig.1E). There 
was a significant increase of this measure in the hippocampus and prefrontal 
cortex of FST group in comparison with controls (p=0.025 and p=0.03, 
respectively, Tukey’s test). No such changes were shown for Imi-FST and 
Thi-FST groups (p=0.44 and p=0.90, respectively), and the latter but not the 
former group displayed a significantly lower protein carbonyl concentration 
in the hippocampus than the FST group (p=0.406 and p=0.01; respectively). 
3.2 Brain over-expression of pro-inflammatory factors and c-Fos is 
associated with increased floating in the modified swim test and 
precluded by thiamine and imipramine   
We revealed significant group differences in mRNA expression of GSK-3β 
and GSK-3α in the hippocampus (F3,38=4.39, p=0.008 and F3,38=4.13, 
p=0.01, respectively) and of GSK-3β, but not GSK-3α, in the prefrontal 
cortex (F3,38=3.92, p=0.03 and F3,38=2.35, p=0.096, one-way ANOVA; data 
not shown). This replicated our former findings of an upregulation of gene 
expression of GSK-3 in the brain of mice exposed to the modFST. There 
were significant group differences in IL-1β mRNA expression in the 
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hippocampus (F3,38=3.73, p=0.01), but not in the prefrontal cortex 
(F3,38=0.42, p=0.73; Fig.2A,B). TNF mRNA expression was significantly 
different between the groups in the hippocampus (F3,38=3.64, p=0.01) and 
prefrontal cortex (F3,38=4.57, p=0.007). There was a significant increase in 
the FST group in comparison with control mice in this measure in 
hippocampus and in the prefrontal cortex (p=0.03 and p=0.01, respectively) 
that was not found in Imi-FST and Thi-FST groups (p=0.35 and p=0.17, 
respectively, and p=0.52 and p=0.09, respectively; Fig.2C,D). 
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Figure 2. Pro-inflammatory changes during delayed swimming session.  
Mice on Day 5 displayed increased (A) IL-1β mRNA expression, (C) TNF 
expression, (E) COX-1 expression and (G) c-Fos expression in the 
hippocampus in comparison with controls.  Mice treated with imipramine 
or thiamine did not differ from controls in these parameters and displayed 
significant decrease of these measures in comparison with FST group. 
Moreover, on Day 5, these mice displayed increased (D) TNF expression 
and (H) c-Fos expression in the prefrontal cortex in comparison with 
controls. Mice treated with imipramine or thiamine did not differ from 
controls in TNF expression and displayed significant decrease of this 
measure in comparison with non-treated group. At the same time, only Thi-
FST, but not Imi-FST, mice had significantly decreased c-Fos expression in 
the prefrontal cortex in comparison with FST group. There were no 
significant differences between groups in (A) IL-1β and (F) COX-1 mRNA 
levels in the prefrontal cortex. *p<0.05 vs. controls, #p<0.05 vs. non-treated 
mice on Day 5; one-way ANOVA and post hoc Tukey’s test.  
 
Significant group differences in mRNA expression of COX-1 was found in 
the hippocampus (F3,38=3.42, p=0.02), but not in the prefrontal cortex 
(F3,38=0.84, p=0.47). In the hippocampus, this parameter showed a 
significant increase in the FST group in comparison with control mice 
(p=0.04) that was not found in Imi-FST and Thi-FST groups (p=0.28 and 
p=0.14, respectively; Fig.2E, F). 
Finally, significant group differences in mRNA expression of c-Fos were 
shown both in the hippocampus (F3,38=5.68, p=0.002) and prefrontal cortex 
(F3,38=3.66, p=0.01); significant over-expression of this gene was found in 
FST groups (p=0.01 and p=0.03, respectively) but not in Imi- and Thi-FST 
116 
 
groups in comparison with controls (p=0.55 and p=0.97, respectively and 
p=0.63 and p=0.75, respectively; Fig.2G,H).  
3.3 Correlation analysis of expression of GSK-3 isoforms with 
behavioral and molecular alterations during delayed swimming 
session 
Significant correlations were found between GSK-3α expression and IL-1β 
expression in the hippocampus (p=0.04, r=0.37, Spearman correlation; 
Fig.3A) and TNF expression in the prefrontal cortex (p=0.01, r=0.46; 
Fig.3G). There were significant correlations between GSK-3β expression 
and expression of IL-1β in the hippocampus (p=0.007, r=0.49; Fig.3B) and 
in the prefrontal cortex (p=0.013, r=0.22; Fig.3D), expression of TNF in the 
hippocampus (p=0.02, r=0.43; Fig.3F) and c-Fos expression in the 
prefrontal cortex (p=0.01, r=0.45; Fig.3P). No significant correlations were 
found between GSK-3α expression and expression of IL-1β in the prefrontal 
cortex (p=0.26, r=-0.21; Fig.3C), expression of TNF in the hippocampus 
(p=0.48, r=-0.19; Fig.3E), c-Fos expression in the hippocampus (p=0.12, 
r=-0.29; Fig.3M) and prefrontal cortex (p=0.99, r=-0.002; Fig.3K) and 
expression of COX-1 in the hippocampus (p=0.079, r=0.11; Fig.3I) and 
prefrontal cortex (p=0.21, r=0.24; Fig.3O). Notably, mRNA expression of 
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IL-1β in the hippocampus positively correlated with total duration of 
floating (p=0.03 r=0.352; data not shown).  
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Figure 3. Correlation analysis between gene expression of GSK-3 
isoforms and stress-associated molecules.  
(A) Significant correlations were found between GSK-3α expression and 
IL-1β expression in the hippocampus and (G) TNF expression in the 
prefrontal cortex. (B) Significant correlations were also found between 
GSK-3β expression and IL-1β expression in the hippocampus and (D) in 
the prefrontal cortex, (F) TNF expression in the hippocampus and (P) c-Fos 
expression in the prefrontal cortex. (C) No significant correlations were 
found between GSK-3α gene expression and IL-1β expression in the 
prefrontal cortex, (E) TNF expression in the hippocampus, (M) c-Fos 
expression in the hippocampus and (O) prefrontal cortex, (I) COX-1 
expression in the hippocampus and (K) in the prefrontal cortex. (H) There 
were no significant correlations between GSK-3β expression and TNF 
expression in the prefrontal cortex, (N) c-Fos expression in the 
hippocampus, (J) COX-1 expression in the hippocampus and (L) in the 
prefrontal cortex. p<0.05, trend line indicates significant correlations; 
Spearman correlation.  
 
No other significant correlations were found, including correlations 
between expression of  GSK-3β and other molecules: TNF expression in 
the prefrontal cortex (p=0.33, r=0.19; Fig.3H), c-Fos expression in the 
hippocampus (p=0.06, r=0.35; Fig.3N) and expression of COX-1 in the 
hippocampus (p=0.68, r=0.079; Fig.3J) and prefrontal cortex (p=0.206, 
r=0.13; Fig.3L).  
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4. Discussion 
To summarize, we found an upregulation in the pro-inflammatory factors 
IL-1β, TNF and COX-1 mRNA expression in the hippocampus and 
prefrontal cortex of mice subjected to the modFST, which was prevented by 
antidepressant treatments with imipramine or thiamine. These findings 
provide the first evidence for the involvement of pro-inflammatory 
mechanisms in an animal model of enhanced learning of adverse memories 
and the effects of antidepressant treatments on these changes. Furthermore, 
we found significant correlations of most of pro-inflammatory changes with 
key molecular features of the employed paradigm, particularly the 
expression of GSK-3α and GSK-3β; the expression of IL1-β correlated with 
floating behavior. Pro-inflammatory changes were accompanied by signs of 
oxidative stress, i.e. increased concentration of protein carbonyl, in the 
prefrontal cortex and hippocampus. Markers of increased systemic stress 
response, brain over-expression of c-Fos and hypercorticosteronaemia were 
found in modFST groups as well. The majority of these neurobiological 
abnormalities were prevented by chronic pre-treatment with low dose of 
imipramine and administration of anti-oxidant thiamine. 
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We previously reported that in the modFST increased floating scores and 
brain GSK-3β activities during an additional delayed swimming session, 
which are positively correlated and context-dependent (Strekalova et al., 
2016; Pavlov et al., 2017). In accordance with earlier results, increased 
floating behaviour and brain GSK-3β over-expression was prevented by 
pre-treatment with imipramine or thiamine (Markova et al., 2016; Pavlov et 
al., 2017). Detailed behavioural analyses of delayed swimming session 
revealed a significant increase of floating behavior only during its initial 
period in comparison with preceding session in pharmacologically naïve 
mice. This suggests that exposure to aversive context of swimming, not 
unescapable swimming itself, was likely to be the cause of this increase. 
Such increase was not found in pharmacologically-treated groups 
supporting our previous results (Markova et al., 2017; Pavlov et al., 2017).  
Given established links between stress-induced release of glucocorticoids 
and elevated GSK-3 activities (Beurel et al., 2015), both of which were 
found in our study, and pro-inflammatory consequences of the latter (Huang 
et al., 2009; Chang et al., 2013), we suggest that over-expression of IL-6, 
TNF and COX-1 in modFST results from these changes. Elevated GSK-3 
activities were previously shown to inhibit expression of calcium-
responsive-element-binding protein (CREB) and anti-inflammatory 
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cytokine IL-10 (Huang et al., 2009) and promote expression of 
proinflammatory cytokines via activation of nuclear factor-κB (NF-κB) 
(Chang et al., 2013). In a contrary, the blockade of Toll-like receptor 4 
(TLR4), a major mediator of inflammatory processes (Buchanan et al., 
2010) during psychological stress in mice ameliorated GSK-3 activities and 
depressive-like symptoms (Cheng et al., 2016).  
Over the years, most attention has focused on the role of central IL-1β 
expression in the generation of sickness behaviour while by now IL-1β 
signaling pathways are established as mediators of chronic stress in the 
induction of depressive-like changes in the brain (Gadek-Mishalska, 2013; 
D'Mello and Swain, 2017). Over-expression of IL-1β in the brain was 
shown to correlate with individual predisposition to stress-induced 
anhedonia in mice (Couch et al., 2013) and accompany the depressive 
syndrome induced in other models in mice and rats (Cordeiro et al., 2019; 
Fang et al., 2019), including the ultrasound stress model of “emotional 
stress” (Morozova et al., 2016; Pavlov et al., 2018; Gorlova et al., 2019). 
The present study revealed up-regulation of this cytokine both in the pre-
frontal cortex and hippocampus, as well as its correlation with floating 
behaviour and overexpression of GSK-3β in the prefrontal cortex. Notably, 
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overproduction of IL-1β was shown in patients with PTSD (Wang et al., 
2017; Toft et al., 2019) indicating its translational potential.   
TNF, another cytokine studied in our work, was over-expressed in the brain 
of mice exposed to modFST. The potential for TNF to contribute to mood 
disorders has gained attention based on the basal ‘antidepressant’ phenotype 
of TNF and TNF receptor knockout mice (Simen et al., 2006), “pro-
hedonic” effects of  targeted deletion of TNF receptor 2 in sucrose intake 
test (Yamada et al., 2000) and evidence that TNF blockade can reduce 
depression symptoms (Krugel et al., 2013). The present study revealed a 
link between TNF over-expression and augmented learning of adverse 
memories that is in line with clinical data suggesting altered TNF expression 
during PTSD and depression (Passos et al., 2015; Miller et al., 2018; Yuan 
et al., 2019). 
Our study also revealed an increase in gene expression of hippocampal 
COX-1, which previously appeared to accompany the development of 
stress-induced anhedonia in mice (Couch et al., 2013). In line with these 
findings, mice lacking COX-1 were reported to be resilient to social stress-
induced anhedonia (Tanaka et al., 2012). COX-1 was found to be over-
expressed in depressed patients as well as in patients with acute PTSD 
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(Passos et al., 2015; Powers et al., 2019; Michopoulos et al., 2019). The 
reported significant correlations between molecular markers and floating 
behavior in the modFST suggests functional relationship between these 
factors in the regulation of floating behavior in the test and the acquisition 
of aversive memories. This was particularly true for the pro-inflammatory 
cytokines that were investigated here and both isoforms of GSK3. 
Additionally, we demonstrated that administration of imipramine and 
thiamine exerted central anti-inflammatory and anti-oxidative stress effects 
in the modFST. These treatments were previously shown to normalize 
depressive- and anxiety-like behaviours, GSK-3 expression, markers of 
oxidative stress and hippocampal cell proliferation during predation stress, 
the ultrasound model of emotional stress and the modFST (Cline et al., 
2012, 2014, 2015; Vignisse et al., 2017; Pavlov et al., 2017; Gorlova et al., 
2019). As over-production of cytokines, including TNF has  been shown to 
stimulate glutamate release from astrocytes (Bezzi et al., 2001) and 
microglia (Takeuchi et al., 2006) that can result in excessive intracellular 
calcium, leading to activation of calcium-dependent lipases and up-
regulation of reactive oxygen species (Dargelos et al., 2010), these 
mechanisms can explain increases in brain oxidative stress markers during 
the modFST. Administration of thiamine or imipramine ameliorated protein 
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carbonyl levels in the brain, suggesting improved balance of direct 
oxidation processes by reactive oxygen species (ROS) of amino acid 
residues (Cecarini et al., 2007). These data are in line with the literature 
suggesting compromised markers of oxidative stress during depression and 
comorbid disorders such as PTSD, anxiety disorders and their normalization 
by antidepressant treatment (Berk et al., 2013; Miller et al., 2018). Finally, 
the above-mentioned effects of treatments were accompanied by lowered c-
Fos expression in the hippocampus and prefrontal cortex of the 
experimental animals suggesting activity-dependent normalizing changes 
in these brain structures, which may be due to previously described 
functional links to oxidative stress, GSK3, and neuroinflammatory 
mechanisms (Kadry et al., 2018; Rana and Singh, 2018).  
Conclusions 
Taken together, our study suggests that the development of enhanced 
contextual conditioning of adverse memories in the modFST mouse 
paradigm is associated with a proinflammatory profile and signs of 
oxidative stress. These changes are likely to be due to increases in blood 
glucocorticoid levels and GSK-3 activities (Thoeringer et al., 2012). A pre-
treatment with low dose of tricyclic antidepressant imipramine and thiamine 
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can prevent the most of these changes.  Given that patients with symptoms 
of depression and PTSD disorders revealed signs of neuroinflammation 
(Michopoulos et al., 2017, 2019), it seems likely that treatments employed 
here may have considerable therapeutic potential. Our findings are in line 
with  clinical data on the pathophysiology of depression, suggesting that 
depression of distinct forms leads to elevated levels of inflammation and an 
oxidant/antioxidant imbalance (Ogtodek and Just, 2018), as well as 
emphasize a role for neuroinflammatory processes during augmented 
learning of aversive memories (Miller et al., 2018). They further validate 
the applied model as a tool for studying inappropriate learning of aversive 
memory in the pathophysiology of depressive syndromes and highlight 
future directions for the development of novel therapeutics targeting 
oxidative stress and inflammation in patients with related 
psychopathologies. 
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SUPPLEMENTARY DATA  
 
Animals and housing conditions 
Experiments were performed on male C57BL6 mice that were 12 weeks 
old. All animals were provided by Stolbovaja, RAS, Moscow region, a 
provider licensed by Charles River (http://www.spf-
animals.ru/about/providers/animals). Mice were housed individually in 
standard plastic  cages (27x22x15 cm for mice) and maintained on a 12-
hour light/dark cycle, under controllable laboratory conditions (lights are on 
at 21.00; 22±1°C, 55% humidity, room temperature 22ºC), food and water 
were available ad libitum. Housing conditions and all experimental 
procedures were set up and maintained in accordance with a Directive 
2010/63/EU of 22 September 2010 and carried out under approval of the 
local veterinarian committee (MSMU #11-18-2018).  All efforts were 
undertaken to minimize the potential discomfort of experimental animals.  
Modified swim tests with additional delayed testing  
Mice were subjected to one or two swimming sessions with an interval of 
24 h, or, to three session, where after the first two tests the third test was 
carried out on Day 5 following the initial test on Day 1 as described 
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elsewhere (Strekalova et al., 2016; Markova et al., 2016). All sessions were 
6-min long and were performed by placing a mouse in a transparent cylinder 
(Ø 17 cm) filled with water (+23 °C, water height 13 cm, height of cylinder 
20 cm). The duration of floating behavior that was defined by the absence 
of any directed movements of the animals’ head and body, was scored 
manually using criteria, which were previously validated by automated 
scoring with Noldus EthoVision XT 8.5 (Noldus Information Technology, 
Wageningen, The Netherlands) and CleverSys (CleverSys, Reston, VA, 
USA) as described elsewhere (Malatynska et al., 2012; Strekalova et al., 
2015). Time spent with floating was evaluated for the entire duration of the 
test. In all assays mice were sacrificed ten minutes after swimming. Imi-
FST and Thi-FST mice were tested in all three session and sacrificed after 
the last session, alone with respective non-treated control mice. With all 
tests, naïve control groups that were not exposed to a swimming were 
sacrificed simultaneously with experimental groups of mice. 
Administration of drugs 
Experimental solutions replaced normal drinking water. Thiamine and 
imipramine were obtained from Sigma-Aldrich, St. Louis, MO, USA. All 
agents were dissolved in tap water and were changed every 4-5 days (Pavlov 
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et al., 2017, Vignnisse et al., 2017). Drinking behaviour of mice was 
monitored by evaluating a 24-h liquid intake during the first three days of 
dosing. The dose of imipramine dose (7.5 mg/kg/day), was based on 
previous results showing that this dose had no effect on general locomotor 
behaviour (Strekalova et al., 2015; Costa-Nunes et al., 2015). 
Sequences of primers 
Sequences of primers used are listed below (Supplementary Table 1).   
Table 1. Sequences of primers used  
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Enzyme-linked immunosorbent assay of CORT 
To study the concentrations of CORT in the blood plasma, mouse enzyme-
linked immunosorbent assay (ELISA) was performed using MOUSE 
ab108821 kit (Abcam, Cambridge, UK) according to the manufacturer's 
instructions. The microwell absorbance was measured at 450 nm with 
Promega microplate reader (Madison, WI, USA). 
Protein carbonyl 
Determination of protein carbonyls using the OxiSelect™ Protein Carbonyl 
Fluorometric Assay kit (Cell Biolabs, Inc., San Diego, USA). Glass-glass 
homogenization followed by a sonification was performed on ice in 1 ml of 
1xSample Diluent from the OxiSelect™ kit, centrifuged at 10000 g for 5 
min at +4°C, and the supernatant was removed. The total protein 
concentration was adjusted to 1–10 mg/ml with 1xSample Diluent and 
protein carbonyls were determined according to the guidelines of the 
manufacturer using the GloMax Multi Detection System (Promega, 
Madison, WI, USA) equipped with a fluorescence module (485/540 nm 
filter set). Results were normalized to protein concentration as described 
previously (Vignisse et al., 2017; Pavlov et al., 2019). 
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Supplementary tables 
Table 2. Floating behavior in the modified swim test. Total duration of 
floating and floating for 1-2 min period at Day 5 were significantly 
increased in comparison with these measures scored on Day 2 in the FST 
group, but not in Imi-FST or Thi-FST groups. On day 5, total duration of 
floating was significantly shorter in Thi-FST group than in the FST group. 
In comparison to values obtained on Day 1, all groups showed significantly 
elevated total duration of floating and duration of floating during the first 
two periods of scoring as compared with Day 2 and Day 5. Significant 
differences are in bold (p<0.05, repeated measures ANOVA and Tukey’s 
test). FST - vehicle-treated FST group; Imi-FST - imipramine-treated FST 
group; Thi- FST - thiamine-treated FST group. 
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Table 3. Gene expression in the hippocampus and prefrontal cortex of 
mice subjected to modFST. Following delayed swimming session brain 
overexpression of GSK-3 and  isoforms, IL-1, TNF, c-Fos and COX-1 
was overall augmented. Groups that were re-treated with thiamine and 
imipramine treatments demonstrated normalized expression of investigated 
genes. Significant differences are in bold (p<0.05, one-way ANOVA and 
Tukey’s test). FST - non-treated FST group; Imi-FST - imipramine-treated 
FST group; Thi-FST - thiamine-treated FST group. 
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Chapter 4 
 
Neuroinflammation and aberrant hippocampal plasticity in a mouse 
model of emotional stress evoked by exposure to ultrasound of 
alternating frequencies 
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ABSTRACT  
 
Emotional stress is a form of stress evoked by processing negative mental 
experience rather than an organic or physical disturbance and is a frequent 
cause of neuropsychiatric pathologies, including depression. Susceptibility 
to emotional stress is commonly regarded as a human-specific trait that is 
challenging to model in other species. Recently, we showed that a 3-week-
long exposure to ultrasound of unpredictable alternating frequencies within 
the ranges of 20-25kHz and 25-45kHz can induce depression-like 
characteristics in laboratory mice and rats. In an anti-depressant sensitive 
manner, exposure decreases sucrose preference, elevates behavioural 
despair, increases aggression, and alters serotonin-related gene expression. 
To further investigate this paradigm, we studied depression/distress-
associated markers of neuroinflammation, neuroplasticity, oxidative stress 
and the activity of glycogen synthase kinase-3 (GSK-3) isoforms in the 
hippocampus of male mice. Stressed mice exhibited a decreased density of 
Ki67-positive and DCX-positive cells in the subgranular zone of 
hippocampus, and altered expression of brain-derived neurotrophic factor 
(BDNF), its receptor TrkB, and anti-apoptotic protein kinase B 
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phosphorylated at serine 473(AktpSer473). The mice also exhibited 
microglial activation, increased oxidative stress, increased levels of 
interleukin-1β (IL-1β), interleukin-6 (IL-6) in the hippocampus and plasma, 
and elevated activity of GSK-3 isoforms. Together, the results of our 
investigation have revealed that unpredictable alternating ultrasound evokes 
behavioural and molecular changes that are characteristic of the depressive 
syndrome and validates this new and simple method of modeling emotional 
stress in rodents. 
 
 
Keywords: depression, ultrasound radiation, plasticity, neuroinflammation, 
glycogen synthase kinase 3 (GSK-3), mice. 
 
Abbreviations: Iba-1 - ionized calcium binding adaptor molecule 1, 
AktpSer473 - phosphorylated at Serine 473 protein kinase B, BDNF - brain-
derived neurotrophic factor, BLBP - brain lipid binding protein, CNS – 
central nervous system, DG – dentate gyrus, DCX - doublecortin, FOXO3a 
- forkhead box O3, GSK-3 - glycogen synthase kinase-3, IL-1β 
–  interleukin-1β, IL-2 - interleukin-2, IL-6 - interleukin-6, IL-8 - 
interleukin-8, IL-15 - interleukin-15,  MD- malondialdehyde, NGF – nerve 
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growth factor, PCR - polymerase chain reaction, PTEN - phosphatase and 
tensin homolog deleted on chromosome 10, SGZ - subgranular zone of 
hippocampus,  TrkB - tropomyosin receptor kinase B, TNF-α  - tumor 
necrosis factor-α,   VEGF - vascular endothelial growth factor,  3-NT - 3-
nitrotyrosine. 
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1. Introduction   
Emotional stress is defined as mental distress or anxiety suffered as a 
response to a sudden, severe, and saddening experience, which is not primed 
by any organic or physical disturbance (Simonov, 1997; Bao et al., 2008; 
Fontes et al., 2014). The term “emotional stress” is often used 
interchangeably with other terms such as “psychological stress” or “mental 
stress”, which all referred to a state that is primarily triggered by perception 
and cognitive evaluation of adverse events (Chrousos and Gold, 1992). 
Challenges such as humiliation or defeat, loss of relatives, deterioration of 
a financial, marital or social status are typical drivers of emotional stress. 
Other clinically relevant conditions associated with a stress response, such 
as chronic pain, physical stressors, infection and inflammation, hormonal 
disbalances are frequently accompanied by negative emotions that are 
downstream of these organic factors (Selye, 1974) and may interact with 
emotional stress. 
Emotional stress is suggested to play a major role in the development of 
major depressive disorder (Lesch, 2004; Roy et al., 2014; Kessler et al., 
2015). For example, it was demonstrated that chronic, uncontrollable and 
unpredictablele stress can trigger maladaptive changes in humans and 
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animals leading to the development of a depressive syndrome (McEwen and 
Stellar, 1993; de Kloet et al., 2005; Willner et al., 2005; Strekalova et al., 
2011). Based on this evidence, we recently reported the development of a 
new rodent model of emotional stress in which chronic ultrasound exposure 
employing “emotionally negative” sound cues that avoids the application of 
physical stressors (restraint, food and water deprivation, cold temperatures 
or forced swim for example) (Morozova et al., 2016; Strekalova et al., 
2018). In this new model, mice and rats are continuously exposed to 
ultrasound of variable frequencies for three weeks; the frequencies used 
during the ultrasound exposure are chosen to mimic ultrasonic vocalizations 
of rodents in nature (Brudzynski and Fletcher, 2010). The ultrasound is 
randomly alternated between 20 and 25 kHz, which corresponds to a rodent 
vocalization of a negative emotional state, and frequencies of 25-45 kHz, 
that are associated with a neutral emotional state (Kuraoka and Nakamura, 
2010). Ultrasound signals of>50 kHz are known to be emitted by mice 
during physiologically positive experiences, including mother-pup 
interactions, mating and others, whereas the sounds in a range of 20–25 kHz 
are generated by them in life-threatening conditions, such as social 
confrontation, pain and maternal separation (Constantini and D'Amato, 
2006; Panksepp et al., 2007; Okabe et al., 2010). 
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We previously reported that both rats and mice exposed to the three-week 
ultrasound exposure resulted in decreased sucrose preference, locomotion 
and social exploration, increased aggressive behaviour and elevated 
“despair” behaviour in a swim test (Morozova et al., 2016; Strekalova et al., 
2018). These depression-like behaviours were accompanied by increased 
expression of the serotonin transporter and 5-HT2A receptor, decreased 
expression of 5-HT1A receptor and brain-derived neurotrophic factor 
(BDNF) in the brain. Treatment with the selective serotonin reuptake 
inhibitor (SSRI) fluoxetine at the dose of 10 mg/kg, largely ameliorated 
these depression-like changes. Separate experiments that involved exposure 
of experimental animals to ultrasound of similar intensity and duration as 
used in our study, but of mixed frequency (“white noise”) or similar 
frequencies with lower intensity or duration, failed to induce depressive-
like behavioural syndrome, thus, suggesting the specificity of the adverse 
effects of selected regime of ultrasound radiation (Morozova et al., 2016, 
see also below). 
Furthermore, short exposures of Balb/c mice to the ultrasound of 
“emotionally negative” frequencies of 20–25 kHz versus “physiologically 
neutral” frequencies of about 16 or 50–60 kHz revealed temporary 
behavioural effects only in the 20-25 kHz frequency range, further 
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demonstrating physiological relevance of selected parameters of the 
ultrasound stimulation (Morozova et al., 2016). 
The aim of the present study was to further explore the cellular and 
molecular changes, such as brain plasticity and neuroinflammation, that 
underpin the depressive-like syndrome induced by ultrasound exposure in 
comparison to stress regimes that employ physical factors (Dantzer et al., 
2008; Masi and Brovedani, 2011; Strekalova et al., 2011, 2016; Willner et 
al., 2005, 2018). 
Accumulated evidence suggests functional interconnections exist between 
inflammation in the brain, oxidative stress, the glycogen synthase kinase 3 
(GSK-3) cascade, and the inhibition of brain plasticity mechanisms during 
depression-like syndromes (Leonard and Maes, 2012; Chesnokova et al., 
2016; Strekalova et al., 2016). In particular, elevated concentrations of 
proinflammatory cytokines in the CNS trigger changes in microglial 
morphology (Lee et al., 1993; Bluthe et al., 1994; Dantzer et al., 2008), 
which are associated with the suppression of plasticity and the production, 
survival, migration, and recruitment of new neurons (Ekdahl et al., 2003; 
Lazarini et al., 2012; Chen et al., 2012; Belarbi et al., 2013). 
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Furthermore, the change in morphology of microglia from a highly ramified 
to a more rounded phenotype is often associated with increased oxidative 
stress within the brain that may promote progressive neuronal damage 
(Block and Hong, 2007; Mao et al., 2007; Roy et al., 2008; Saliba et al., 
2017). Local and circulating pro-inflammatory cytokines can stimulate 
expression of c-Jun-N-terminal kinase (JNK) which, in turn, inhibits a 
production of phosphorylated Akt kinase (Karin et al., 2005), a functional 
antagonist of major pro-apoptotic molecules: glycogen synthase kinase-3 
beta (GSK-3β), forkhead box protein O3a (FOXO3a) and PTEN 
(phosphatase and tensin homolog deleted on chromosome 10) (Wu et al., 
2009; Fey et al., 2012; Pomytkin et al., 2015). Increased expression and 
protein activities of GSK-3β are well-documented correlates of neuronal 
degeneration and behavioural abnormalities during depression (Polter et al., 
2009; Fey et al., 2012; Huang et al., 2013; Cline et al., 2015a, 2015b; Pavlov 
et al., 2017). As such, GSK-3β/Akt/FOXO3a cascade is an important 
pathophysiological regulator of depression that is functionally related to the 
above mentioned mechanisms of neuroinflammation, excessive oxidative 
stress and deficient brain plasticity associated with this condition 
(Kaidanovich-Beilin and Woodgett, 2011; Beurel et al., 2015). 
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Here we found that mice exposed to ultrasound stress had lowered 
immunohistochemical markers of neuronal proliferation in the 
hippocampus, gene and protein expression of neurotrophin brain-derived 
neurotrophic factor (BDNF) and its receptor TrkB, marker of glial 
proliferation Nestin and several other regulatory molecules of plasticity 
whose changes were previously shown to be associated with depressive 
syndrome: brain lipid binding protein (BLBP), vascular endothelial growth 
factor (VEGF) and neuron growth factor (NGF) (Duman, 2004; Colle et al., 
2015; Oglodek et al., 2016; Xie et al., 2017; Fukunaga and Moriguchi, 
2017). 
To explore the possible role of the host immune system in the hippocampus 
in this stress paradigm, we studied the microglial marker, ionized calcium 
binding adaptor molecule 1 (Iba-1), and found that ultrasound exposure 
increased the density of Iba-1-positive cells. The hippocampal gene and 
protein expression of the pro-inflammatory interleukins (IL) IL-1β, IL-6, 
and anti-inflammatory interleukins IL-2, IL-8 and IL-15, as well as plasma 
concentrations of IL-1β, IL-6 and tumor necrosis factor-α (TNFα) was also 
investigated; changes the levels of these cytokines is associated with the 
depressive state (Maes et al., 2012; Couch et al., 2013, 2016). 
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In addition, hippocampal concentrations of 3-nitrotyrosine and 
malondialdehyde were determined as markers of oxidative stress (Bakunina 
et al., 2015; Vignisse et al., 2014, Vignisse et al., 2017). Hippocampal gene 
and protein expression of beta and alpha isoforms of GSK-3 (GSK-3β and 
GSK-3α) and molecules that are functionally related to GSK-3β cascade, 
FOXO3a, 10 PTEN and phosphorylated at Serine 473 protein kinase B 
(AktpSer473), were evaluated. Finally, correlational analysis of the 
molecular expression profile was to assess functional impact of 
neurobiological alternations during stress for behavioural changes and, to 
address potential cross-correlations between parameters of inflammation, 
plasticity and depressive-like behaviours.  
We found that in addition to the increase in microglial density, mice 
exposed to the ultrasound exhibited increased oxidative stress and 
proinflammatory cytokines in the hippocampus and plasma, and elevated 
activity of GSK-3 isoforms. In summary, our results reveal that 
unpredictable alternating ultrasound evokes behavioural and molecular 
changes in mice that are characteristic of the depressive syndrome described 
in depressed patients and in animals subjected to physical stressors. 
2. Materials and methods 
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2.1. Animals 
Experiments were performed using 10-weeks-old male Balb/c mice that 
were obtained from certified Charles River provider, Stolbovaja, RAS, 
Moscow region (http://www.spf-animals.ru/about/providers/animals). 
Animals were housed individually in the standard plastic cages (27x22x15) 
and maintained on a 12-h light/dark cycle (lights on at 19:00), under 
controlled laboratory conditions (22 ± 1 °C, 55% humidity, room 
temperature+23 °C), with food and water provided ad libitum. Housing 
conditions and all experimental procedures were set up and maintained in 
accordance with Directive 2010/63/EU of 22 September 2010 and carried 
out under the approval of the local veterinarian committee (10–02-15 N72). 
All efforts were undertaken to minimize the potential discomfort of 
experimental animals. 
2.2. Study design 
One day prior to the onset of ultrasonic exposure, mice were weighed, tested 
for sucrose preference (see below) and assigned to control and stress groups 
(data not shown); each group was comprised of twelve mice (Fig. 1A). 
Stress group was subjected to a three-week ultrasound radiation in a 
separate room as described elsewhere (Morozova et al., 2016; Strekalova et 
167 
 
al., 2018; see below). Control group was housed under similar conditions, 
but not exposed to the ultrasound radiation. On the next day after the three-
week stress (Day 22), sucrose preference test was conducted in all mice. On 
Day 23, animals were subsequently tested in the open field test, resident-
intruder paradigm, and forced swim test (see below; Fig. 1A). On day 24, 
mice were sacrificed: right hippocampi from seven randomly chosen mice 
of each group were harvested for quantitative real-time polymerase chain 
reaction (qRT-PCR) and Western Blot, left hippocampi of these mice were 
harvested to study malondialdehyde or 3-nitrotyrosine concentrations; 
blood plasma was collected. Using customized method for brain perfusion 
(Couch et al., 2013, 2016, see below), right hippocampi from remaining five 
mice of each group were additionally dissected for subsequent qRT-PCR 
and Western Blot, left hippocampi were collected for the 
immunohistochemical study (Fig. 1A); blood was collected from all animals 
(see below). Together, all twelve animals from each group were studied for 
gene expression, Western blot and ELISA experiments. Brain oxidative 
stress was studied in seven mice with a malondialdehyde assay and in five 
mice with 3- nitrotyrosine assay. Five mice were used for 
immunohistochemical studies. 
2.3. Ultrasound radiation 
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Stress procedure of ultrasound exposure was carried out as described 
elsewhere (Morozova et al., 2016; Strekalova et al., 2018). Ultrasound 
radiation of average intensity of 50 ± 5 dB and variable frequencies in a 20-
45 Hz range was constantly delivered in a laboratory room to the 
experimental groups of mice using a random schedule of alternating 
frequencies via a manufactured device (Weitech, Wavre, Belgium). The 
range of ultrasound stimulation frequency was alternating each 10 min 
between the following intervals: low frequencies (20–25 kHz), middle 
range frequencies (> 25 < 40 kHz) and high range frequencies (40–45 kHz). 
During the 10-min periods, ultrasound frequencies were fluctuating at 
variable short time spans of ≤1 s (averaged frequency 70 Hz ± 10 Hz) at the 
above-indicated intervals. 35% of the emission time consisted of 20–25 and 
25–40 kHz intervals, and 30% of the emission time was constituted of 40–
45 kHz. 
The intensity of the sound during above-indicated intervals was fluctuating 
at the range ± 10% of the averaged value, i.e.,±5 dB. The shape of the 
ultrasound signals was fluctuating that mimics natural ultrasonic 
vocalizations of rodents (Fig. 1B; Brudzynski and Fletcher, 2010). 
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Distribution of the ultrasound radiation was controlled by the ultrasound 
detector (Discovery Channel, Rochester, NY, USA) during the study. The 
ultrasound device was hung 2m above the cages of the experimental groups 
with an average horizontal distance to cages of 2.5 m. The position of the 
cages, with respect to the stimulator, was changed weekly. The selectivity 
of the adverse effects of low-frequency ultrasound during the radiation 
period versus the potential general negative effects of a constant noise 
accompanying the procedure described here has been previously described 
by us (Morozova et al., 2016). As part of these studies, when mixed 
frequencies (“white noise”) at the range of 16–20 kHz were employed no 
changes in social and depressive-like behaviours were observed (Morozova 
et al., 2016). A comparison of immediate behavioural effects of the 
ultrasound exposure of fluctuating frequency 20-45 Hz at varying 
intensities revealed that 50 dB and 90 dB ultrasound signs will supress 
burying, feeding and drinking in a home cage after, but no such changes 
were observed at 30 dB stimulation (see Supplementary material, Figs. 1-
3). Furthermore, we also found that a shortened period of ultrasound 
exposure of 1 to 2-weeks duration were not as effective as 3-weeks of 
continuous exposure to of animals to a fluctuating signal of 20-45 Hz with 
an average intensity of 50 dB (Morozova et al., 2016). 
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2.4. Behavioural tests 
2.4.1. Sucrose test 
Mice were given a free choice between a bottle with 1%-sucrose solution 
and another one with tap water for 24 h, as described elsewhere (Strekalova 
et al., 2004, see Supplementary material). At the beginning and the end of 
the test, the bottles were weighed and consumption was calculated. The 
percentage preference for sucrose over water was calculated using the 
following formula: Sucrose Preference= Volume (Sucrose 
solution)/(Volume (Sucrose solution)+ Volume (Water)) x 100. 
2.4.2. Forced swim test 
This test was carried out as described previously (Strekalova and 
Steinbusch, 2010; Malatynska et al., 2012, see Supplementary material). 
Mice were placed in the pool and their latency to float and total duration of 
floating behavior was scored during the 6 min offline using Any-maze 
software (Stoelting Co, Wood Dale, IL, USA). 
2.4.3. Open field test 
The open field test was performed as described elsewhere (Strekalova and 
Steinbusch, 2010; Morozova et al., 2016, see Supplementary material), 
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using white light; time spent in the central zone and number of grooming 
events were scored for a 5 min period using automated video tracking 
AnyMaze software (Stoelting Co, Wood Dale, IL, USA). 
2.4.4. Resident-intruder test 
The resident-intruder test procedure was adapted from the previously 
described protocols (Couch et al., 2016; Strekalova et al., 2018, see 
Supplementary material); during the 10-min observation period, mice were 
scored for the latency to attack and the number of attacks.  
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Fig. 1. Experiment design. A. Schematic study outline. After 21 day-
period of ultrasound stress exposure, both control and stress group were 
tested in a battery of behavioural tests and used for subsequent in vitro 
assays (n=12 and 5–7 per group, respectively). Hip – hippocampus, qRT-
PCR - quantitative reverse transcription polymerase chain reaction, WB 
assay – western blot, ELISA - enzyme-linked immunosorbent assay, IHC 
assay – immunohistochemical assay. B. Representation of the ultrasound 
signal mimicking a natural sound of mice: frequency-intensity fluctuations. 
 
2.5. Brain and blood collection 
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Mice were terminally anaesthetized with an intraperitoneal injection of 
Nembutal (Bayer, Wiesbaden, Germany). Blood collection was performed 
transcardially and was followed by perfusion of the left ventricle with 10 
ml of the ice-cold 0.9% NaCl. Blood was stored in heparinized vials prior 
to centrifugation (10,000 rpm, 15 min, 4 °C); plasma was removed and 
immediately stored at −20 °C until use. The brain of seven mice from each 
group was dissected and the right and left hippocampi were isolated and 
immediately frozen at −80 °C on a dry ice. Five mice from each group were 
first subjected to the same procedure where only the right hemispheres and 
hippocampi were dissected as previously reported (Couch et al., 2013; see 
Supplementary material). Thereafter, these mice were transcardially 
perfused by 4%- paraformaldehyde (PFA) in 0.1M phosphate buffer. Left 
hemispheres and hippocampi were removed and postfixed in 4%-PFA for 
12 h at +4 °C, and thereafter were immersed in 0.1M phosphate-buffered 
saline (PBS, pH 7.4) for 12 h at +4 °C. Finally, samples from the left 
hippocampi perfused with 4% PFA were processed for paraffin embedding 
as described elsewhere (Morozova et al., 2016). 
2.6. Brain sectioning and immunohistochemistry 
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All steps were essentially performed as described previously, five  animals 
per group were used in these experiments (Strekalova et al., 2015, 2018; 
Vignisse et al., 2017, see Supplementary material). 20-μmthick coronal 
sections were obtained from paraffin brain blocks using a Leica CM 1850 
cryostat (Leica Microsystems, Wetzlar, Germany) and mounted on gelatin-
covered glass with coverslips. Hippocampal sections were taken from 
lateral 3.6 to lateral 0.4mm along the mediallateral axis ahead of bregma 
(Paxinos and Franklin, 2001). The dorsal and ventral hippocampus was 
examined in our studies. The area examined was rostro-caudal from 
Bregma−2.5mm to 4.5mm and medial-lateral from -1mm to -3 mm. Details 
on paraffin removal, antigen retrieval and blocking of non-specific staining 
are presented in the Supplementary material. Three sections per each animal 
were then incubated overnight at 4 °C with primary antibodies: rat anti-Ki67 
(Dako, Glostrup, Denmark), or rabbit polyclonal anti-DCX (Chemicon, 
Temecula, CA, USA), or rabbit anti-ionized calcium binding adaptor 
molecule 1 (Iba-1; Dako, Glostrup, Denmark). Subsequently, sections were 
incubated with respective secondary antibodies, using or anti-rat-Alexa 
Fluor 594, donkey anti-rabbit-Alexa Fluor 488 and anti-rabbit- Alexa Fluor 
647, respectively (Life Technologies-Molecular Probes, Grand Island, NY, 
USA). 
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In addition, to visualize the nuclei of the hippocampal cells, sections were 
double-stained with 4′,6-diamidino-2-phenylindole (DAPI) (Santa Cruz 
Biotechnology, Dallas, TX, USA). Quantification of Ki67-, DCX and Iba-
1- positive cells was carried out by an experimenter blind to the  
experimental conditions as described elsewhere (Strekalova et al., 2015, 
2018; Vignisse et al., 2017). Briefly, images were acquired using a 
microscope BX51 (Olympus, Tokyo, Japan), photographed with a digital 
DP70 camera (Olympus, Tokyo, Japan) and were simultaneously quantified 
in the control and stress groups using ImageJ Software (NIH, Bethesda, 
MD, USA). 
Ki67- and DCX- positive cells were counted in the area of the subgranular 
zone of the hippocampus (SGZ), which was defined as previously described 
(Vignisse et al., 2017, see Supplementary material, Suppl. Fig. 4). Seven 
coronal sections were randomly selected to perform Nissl staining to 
calculate densities of Ki67- and DCX- positive cells per mm3 (see 
Supplementary material, Vignisse et al., 2017; Strekalova et al., 2018). Iba-
1-positive cells were counted in the area of the hilus of the hippocampus 
and their densities per mm2 were calculated as described previously, only 
cells with distinct DAPI-stained nuclei were counted as positive (Vignisse 
et al., 2017, see Supplementary material, Suppl. Fig. 6). Further details of 
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the size of the examined area, section selection, and application of 
mathematical formulas can be found in the Supplementary material. 
2.7. Quantitative real-time PCR 
Quantitative real-time PCR was carried out as described elsewhere 
(Morozova et al., 2016; Couch et al., 2013, 2016). Briefly, first-strand 
cDNA synthesis was performed using random primers and Superscript III 
transcriptase (Invitrogen, Carlsbad, CA, USA); 1 μg total RNA was 
converted into cDNA. qRT-PCR was performed using the SYBR Green 
master mix (Bio-Rad Laboratories, Philadelphia, PA, USA) and the CFX96 
Deep Well Real-Time PCR Detection System (Bio-Rad, Hercules, CA, 
USA). Further details in the protocol used and sequences of primers can be 
found in Supplementary material and Suppl. Table 1. The housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was selected 
as the reference gene since previous experiments demonstrated relatively 
low variability in GAPDH expression in the limbic structures of the rodents 
exposed to the ultrasound stress (Morozova et al., 2016). Data were 
normalized to GAPDH mRNA expression and calculated as relative-fold 
changes compared to control mice as described elsewhere (Morozova et al., 
2016; Couch et al., 2016; Pavlov et al., 2017). 
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2.8. Protein isolation and Western blot analysis 
Tissue samples were prepared using glass-glass homogenization followed 
by a sonification in ice-cold buffer (Roche Diagnostics, Indianapolis, IN, 
USA). Details of the Western blot analysis can be found in the 
Supplementary material. Briefly, protein concentration was quantified 
using the BCA protein assay kit (Pierce, Rockford, IL, USA, see 
Supplementary material), 25 μg of proteins were treated with SDS-PAGE 
and electroblotted on the PVDF membrane (EMD Millipore, Billerica, MA, 
USA). These samples were incubated with primary antibodies overnight at 
4 °C (for information on antibodies used, see Suppl. Table 2) that was 
followed by the incubation with respective secondary antibodies (Sigma-
Aldrich, St. Louis, MO, USA) for 2 h at room temperature. Immunoreactive 
bands were detected using Bio-Rad Molecular Imager Software (BioRad 
Laboratories, Richmond, CA, USA). β-tubulin was used as a reference 
protein as low fluctuation of its expression was found previously in similar 
experiments (Morozova et al., 2016; Gorlova et al., 2018, 2019); expression 
of proteins of interest were calculated in fold changes from levels of β-
tubulin, as described elsewhere (Morozova et al., 2016). 
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2.9. Enzyme-linked immunosorbent assays of plasma cytokines and brain 3-
nitrotyrosine 
To study the concentrations of IL-1β, IL-6, and TNF-α in a blood plasma, 
mouse enzyme-linked immunosorbent assay (ELISA) was performed using 
MOUSE IL-1β, IL-6, and TNF-α ELISA MAX™ Deluxe Sets (BioLegend, 
San Diego, CA, USA) according to the manufacturer's instructions (see 
Supplementary material). Protein concentrations were measured using the 
BCA protein assay kit (Pierce, Rockford, IL, USA, see Supplementary 
material). The microwell absorbance was measured at 450 nm with 
Promega microplate reader for all cytokines (Madison, WI, USA). 
Concentrations of 3-nitrotyrosine in protein samples of hippocampi were 
determined using OxiSelect™ Nitrotyrosine ELISA Kit (Cell Biolabs, Inc., 
San Diego, CA, USA) according to the manufacturer's instructions (see 
Supplementary material). Microwell absorbance was measured as described 
elsewhere (Vignisse et al., 2017). 
2.10. Malondialdehyde assay 
Malondialdehyde content in hippocampal samples was measured with the 
OxiSelect™ TBARS Assay Kit (Cell Biolabs, Inc., San Diego, CA, USA). 
Tissue samples were homogenized and sonicated on ice, in a proportion of 
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1 ml of sample per 1 ml of Sample Diluent (OxiSelect™ kit, Cell Biolabs, 
Inc., San Diego, CA, USA). Butylated hydroxytoluene (BHT) solution in 
methanol was added to samples in a proportion 1:100. Samples were 
centrifuged at 10.000 rpm at 4 °C for 5 min and the supernatant was 
collected. Total protein concentration was adjusted to 10 mg/ml. Samples 
were diluted 1 to 10, and malondialdehyde content was determined using 
the GloMax Multi Detection System equipped with a fluorescence module 
(reading range 540–590 nm; Promega, Madison, WI, USA) according to the 
guidelines of the manufacturer. 
Protein concentrations were measured using the BCA protein assay kit 
(Pierce, Rockford, IL, USA, see Supplementary material). Results were 
normalized to protein concentration as described previously (Vignisse et al., 
2017). 
2.11. Statistical analysis 
Data analysis was performed using GraphPad Prism software version 5.03 
for Windows (San Diego CA, USA). A comparison of two groups was 
carried out with a Mann-Whitney U test, and Spearman correlation was used 
for the correlation analysis of the molecular and behavioural data. Statistical 
significance was set at p < .05. Data are shown as mean ± SEM. 
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3. Results 
3.1. Ultrasound exposure induces depressive-like syndrome 
In the sucrose preference test, mice exposed to the ultrasound, as compared 
with control group, displayed a significant reduction in sucrose preference 
and decreased sucrose intake (U=17.5, p=.012, and U=15, p=.0064, Mann-
Whitney test; respectively, Fig. 2A,B), suggesting diminished sensitivity to 
reward in stressed mice. Water intake did not significantly differ between 
the groups (U=28, p=.1008, Fig. 2C). In the forced swim test, the stressed 
group of mice showed a significant prolongation of the duration of floating 
as compared to control (U=21, p=.027, Fig. 2D) indicating increased 
helplessness in the former group. There was a trend to shorter latency to 
float in stressed animals as compared to control group (U=27, p=.085, Fig. 
2E). 
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Fig. 2. Ultrasound stress exposure induces depressive- like syndrome in 
mice. In the test, in comparison to the control group, stress group showed a 
significant decrease of (A) sucrose preference and (B) sucrose intake 
demonstrating decreased sensitivity to reward (*p < .05 vs. control, Mann-
Whitney test). (C) No significant group differences were found in water 
intake (p > .05 vs. control, Mann-Whitney test). In the forced swim test, in 
comparison to the control group, stressed animals showed (D) elevated total 
duration of floating (*p < .05 vs.control, Mann-Whitney test); (E) latency 
to float did not change significantly (p > .05 vs.control, Mann- Whitney 
test). In the open field test, in comparison to control group, stressed mice 
demonstrated (F) significantly shorter time spent in the central zone, a sign 
of anxiety-like behaviour and (J) increased number of grooming events, a 
sign of behavioural invigoration (*p < .05 vs. control, Mann-Whitney test). 
In the resident-intruder test, in comparison with control animals, stressed 
mice displayed (H) increased number of attacks and (K) decreased latency 
to attack (*p < .05 vs. control). Bars are Mean ± SEM, 12 animals per group 
were used. 
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In addition to behavioural manifestations of anhedonia and helplessness, 
mice exposed to the ultrasound stress displayed a decrease in time spent in 
the central zone of the open field (U=36, p=.037, Mann-Whitney test, Fig. 
2F), a sign of anxiety-like behavior. In addition, stressed animals showed a 
significant increase in the number of grooming events (U=18.5, p=.0014, 
Fig. 2J) that is commonly regarded as a sign of behavioural invigoration of 
rodents subjected to stressed conditions. 
In line with the previous findings, ultrasound exposure has affected 
aggressive behavior in the Resident-intruder test, in which increased 
aggressive behaviour in mice subjected to ultrasound exposure was found. 
In comparison with control group, stressed animals displayed a significantly 
elevated number of attacks (U=16.5, p=.007, Mann-Whitney test, Fig. 2H) 
and shortened latency to first attack (U=15, p=.04, Fig. 2K). 
Merged staining of the neuronal nuclear marker DAPI and markers of cell 
proliferation Ki67 and progenitor neuronal cells DCX (Fig. 3A) revealed 
decreased, in compared with control group, density of Ki67- and DCX- 
positive cells in the SGZ of the hippocampus of stressed mice (U=1.5, 
p=.023 and U=2.5, p=.039, Mann-Whitney test, respectively, Fig. 3B,C), 
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suggesting that ultrasound stress inhibits neuronal proliferation in this brain 
structure.  
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Fig. 3. Effects of ultrasound stress on the markers of hippocampal 
plasticity. (A) Immunohistochemical staining of DAPI, Ki67, DCX, and 
analysis of their merged images with DOPI-staining revealed diminished 
numbers of Ki67- positive and DCX – positive cells in the hippocampus of 
stressed mice as compared with control animals. In comparison to the 
control group, stressed mice had a significant decrease in the density of (B) 
Ki67- positive and (C) DCX - positive cells in the subgranular zone of the 
dentate gyrus of the hippocampus (*p < .05 vs. control, Mann-Whitney test; 
5 animals per group were used). (D) Stressed mice had a significant 
decrease of mRNA concentrations of plasticity factors BDNF, TrkB, 
Nestin, and BLBP as compared with control mice (*p < .05 vs. control, 
Mann-Whitney test; 12 animals per group were used) that suggests reduced 
levels of neurotrophic factors in animals subjected to the ultrasound 
exposure; mRNA expression of VEGF and NGF was unchanged (p > .05 
vs. control, Mann-Whitney test). In comparison with control mice, there 
was a significant decrease of hippocampal levels of BDNF, TrkB, Nestin, 
and BLBP in stressed mice in the gene expression in the (E) RTPCR and 
(F) Western blot assays (*p < .05 vs. control, Mann-Whitney test; 12 
animals per group were used). Scale bar is on the microphotograph is 50 
μm. Ki67+−Ki67- positive cells, DCX+−DCX-positive cells. Bars are 
Mean ± SEM. β-tubulin was used as a 
reference in the Western blot assay, the expression of all proteins is 
normalized to β-tubulin expression. 
 
 
In addition, hippocampal gene expression of markers of morphological 
plasticity was significantly reduced in mice exposed to the ultrasound stress. 
In comparison with control group, mRNA concentrations of neurotrophin 
BDNF, its receptor TrkB, early progenitor cells marker Nestin and a marker 
of immature neurons BLBP were significantly decreased in comparison 
with control group (U=1, p=.0001; U=3, p=.016, U=5, p=.042, and U=1, 
p=.015, respectively, Mann-Whitney test; Fig. 3D). 
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3.2. Ultrasound stress suppresses hippocampal plasticity 
mRNA levels of plasticity factors VEGF and NGF did not differ 
significantly between the groups (U=9, p=.24 and U=8, p=.67 respectively; 
Fig. 3D). Changes found in gene expression were further confirmed with 
Western blot method. In this assay, we found a significant reduction of 
hippocampal levels of BDNF, TrkB, Nestin, and BLBP in stressed mice as 
compared with control group (U=4, p=.016; U=2, p=.025, U=0, p=.009; 
U=1, p=.004, respectively, Fig. 3E,F). 
3.3. Pro-inflammatory effects of the ultrasound stress 
Merged staining of the hippocampal slices with DAPI, a marker of neuronal 
nuclei, and Iba-1, a marker of microglia (Fig. 4A), revealed increased 
densities of Iba-1-positive cells in the hilus of hippocampi of stressed mice 
as compared with control animals (U=2, p=.031, Mann-Whitney test; Fig. 
4B). 
Gene expression analysis of the hippocampus of stressed mice showed a 
significant up-regulation of mRNA levels of pro-inflammatory cytokines 
IL-1β (U=2, p=.007) and IL-6 (U=4, p=.029, respectively, Fig. 4C), but not 
anti-inflammatory cytokines IL-2, IL-8 and IL-15 (U=9, p=.27; U=7, p=.09; 
U=8, p=.51; respectively), as compared with control groups (Fig. 4D). Up-
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regulation of pro-inflammatory cytokines was further supported in the 
Western blot assay. 
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Fig. 4. Ultrasound stress induces inflammation and oxidative stress in 
the hippocampus. (A) Analysis of immunohistochemical staining of Iba-
1- and DAPIpositive cells revealed increased numbers of Iba-1- positive 
neuronal cells in the stressed group, as compared with control mice. (B) 
Stressed mice had a significantly increased density of Iba-1-positive cells, 
as compared with control group (*p < .05 vs. control, Mann-Whitney test; 
5 animals per group were used) and the appearance of the microglia was 
more rounded in these animals (see Suppl Fig. 6). In the assays performed 
here, an n=12 was used. A qRTPCR experiment (C) revealed significantly 
elevated levels of mRNA of IL-1β and IL-6 in stressed animals, in 
comparison with control mice (*p < .05 vs.control, Mann-Whitney test); no 
such changes were found for IL-2, IL-8 and IL-15 (p > .05 vs.control, Mann-
Whitney test). (D, E) In the Western Blot assay, similar group differences 
were found for IL-1β and IL-6 (*p < .05 vs.control, Mann-Whitney test); no 
group changes were shown for IL-2, IL-8 and IL-15 (p > .05 vs.control, 
Mann-Whitney test). (F) In ELISA assay, plasma concentrations of IL-1β, 
IL-6 and TNF-α in the stressed group were significantly higher than in 
controls (*p < .05 vs.control, Mann-Whitney test). Hippocampal levels of 
(G) malondialdehyde and (I) 3-nitrotyrosine were significantly higher in 
stressed mice than in the control group (*p < .05 vs. control, Mann-Whitney 
test). Bars are Mean ± SEM. The scale bar on the microphotograph is 50 
μm. β-tubulin was used as a loading control in the Western blot assay; the 
expression of all proteins is normalized to β-tubulin expression. 
 
In comparison with control group, stressed animals had a significant 
increase in protein fold expression of IL-1β, IL-6 in the hippocampal 
formation (U=3, p=.06; U=6, p=.031, respectively; Fig. 4D,E). In addition, 
concentrations of all these factors and TNF-α were significantly higher in 
the plasma of stressed versus control groups of mice, as shown in ELISA 
assay (U=2, p=.035; U=6, p=.002; U=6, p=.007, respectively; Fig. 4F). 
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Finally, hippocampal concentrations of markers of oxidative stress, whose 
accumulation is known to be associated with up-regulated 
neuroinflammatory processes, malondialdehyde, and 3-nitrotyrosine 
content, were significantly elevated in the stress group as compared with 
control mice (U=7.6, p=.019; U=1.8, p=.012, respectively, Mann-Whitney 
test; Fig. 4G,I). 
3.4. Altered activities of GSK-3β and related pathways during ultrasound 
stress 
In this study, we sought to discover whether GSK-3β and related pathways 
would be altered during the ultrasound stress. We found a significant 
increase in mRNA levels of GSK-3β (U=5, p=.009, Mann- Whitney test) as 
well as of GSK-3α (U=7, p=.034) in stressed versus control mice (Fig. 5A). 
Western blot analysis revealed significant upregulation of these molecules 
on a protein level (U=6, p=.041, U=4, p=.047, respectively, Fig. 5B,C).  
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Fig. 5. Ultrasound stress increases activities of GSK- 3β-related 
mechanisms in the hippocampus. (A) Stressed animals, as compared with 
the control group, had significantly higher hippocampal concentrations of 
both β and α isoforms of GSK-3 (*p < .05 vs. control, Mann-Whitney test). 
(B, C). In stressed mice, in comparison with the control group, protein fold 
expression of GSK-3β, GSK-3α, FOXO3a and PTEN was significantly 
elevated, and expression of AktpSer473 was significantly decreased (*p < 
.05 vs. control, Mann-Whitney test). Bars are Mean ± SEM; 12 animals per 
group were used in all assays. β-tubulin was used as a loading control in the 
Western blot assay, the expression of all proteins is normalized to β-tubulin 
expression. 
 
Moreover, a significant increase of FOXO3a and PTEN molecules 
(functionally related to GSK-3 pathway), as well as decreased expression 
of AktpSer473, were observed (U=30.5, p=.0148, U=11.5, p=.0001 and 
U=37, p=.0425, respectively; Fig. 5B,C). Thus, exposure of mice to the 
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ultrasound resulted in heightened brain activities if the GSK-3-related 
cascades. 
3.5. Correlation analysis of behavioural and hippocampal changes during 
ultrasound stress 
To assess potential relationship between depressive-like behaviours and 
molecular changes in the hippocampal formation we performed a 
correlation analysis between individual parameters. Significant correlations 
were found exclusively within the stress groups, but not in the control 
groups. However, owing to the smaller group sizes used in 
immunohistochemical and oxidative stress assays, these data were not 
included in the analysis. We found that total duration of floating positively 
correlated with GSK-3β expression on gene and protein levels (p=.003, 
r=0.62 and p=.04, r=0.58, respectively, Spearman correlation), but not with 
measures of GSK-3α expression (p=.17, r=0.41, and p=.48, r=−0.22, 
respectively, Fig. 6A).  
Similarly, there was a significant positive correlation of GSK-3β mRNA 
expression and GSK-3β fold protein changes with the number of attacks 
(p=.01, r=0.69, p=.01, r=0.7) that was not found for alpha form of GSK-3 
in either measurement (p=.63, r=0.15, p=.68, r=0.13, respectively, Fig. 6B).  
191 
 
 
Fig. 6. Correlation analysis of depressive-like behaviours and gene and 
protein expression of the elements of GSK-3β-related pathways. For the 
most of cases, significant correlations between mRNA and protein level of 
GSK-3β but not GSK-3α were found, and (A) protein level of AktpSer473, 
behavioural parameters of (B) the forced swim test, (C) resident-intruder 
test, but not in (D) open field, as well as were found in stressed mice. 
Grooming behavior in the open field test has significantly correlated with 
mRNA levels of GSK-3α; there was a trend toward such correlation for 
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mRNA GSK-3β. Line: p < .05, Spearman correlation for linear trend; 12 
animals per group were used in all assays. 
 
Number of grooming events has positively correlated with GSK-3β or GSK-
3α expression on protein level (p=.04, r=0.58; p=.02, r=0.63, respectively, 
Spearman correlation), but not in gene expression measures (p=.17, r=0.41, 
p=.31, r=0.31, respectively Fig. 6C). Finally, we found significant negative 
correlations between mRNA and protein changes of GSK-3β, and 
AktpSer473 on a protein level (p=.03, r=−0.61, p=.04, r=−0.59, 
respectively, Fig. 6D). No such correlations were revealed for the 
expression of GSK-3α on either gene or protein levels (p=.66, r=−0.12, 
p=.47, r=−0.21, respectively). No other significant correlations were found 
(p > .05, Spearman). 
4. Discussion 
The present study demonstrated profound neurobiological changes, 
characteristic for a depressive syndrome in humans and experimental 
animals, in mice subjected to the ultrasound stress of alternating 
frequencies. In addition to previously reported decrease in reward 
sensitivity, elevated “despair behaviour” during forced swimming, 
increased aggression, anxiety and behavioural invigoration, mice exposed 
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to the ultrasound stress have displayed morphological and molecular signs 
of deficient hippocampal plasticity, pro-inflammatory and pro-oxidative 
changes, and dysregulated activities of the GSK-3β/Akt/FOXO3a pathway. 
Our experiments reveal that ultrasound stress decreased the densities of 
Ki67-positive and DCX-positive cells and expression of neurotrophins, 
including BDNF and its receptor TrkB in the hippocampus. Together these 
findings suggest that plasticity and the production of neuronal progenitors 
during ultrasound stress are decreased. Stressed mice displayed increased 
plasma levels of TNFα and cytokines IL-1β and IL-6 and of hippocampal 
expression of IL-1β and IL-6. These proinflammatory changes were 
accompanied by increased microglia, and of oxidative stress markers 3-
nitrotyrosine and malondialdehyde, indicating increased oxidative stress in 
the brain of mice exposed to the ultrasound of unpredictably alternating 
frequencies. Furthermore, brain expression of beta and alpha isoforms of 
GSK-3 and the functionally related molecules FOXO3a, PTEN and 
AktpSer473 were significantly altered in stressed mice, suggesting the 
involvement of GSK-3β/Akt/FOXO3a pathway, in the depressive-like 
syndrome induced by the ultrasound exposure. 
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Extensive literature of the last decade has evidenced the impact of 
neuroinflammatory processes, in particular, changes in microglial 
morphology and number and over-expression of pro-inflammatory 
cytokines, in the development of depressive syndrome in clinical and 
preclinical situations (Dantzer et al., 2008; Paolicelli et al., 2011; Couch et 
al., 2013, 2016). Similarly to these results, the current study revealed signs 
of the activation of resident microglia in the hippocampus of mice exposed 
to the ultrasound stress. As activated microglia can suppress the production, 
survival, migration, and recruitment of new neurons (Qin et al., 2002; 
Ekdahl et al., 2003; Wang et al., 2005; Lazarini et al., 2012; Chen et al., 
2012), this mechanism is likely to underlie abovedescribed manifestations 
of deficient hippocampal neuroplasticity. 
Our previous studies with the ultrasound stress model revealed that brain 
expression of the serotonin transporter and the receptors 5-HT1A and 5-
HT2A are significantly altered in the stressed animals (Morozova et al., 
2016). These components of the serotoninergic system and serotonin itself 
are known to be involved in neuronal plasticity (Mahar et al., 2014; Carhart-
Harris and Nutt, 2017) and their expression is also regulated by pro-
inflammatory mediators secreted by microglia (Müller, 2014; Dukhinova et 
al., 2018). Thus, it seems likely that the hippocampal plasticity changes 
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observed here might be underpinned by serotoninergic mechanisms. The 
normalizing effects of SSRI fluoxetine on the BDNF levels further support 
this view (Morozova et al., 2016).  
Changes in microglial morphology and number may be triggered by local 
over-production of cytokines by neurons (Bluthe et al., 1994) or/and 
excessive penetration of inflammatory cytokines from the systemic 
circulation to the brain (Dantzer et al., 2008). Increased gene and protein 
expression of not anti-, but pro-inflammatory cytokines, and their elevated 
plasma concentrations in animals subjected to the ultrasound stress suggest 
the role of both central and peripheral mechanisms of activation of 
microglia by cytokines in the present study. 
Moreover, resident microglia can be a source of pro-inflammatory 
cytokines (Lee et al., 1993) and inflammatory prostaglandins (Saliba et al., 
2017) that can further aggravate neuroinflammation and its inhibitory 
effects on the neurogenesis (Wang et al., 2005). Perturbation of microglia 
has been reported to stimulate an oxidative stress that drives progressive 
neuronal damage (Qin et al., 2002; Block and Hong, 2007; Mao et al., 2007; 
Roy et al., 2008). The latter fact is important for the interpretation of the 
outcomes from our study in light of our findings that the concentration of 
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markers of oxidative stress – malondialdehyde and 3-NT – are increased in 
the hippocampus of stressed mice. Thus the increase in microglial number 
and the pro-inflammatory changes in the hippocampus suggest that 
microglia may be responsible for the increase in oxidative stress induced by 
the ultrasound stress paradigm. Microglia may also affect neuronal function 
by directly altering synaptic transmission by the release of mediators 
(chemokines for example) or, indirectly, by contributing to a physical 
remodeling process. With regard to the modulation of neuronal activity by 
an altered microglial phenotype, an intimate relationship between 
astrocytes, neurons, and microglial processes has been described (Tremblay 
et al., 2012). However, electron microscopy studies have also shown that 
only a small percentage of synapses receive direct contact by a microglial 
process (Sogn et al., 2013). In relation to the structural changes, microglia 
can actively remove live and dying neurons from the brain as part of a 
“phagoptosis” process (Brown and Neher, 2012). A smaller hippocampal 
CA1 in post-traumatic stress disorder, consistent with model systems in 
rodents that exhibit increased anxiety-like behaviour that occurs after 
repeated exposure to stress (Chen et al., 2018). While we did not measure 
hippocampal volume in our studies, we might speculate that the increased 
numbers of Iba-1-positive microglia may reflect an increase in phagoptosis 
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within the hippocampus that could lead to adaptive structural changes. 
Ongoing work in our laboratory is seeking to discover how long-lived are 
the stress induced changes.   
In addition to phagocytosis and the clearance of cellular fragments 
(Hosmane et al., 2012; Schafer et al., 2012), microglia may also be involved 
in synaptic stripping in neurodegenerative conditions (Perry and O'Connor, 
2010). For example, the role of microglia in the active elimination of 
extranumerary synapses was proposed many years ago in the context of the 
developing retinogeniculate system, where a complement-dependent 
remodeling process leads to eye-specific segregation (Stevens et al., 2007). 
However, in the early phase of prion disease, the loss of synapses is not 
associated with microglia processes, and thus it cannot be assumed that the 
presence of microglia with a more rounded appearance means that they are 
playing an active role in a remodeling process. However, following stress, 
we and others have noted that there is an increase in the number of microglia 
and a change in their morphology in key brain regions associated with 
mood. While altered Iba-1 staining in these circumstances is often 
associated with regional increases in cytokine expression, it still remains 
unclear how microglia might be contributing to stress-induced structural 
remodelling of the hippocampus or the modulation of neuronal activity. We 
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found that ultrasound stress altered hippocampal mRNA gene and protein 
expression of GSK-3β, a marker of distress and depression (Beurel et al., 
2015), as well as the associated molecules FOXO3a, PTEN and 
AktpSer473. GSK-3β is known as a key regulator of cell apoptosis, 
metabolism, and plasticity and its up-regulation accompanies the 
development of depressive-like syndrome in a clinical and in animal models 
(Kaidanovich-Beilin and Woodgett, 2011; Markova et al., 2016; Strekalova 
et al., 2016). In this context described here, over-expression of GSK-3α, 
FOXO3a, and PTEN in the hippocampus of stressed animals is well known 
to be functionally synergistic to over-production of GSK-3β. Heightened 
activities of these molecules can result in cell death and associated with 
maladaptive stress responses (Polter et al., 2009; Fey et al., 2012; Cline et 
al., 2015b; Pomytkin et al., 2015; Pavlov et al., 2017). Increased activity of 
GSK-3β activates PTEN and FOXO3a, consequently resulting in activation 
of mechanisms of apoptosis, while AktpSer473, whose hippocampal 
expression was decreased in mice subjected to the ultrasound stress, is a 
molecule with anti-apoptotic functions (Wu et al., 2009; Fey et al., 2012); 
its production is known to be suppressed by the above-mentioned factors 
(Chang et al., 2003; Huang et al., 2013). Thus, changes in expression of the 
GSK-3β/Akt/FOXO3a cascade suggest the activation of pro-apoptotic and 
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pro-inflammatory mechanisms which are consistent with effects of stress 
reported here, including impairments in hippocampal plasticity. 
In a similar manner to other established depression paradigms in mice, 
exposure to the ultrasound stress in the current study resulted in the over-
expression of hippocampal GSK-3β (Gould et al., 2006; Garza et al., 2012; 
Cline et al., 2015b; Strekalova et al., 2016; Pavlov et al., 2017). Moreover, 
these increases positively correlated with the measures of behavioural 
despair and aggression, but not with grooming behaviour in the open field. 
While the upregulation of GSK-3β activities in stressed animals was 
accompanied by similar over-expression of hippocampal GSK-3α, no 
correlation between the latter and behavioural changes were found with the 
exception of grooming, a sign of behavioural invigoration (Willner and 
Belzung, 2015), and suggests that there are differences in the functional and 
dynamic characteristics of two GSK-3 isoforms (Liang and Chuang, 2007; 
Beurel et al., 2015; Pavlov et al., 2017). 
Additional studies employing the ultrasound stress model have 
demonstrated molecular and biochemical changes in other brain areas of the 
limbic system, which were similar to the changes reported here within the 
hippocampal formation. Such a result was not unexpected, given that 
200 
 
emotional stress activates the hypothalamus-pituitaryadrenal stress system, 
which receives inputs from a number of limbic structures, such as amygdala 
and the prefrontal cortex (Tsigos and Chrousos, 2002; Mehta et al., 2018). 
As in the hippocampus, the prefrontal cortex of mice exposed to the 
ultrasound was found to exhibit downregulated BDNF, TrkB, and other 
plasticity factors. Furthermore, there was over-production of pro-
inflammatory cytokines IL-1β and IL6, and signs of oxidative stress 
(Morozova et al., 2016; Gorlova et al., 2018, 2019). These mice showed an 
increase of protein carbonyl content, a decrease of levels of glutathione and 
mitogen-activated protein kinase phosphatase (MKP1); systemic pro-
oxidative changes in the brain were further suggested by the recent findings 
of the elevated total glutathione levels in the amygdala, striatum and raphe 
dorsalis (o be corrected: Gorlova et al., 2018, 2019). Given distinct 
functional roles of dorsal versus ventral hippocampus in the regulation of 
memory processes and mood / stress responses (Maras et al., 2014; Bagot 
et al., 2015, Calabrese et al., 2015), it would be of interest to explore other 
anatomical differences at a more detailed level now that we have established 
that ultrasound stress can induce such profound changes. 
Elevated protein levels of GSK-3β and PTEN, coupled with decreased 
concentrations of Akt in the prefrontal cortex in these animals suggest that 
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ultrasound stress induces more widespread changes throughout the brain 
(Gorlova et al., 2018, 2019). The present study with ultrasound stress 
provides further validation for the use of this model for translational 
research on stress and depression. There has been a general move toward 
the use of experimental approaches in mice that employ a naturalistic 
element. For example the exposure of rodents to altered maternal care (Rice 
et al., 2008; Baram et al., 2012), social confrontation and defeat, social 
isolation, social fear conditioning, chronic subordinate colony housing, 
conditions of social instability (Buwalda et al., 2005; Nestler and Hyman, 
2010; Chaouloff, 2013; Toth and Neumann, 2013), and housing in the 
deficient cage environment (Baram et al., 2012) have all been employed. 
While naturalistic stress depression models appear to have more validity in 
modeling depressive disorder (Pollak et al., 2010; Iraci et al., 2016), 
numerous limitations exist that limiting their practical application and 
include a lack of reliability in the induction of the depressive phenotype, 
and high sensitivity to subtle alterations in the environmental conditions 
(van Hasselt et al., 2012; Bouwknecht, 2015; Willner and Belzung, 2015). 
These limitations can explain, at least in part, why the use of artificial 
physical stressors to give more controllable and predictable outcomes is an 
attractive alternative (Strekalova and Steinbusch, 2010, Strekalova et al., 
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2011; Overstreet, 2012; Willner and Belzung 2015; Willner et al., 2018). 
No systematic comparisons of the behavioural and neurobiological 
outcomes of naturalistic or physical stress paradigms has been undertaken. 
However, the current literature suggests that both types of models evoke 
overall similar degrees of the neurobiological changes in animals, including 
the pro-inflammatory changes, impairment of the hippocampal 
morphological and functional plasticity, as well as increases in the oxidative 
stress and the activities of GSK-3β-related pathway (Goto et al., 2015; 
Bakunina et al., 2015; Bian et al., 2015; Anacker and Hen, 2017; Lisboa et 
al., 2018). Many results suggest that the use of established chronic stress 
models can be more reliable than naturalistic paradigms to induce 
anhedonic behaviour, but the use of social avoidance stress, maternal 
separation, and other naturalistic stress paradigms seem better able to evoke 
helpless behaviour and alter social interactions in the experimental animals. 
In this context, and taking into account the present results, we believe that 
the ultrasound stress employed here can offer a useful compromise between 
the two types of stress models by combining etiological relevance with 
improved reliability and reproducibility of the physical stress paradigms. 
5. Conclusion 
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In summary, the ultrasound stress model with alternating frequencies that 
mimic the features of emotional stress in humans is able to induce the 
typical behavioural and neurobiological hallmarks of the depressive state, 
including deficient hippocampal plasticity, neuroinflammation, oxidative 
stress and altered activity of the GSK-3β/Akt/FOXO3a cascade. These 
inter-connected processes result in aberrant hippocampus activity and the 
activity of other limbic structures, including prefrontal cortex and amygdala 
resulting in the behavioural, vegetative and hormonal features of depressive 
disorder (Tsigos and Chrousos, 2002; Buwalda et al., 2005; Mahar et al., 
2014; Chesnokova et al., 2016; Anacker and Hen, 2017). Accumulating 
clinical evidence suggests that repeated exposure to psychological stress in 
humans profoundly impacts peripheral immune responses and perturbs the 
function of brain microglia, increases levels of circulating pro-
inflammatory cytokines, which can together contribute to the 
neurobiological changes underlying depressive symptoms (Wohleb et al., 
2016; Miller and Raison, 2016). 
The data reported here are consistent with these and other clinical findings 
suggesting cross-talk between GSK-3β/Akt/FOXO3a as a hub of the stress 
response, the neuroimmune system and neuroplasticity mechanisms during 
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depression (Pomytkin et al., 2015; Jope et al., 2017). Anti-neuroplastic 
changes which occur in depressed patients include a decrease in 
proliferation of neural stem cells, decreased survival of neuroblasts and 
immature neurons, reduced levels of neurotrophins and spine density, as 
well as increases of IL-1, IL-6, TNF-α, CD4+CD25+T regulatory cells, 
monocyte-derived macrophages and altered behavior of microglia (Eyre 
and Baune, 2012). Together, the present study highlights the utility and 
relevance of using ultrasound radiation to study the molecular basis of 
clinical depression. 
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SUPPLEMENTARY MATERIAL  
Ultrasound exposure 
A study of a dose-response effect, the threshold and duration of sound 
intensity of ultrasound stimulation on mouse emotional behaviour 
  
To define for the dose-response effect and the threshold sound intensity of 
ultrasound stimulation at the frequencies of 20-45 kHz on animals’ 
emotional behaviour, in a separate preliminary study, Balb/c mice were 
exposed to a 24-h ultrasound of about 50 dB or 90 dB, their emotional 
behaviours were scored in a battery of tests during the first 15 min of this 
period. In another experiment, BALB/c mice were subjected to the same 
housing and experimental conditions as is described in the main text 
ultrasound stress study, except the ultrasound exposure lasted also 1 week 
or 2 weeks. On the next day, emotional and social behaviours of control and 
stressed mice was investigated. Six-eight mice per group were used in these 
studies.   
 
 
 
224 
 
 
Figure 1. Ultrasound of 50 dB or 90 dB, but not 30 dB produces 
immediate behavioral effects in BALBc mice. Mice exposed to 
ultrasound of variable frequency 20-45Hz and  intensity of 50 dB or 90 dB, 
but not 30 dB display (A) significantly reduced latency of burying behavior, 
(B) significantly decreased number of approached to palatable food (C), 
significantly  elevated latency of approaching to a new object, in 
comparison to non-stressed control mice. Mice exposed to a sound of the 
highest loudness tended to display greater changes (*p<0.05 vs. control 
group, one-way ANOVA and post-hoc Tukey test). Bars are means±SEMs. 
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Figure 2. Lack of behavioral effects of a 1-week and 2-week exposure 
to a 50-dB ultrasound of variable frequency of 20-45Hz. In comparison to 
intact control groups, groups of animals exposed to a 1-week or 2-week 50 
dB-ultrasound of mixed frequencies at the range of 16 kHz displayed similar 
(A) duration of social interaction (B) total time spent with floating and (C) 
sucrose preference, thus, demonstrating a lack of significant changes of 
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shortened ultrasound stimulation on depressive-like behaviours. (p>0.05 vs. 
control group, one-way ANOVA and post-hoc Tukey test). Only 3-week 
ultrasound exposure resulted in significant increase of total time spent with 
floating and significant decrease of sucrose preference. Bars are 
means±SEMs. 
 
A study of effects of a frequency range of ultrasound stimulation on 
mouse emotional behaviour 
 
In the next study, we compared immediate behavioural effects of ultrasound 
with an “emotionally negative” frequency range of 20-25 kHz against 
effects of ultrasound of “emotionally neutral” frequencies of about 16 and 
50-60 kHz (Figure 3). Six BALB/c mice were exposed for 15 min to the 
ultrasound of either frequency and averaged loudness 50 dB, or not exposed 
to any stimulation (control group, n=6). Ultrasound at the range of 20-25 
kHz, but not of other frequencies, appeared to alter freezing behaviour (Fig. 
3A), defensive burying (Fig. 3B), approaches to palatable food (Fig. 3C) 
and new object (Fig. 3D).  
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Figure 3. Ultrasound of selective ranges of frequencies produces 
immediate behavioral effects in BALBc mice. Mice exposed to 
ultrasound of frequencies 20-25 kHz, frequencies of 16 and 5-60 kHz, 
display (A) increased number of freezing episodes, (B) reduced latency of 
burying behaviour, (C) decreased number of approached to palatable food 
(D) elevated latency of approaching to a new object. Thus, ultrasound of 
freequences of 50-60 Hz did not affect any of measured behavioural 
parameters. *p<0.05 vs. control group, one-way ANOVA and post-hoc 
Tukey test. Bars are means±SEMs. 
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Thus, both studies on rats and mice evidence a lack of effects of loudness 
alone in the induction of a depressive-like state, as well as the specificity of 
“emotionally meaningful” ultrasound of frequencies 20-25 kHz. 
 
 
Sucrose test   
 
Mice were given a free choice between a bottle with 1%-sucrose solution 
and another one with tap water for 24 hours, as described elsewhere. At the 
beginning and end of the test, the bottles were weighed and consumption of 
liquids was calculated. The test was started with the onset of the dark 
(active) phase of the animals’ cycle. To prevent the possible effects of side-
preference in drinking behavior, the positions of the bottles in the cage were 
switched after 12 hours; no previous food or water deprivation was applied 
before the test. Other conditions of the test were applied as described 
elsewhere (Strekalova and Steinbusch, 2010; Strekalova et al., 2011). 
Percentage of preference for sucrose was calculated using the following 
formula: Sucrose Preference = Volume (Sucrose solution)/(Volume 
(Sucrose solution) + Volume (Water)) x 100. 
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Forced swim test    
 
A plastic transparent pool (diameter of 15 cm and a height of 25 cm) was 
filled with water to the depth for approximately 17 cm; water temperature 
was +23°C and the light intensity was 15 Lux. Mice were placed into the 
pool and their floating behavior was scored during the 6 min, at three 2-min 
intervals. Floating was defined by the absence of any directed movements 
of animals’ head and body; total duration of floating and the latency to float 
were scored offline using Any-maze software (Stoelting Co, Wood Dale, 
IL, USA) as described elsewhere (Strekalova and Steinbusch, 2010; 
Malatynska et al., 2012).  
Open field test   
The open field test was performed in the square gray plastic box 
(45x45x45cm) illuminated with white light (25 lux) as described elsewhere 
(Strekalova and Steinbusch, 2010). The mice were placed near the wall and 
the time spent in the central zone (15 x 15 cm), as well as the number of 
grooming events were recorded for a 5 min period with a digital camera 
placed above the arena. The recordings were subsequently analyzed using 
the automated video-tracking AnyMaze software (Stoelting Co, Wood 
Dale, IL, USA).  
230 
 
Resident-intruder test  
 
The resident-intruder test procedure was adapted from previously the 
described protocols (Couch et al., 2016; Strekalova et al., 2018). Briefly, 
the Balb/c mice from the experimental group were placed individually in an 
observation cage (30x60x30 cm) for 30 min to acclimatize. Thereafter, a 
previously group-housed naïve male Balb/c mouse of a similar weight and 
age to that of the resident was introduced as an intruder to the same cage 
and left with the resident mouse for 10 min. During the observation period, 
mice were scored for the latency to attack and the number of attacks. 
Immunohistochemical analysis 
Immunohistochemical analyses were performed as described previously 
(Strekalova et al., 2002, 2015, 2018; Vignisse et al., 2016). Ki67 
immunofluorescent staining was performed to identify proliferating cells; 
doublecortin (DCX) immunofluorescent staining was performed to examine 
neuronal differentiation; Ionized calcium binding adaptor molecule 1 (Iba-
1) immunofluorescent staining was performed to study microglial 
activation.  
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To produce paraffin blocks of dissected hippocampi, PFA-fixed 
hemispheres were incubated 2 times for 1 h with 70%-ethanol solution, for 
1.5 h with 80%-ethanol solution, for 1 h  with 95%-ethanol solution, 3 times 
for 1.5 h, in 100% -ethanol solution, 3 times for 1.5 hour in  xylene,  for 2 
h, in paraffin first wax paraplast Xtra (at 58°C), for 2 h paraffin second wax 
paraplast Xtra (at 58°C) in cassettes (Sigma-Aldrich, St. Louis, MO, USA). 
Initially, a small amount of molten paraffin was dispensed in mold 
from paraffin reservoir. Tissue was transferred into the mold using warm 
forceps. Subsequently, the mold was placed on a cold plate for paraffin to 
solidify into a thin layer. Hot paraffin was added to the mold from the 
paraffin dispenser to cover the front surface of the plastic cassette. Then 
paraffin blocks were stored until use at the room temperature. 
Samples were sectioned using a cryostat Leica CM 1850 cryostat (Leica 
Microsystems, Wetzlar, Germany). Serially cut sections were taken from 
lateral 3.6 to lateral 0.4 mm along the medial-lateral axis ahead of bregma 
(Paxinos and Franklin, 2001). Paraffin sections were picked up with forceps 
and placed on the surface of deionized water in the bath (Leica HI1210 
Water bath, Wetzlar, Germany) at 40ºC. Subsequently, they were mounted 
onto glass slides. Sections were air dried for 30 minutes and then covered 
with coverslips. 
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To remove paraffin, sections were incubated 3 times for 5 min with xylene, 
2 times for 10 min with 100%-ethanol solution, 2 times for 10 min with 
95%-ethanol solution, 2 times for 10 min with 70%-ethanol solution, 2 min 
for 10 min with 50%-ethanol solution (Sigma-Aldrich, St. Louis, MO, 
USA) and 2 times for 5 min in ice-cold deionized water. 
For antigen retrieval with Ki67- and DCX- staining assays, 3 randomly 
selected hippocampal sections were incubated for 30 minutes at 90°C in 10 
mM sodium citrate and 0.05% Tween 20, pH 6.0 (Applichem, Darmstadt, 
Germany) per each assay. For Iba-1-staining, 3 randomly selected sections 
were incubated 3 times during 10 min per each step, in a Tris-buffered saline 
(TBS), pH 7.6, and then treated with 2N HCl during 30 min at 37 °C and 
washed in 0.1 M borate buffer pH 8.5 for 10 min (Applichem, Darmstadt, 
Germany). We used water bath for heat-induced epitope retrieval. 
Blocking of non-specific staining was performed with 1% bovine serum 
albumin (BSA, Fluka, Buchs, Switzerland) in PBS, pH 7.4, at room 
temperature for 1 h with all three assays. Sections were drained for a few 
seconds and wiped with a tissue paper. Subsequently, overnight incubation 
at 4°C with primary antibodies was performed using rat anti-Ki67 (Dako, 
Glostrup, Denmark), rabbit polyclonal anti-DCX (Chemicon, Temecula, 
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CA, USA), rabbit polyclonal anti-Iba-1 (Dako, Glostrup, Denmark) which 
were diluted in TBS containing 0.1% Triton, 0.1% Tween 20 and 5% 
normal donkey serum in following concentrations: Ki67 (1:100), DCX 
(1:20) and Iba-1 (1:1000).  
Thereafter, sections were washed 3 times with 0.1% BSA in PBS, pH 7.4 
and for 2 hours at 4°C in the dark incubated with secondary antibodies: 
donkey anti-rat-Alexa Fluor 594, anti-rabbit-Alexa Fluor 488 and anti-
rabbit-Alexa Fluor 647, respectively (Life Technologies-Molecular Probes, 
Grand Island, NY, USA).  
 
To visualize cell nuclei, DAPI staining was performed. 10 mg of DAPI 
(1:1000; Santa Cruz Biotechnology, Dallas, TX, USA) was dissolved in 2 
ml of dimethylformamide (DMF) to prepare a stock solution that was 
further diluted to a concentration of 30 nM in PBS; 350 µl of this staining 
solution was used per each slice that was cover-slipped and incubated for 
30 min at the room temperature thereafter. After rinsing of slices with PBS, 
fluorescent microscopy with maximal fluorescence excitation/emission at 
358/461 nm was carried out.  
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With each assay, control samples with secondary antibody alone were 
included for internal autofluorescence reference. Immunofluorescent 
images were captured and analyzed by an experimenter blind to the 
experimental conditions as described elsewhere (Vignisse et al., 2016, 
Strekalova et al., 2015, 2018). Subgranular zone (SGZ) of the hippocampus 
was defined as a two-cell-body wide zone between the hilus and the base of 
the granular layer of the dentate gyrus and was measured using ImageJ 
software (NIH, Bethesda, MD, USA).  
Nissl staining was performed to determine the reference volume and, 
subsequently, the densities of Ki67- and DCX-positive cells defined as cell 
numbers in a volume of mm3 of SGZ (Fig.4A). Therefore, seven saggital 
sections were randomly selected, dewaxed with xylene (Sigma-Aldrich, St. 
Louis, MO, USA), treated with 95%-ethanol solution (Sigma-Aldrich, St. 
Louis, MO, USA), stained with 0.1% cresyl violet for 15 min (Sigma-
Aldrich, St. Louis, MO, USA) and washed with distilled water. 
Iba-1- positive cells were counted in the defined area of the hilus of the 
hippocampus (Vignisse et al., 2017; Fig.4B); cell densities were calculated 
per mm2 as described previously (Couch et al., 2013). Image analysis was 
performed using Image J software (NIH, Bethesda, MD, USA).  
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A                                                              B 
Figure 4.Hippocampal areas defined for scoring of (A) Ki67- and DCX-
positive cells, (B) Ida-1- positive cells in a Nissle staining study. CA1 – 
cornu ammonis 1, CA3 – cornu ammonis 3, DG – dentate gyrus, GCL – 
granule cell layer, SGZ – subgranular zone. Scale bars are 10 μm (A) and 
50 μm (B). 
236 
 
Quantitative reverse transcription polymerase chain reaction analysis 
(qRT-PCR) 
 
Total mRNA was isolated from each hippocampus with TRI Reagent 
(Invitrogen, Carlsbad, CA, USA). First-strand cDNA synthesis was 
performed using random primers and Superscript III transcriptase 
(Invitrogen, Carlsbad, CA, USA); 1 μg total RNA was converted into 
cDNA. qRT-PCR was performed using the SYBR Green master mix (Bio-
Rad Laboratories, Philadelphia, PA, USA) and the CFX96 Deep Well Real-
Time PCR Detection System (Bio-Rad, Hercules, CA, USA). qRT-PCR 
was performed in a 25 μl reaction volume containing a 10хPCR Buffer 
(2.5l), 25 mmol MgCl2 (4 l), 10 mmol dNTPs (2l); 1 l of specific 
forward and reverse primers were used at the concentration 20 pmol/l, 2l  
of cDNA, 1 l of DNA polymerase (5 u/l) and 10 l of ddH2O.  
 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was selected as a 
reference gene, since in previous experiments it was observed relatively low 
variability in its hippocampal expression in ultrasound model (Morozova et 
al., 2016). The initial denaturation step for qRT-PCR was at 95°C for 4 min 
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followed by 40 cycles of denaturation at 95°C for 20 seconds. Annealing 
was at 54°C for 90 seconds.  
 
Further details, as well as the sequences of primers used are listed below 
(Table 1); all primers were purchased from Evrogen, Moscow, Russia. All 
samples were run in triplicate. Data were normalized to GAPDH mRNA 
expression and calculated as relative-fold changes compared to control mice 
that were not exposed to stress, as described elsewhere (Morozova et al., 
2016; Pavlov et al., 2017).   
 
 
 
 
 
 
 
Table 1. Sequences of primers for qRT-PCR 
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Western Blot assay 
Frozen hippocampal tissue was treated with lysis buffer containing 20 mM 
of Tris-HCl (pH 7.5), 450 mM of NaCl, 1%-solution of Triton X-100, 1 mM 
of EDTA, 1 mM of NaF, 1 mM of Na3VO4 and protease inhibitor (Roche 
Diagnostics, Indianapolis, IN, USA); 50 μl of buffer per 1 g of tissue was 
used. Samples were centrifuged at 16 000 rpm for 20 min at 4°C. The 
supernatant was collected and stored until use at -20°C. Subsequently, 25 
239 
 
μg of protein from each sample was mixed with 35 μl of Laemmli buffer. A 
sample of identical volume, comprising of 26 μl of Laemmli buffer, 5 μl of 
Page Ruler and 4 μl of Magic Mark (Sigma, Munich, Germany) was used 
as a reference. For electrophoresis, samples were diluted in a solution 
containing MilliQ H2O, 1.5 M of Tris Buffer (pH 8.8), 30%-solution of 
Acrylamide, 10%-solution of SDS Temed, 10%-solution of ammonium 
persulfate (APS). For the next step, a solution containing MilliQ H2O, 0.5 
M of Tris Buffer (pH 8.8), 30%-solution of Acrylamide, 10%-solution of 
SDS Temed, 10%-solution of APS and gel (Sigma, Munich, Germany) was 
used. The percentage of gel solution was adjusted to sizes of proteins of 
interest and was 20% for proteins of size of 4–40 kDa, 12.5% for proteins 
of the size of 40–70 kDa, 10% for proteins of the size of 70–100, and 7.5% 
for proteins over 100 kDa. A buffer containing 25 mM of Tris Base buffer, 
192 mM of Glycine (Sigma, Mannheim, Germany), 10%-solution of SDS 
and MilliQ H2O (pH 8.3) was used for gel electrophoresis which was carried 
out under the constant voltages of 80 V and 130 V.  
 
Polyvinylidene difluoride (PVDF) membrane (9 x 6 cm, EMD Millipore, 
Billerica, MA, USA) was consequently incubated in a 99%-methanol 
solution for 1 min (Brocacef, Amsterdam, the Netherlands), a MilliQ H2O 
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for 5 min, and a transfer buffer for 15 min. The latter contained 25 mM of  
Tris Base, 192 mM of glycine, 20%-solution of methanol, MilliQ H2O (pH 
8.3). For the next step, blot “transfer sandwich” was composed of buffer 
soaked sponge, consisting of two buffer soaked Whatman filter papers, gel, 
activated membrane, ice-cold transfer buffer;  the constant current of 300 
mA was used for 2 h 30 min. 
 
Thereafter, the membrane was treated with a 5%-dry milk solution  the 
TBST, containing 50 mM of  Tris-HCl  (pH=8.2), 150 mM of NaCl, 0.05%-
solution of Tween 20 (Sigma, Munich, Germany) for 1 h at the room 
temperature and subsequently incubated with primary antibodies at 4°C 
overnight that was followed by the incubation with respective horseradish 
peroxidase-conjugated secondary (HRP) antibodies (Sigma-Aldrich, St. 
Louis, MO, USA) for 2 h at room temperature on a roller. The membrane 
was washed in TBST three times, 5 min each time and placed on the plastic 
cover. Thereafter, Western BrightTM ECL kit (Advansta Inc, Menlo Park, 
CA, USA). A relative optical density of immunoreactive protein bands was 
examined using ImageJ software (NIH, Bethesda, MD, USA). Results were 
normalized to the relative intensity of the β-tubulin band that was selected 
as a reference protein as described elsewhere (Morozova et al., 2016). Blots 
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were stripped by incubation with Restore Western Blot stripping Buffer 
(Thermo Scientific, Rockford, IL, USA) at the room temperature for 15 min.   
 
To normalize the data, the value of each protein of interest was expressed 
in percent from the concentration value of β-tubulin, the reference protein. 
The choice of a reference protein was based on the previous observations 
where its expression was found to vary moderately across various 
experimental conditions as well as the linear representation of its signal 
intensity was demonstrated (Morozova et al., 2016; Bettendorff et al., 
unpublished data). 
Table 2. Primary antibodies used in the Western blot assay 
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Determination of protein concentration  
Protein concentration was quantified using the BCA protein assay kit 
(Pierce, Rockford, IL, USA). Working reagent was prepared in accordance 
with manufacturer instructions. 25µl of each standard or sample  
preparations were pipetted into a microplate well, 200µl of the working 
reagent was added to each well and mixed thoroughly on a plate shaker for 
30 seconds; assay was run in duplicates. Covered plate was incubated at 
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37°C for 30 minutes and cooled to room temperature for 10 min. The 
absorbance was measured at 562 nm in a Biotek Microplate Reader 
(Biotek Instruments, Winooski, VT, USA). Ascent Software Program 
(Winooski, VT, USA ) coupled to the microplate reader was used to 
calculate protein values based on comparing optical densities readings of 
the experimental samples with those obtained from the standard curve; the 
blank value was subtracted from all other optical densities readings. A 
standard curve was generated by plotting the average blank-corrected 562 
nm measurements for each BSA standard vs. its concentration in µg/ml.  
Table 3. Primary and secondary antibodies used in the ICH assay 
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Ultrasound stress suppresses hippocampal plasticity    
 
Staining with the neuronal nuclear marker DAPI (4′,6-diamidino-2-
phenylindole) and markers of cell proliferation Ki67 and progenitor 
neuronal cells DCX revealed decreased, in compared with control group, 
density of Ki67- and DCX- positive cells in the SGZ of the hippocampus of 
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stressed mice, suggesting that ultrasound stress inhibits neuronal 
proliferation in this brain structure. 
Hippocampal staining for plasticity markers 
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Figure 5. Low and high power microphotographs of DAPI/Ki67/DCX 
hippocampal immunostaining. Fluorescence microscopy of DAPI (blue), 
Ki67 (red) and DCX (green)  represents suppressed hippocampal 
proliferation rate as a result of stress exposure in Balb/c mice.  (A1-A2) 
DAPI-staining of hippocampus of stressed and control animals. (B1-B2) 
Ki67- positive cells in the hippocampus of stressed mice and control 
animals. (C1-C2) DCX - positive cells in the hippocampus of stressed and 
control animals. Images A1-C2 represent 4 times magnification of the 
original images. The scale bar is 1250 μm for low power figures and 315 
μm for high power figures.  
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Analysis of phenotypes of  microglia  
Phenotypes of  microglia were analyzed in according to a method of 
Lawson (1990). Round cells with up to three thick branches were counted 
as reactive (amoeboid) microglia; cells with three or more thick branches 
were counted as ramified (resting) microglia. Representative 
microphotographs demonstrate these types of microglial cells in control and 
stressed animals (Fig.6).  
Pro-inflammatory effects of the ultrasound stress 
Staining of the hippocampal slices neuronal nuclear marker DAPI and Iba-
1 (Ionized calcium binding adaptor molecule 1), a marker of microglia, 
revealed increased densities of Iba-1-positive cells in the hilus of 
hippocampi of stressed mice as compared with control animals. 
Hippocampal staining for activated microglia 
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Figure 6. Low and high power microphotographs of DAPI / Iba-1 
hippocampal immunostaining. Fluorescence microscopy of DAPI (blue) 
and Iba-1 (red) displayed microglial activation in stressed Balb/c mice. (D1-
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D2) Image of microglial clusters in the hippocampus of stressed and control 
animals, 4 times magnification of the original images. (A1-A2) Single 
microglial cells in the hippocampus of stressed and control animals, 12 
times magnification of the images D1-D2. The scale bar is 1250 μm for low 
power figures and 300 or 25 μm for high power figures. 
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CHAPTER 5. DISCUSSION AND SOCIETAL IMPACT 
5.1 GSK-3-related molecular and neuroinflammatory changes as 
common mechanisms of the depressive syndrome  
In the examined models we have seen pro-inflammatory changes that were 
accompanied by an increase of oxidative stress markers. Activation of the 
immune system following stress exposure is an adaptive mechanism to 
protect the host from a pathogenic environment and to hasten wound healing 
(Miller et al., 2016; Fig. 6). At the same time, this hyperactivation can be 
maladaptive under certain conditions and here, in the ultrasound stress 
study, we have demonstrated potent activation of microglia that are an 
important source of ROS in the brain. Activation of microglia can be 
triggered by local or systemic overproduction of pro-inflammatory 
cytokines (Bluthe et al., 1994; Dantzer et al., 2008). Notably, while we have 
seen an upregulation of pro-inflammatory cytokines, no changes in the 
production of anti-inflammatory cytokines was observed in our study, 
which is in the line with reports that GSK-3β, overexpressed in our model, 
can inhibit production of anti-inflammatory cytokines (Jope et al., 2017). 
An upregulation of pro-inflammatory cytokine production both on systemic 
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and local levels suggests a role of peripheral and central mechanisms of 
microglial activation in our model. 
It is important to note that microglial cells can produce pro-inflammatory 
cytokines as well (Lee et al., 1993) that can additionally enhance microglial 
activation; activated microglia were shown to be implicated in 
neuroplasticity disruption (Wang et al., 2005). Interestingly, activated 
microglia can facilitate local oxidative stress and lead to an additional 
damage on -a neuronal level and neurodegeneration on a structural level 
(Mao et al., 2007). This observation is crucial in terms of our results 
regarding elevated content of oxidative stress markers such as 3-NT and 
MDA in animals following ultrasound radiation as microglial activation can 
be an important factor for oxidative stress in this case. Microglia are 
implicated in synaptic pruning, dendritic remodeling, and can regulate 
neurotransmission. Microglia can phagocyte neurons thus increased number 
of activated microglial cells may reflect higher rate of phagocytosis in this 
brain area and a reduction in volumetric parameters that was observed in 
our preliminary studies. 
The GSK-3 isoform is often regarded as a molecular marker of distress, 
anxiety and depression (Beurel et al., 2015). In our study its expression was 
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upregulated following stress exposure as well as expression of FOXO3a and 
PTEN, while protein kinase B was downregulated. GSK-3 is implicated in 
a wide spectrum of cell functions ranged from metabolism to apoptosis, it 
is important for neuroplasticity and neurogenetic processes, as well as for 
the development of affective disorders including depression (Markova et 
al., 2016; Strekalova et al., 2016). Regarding described data from our 
experiments, such as overexpression of FOXO3a and PTEN, that are 
functionally related to an upregulation of GSK-3, the collective activities of 
these molecules can provoke cell death and neurodegenerative brain 
changes due to maladaptation (Polter et al., 2009; Pavlov et al., 2017). 
Activity of beta isoform of GSK-3 activates FOXO3a and PTEN thus 
triggering apoptosis. Protein kinase B can be downregulated by these 
cascades; Akt has anti-apoptotic functions (Wu et al., 2009). To sum up, 
observed changes in GSK-3/FOXO3a/Akt pathway represent pro-apoptotic 
alterations which are consistent with the pro-inflammatory profile that we 
revealed previously. Schematically these pathways are outlined in Fig.5. 
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Figure 5. Schematic outline of GSK-3-mediated pro-inflammatory 
pathway. GSK-3β - glycogen synthase kinase 3 beta; Akt - protein kinase 
B; PI3K -phosphoinositide 3-kinase; NF-kB – nuclear factor kappa-light-
chain-enhancer; CREB - cAMP response element-binding protein; IL – 
interleukin, PTEN – phosphatase and tensin homolog, TNF – tumor 
necrosis factor (Adapted from Golpich et al., 2015). 
 
In the modFST study we have established that repeated exposure to the 
same contextual adverse experiences results in the prolonged duration of 
floating behavior and brain overexpression of GSK-3 isoforms and that they 
are positively intercorrelated (Markova et al., 2017; Pavlov et al., 2017). As 
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forced swim re-exposure results in the increased systemic CORT content 
(Pavlov et al., 2019), and given that this upregulation is accompanied by 
GSK-3 overexpression, we may suggest that these changes trigger 
neuroinflammation manifested in central overexpression of TNF, IL-6 and 
COX-1 (Chang et al., 2013; Beurel et al., 2015; see Fig. 5-6). Presumably, 
GSK-3 exerts its pro-inflammatory activities through NF-kB-dependent 
mechanisms (Chang et al., 2013).  
In both the ultrasound and modFST projects we have demonstrated the 
overexpression of TNF, an important pro-inflammatory cytokine and a 
prominent marker of inflammation. The involvement of this cytokine in the 
development of depressive syndrome and its potentials to contribute to the 
vulnerability mechanisms of predisposition to a depressive syndrome has 
gained an extensive attention in the recent years. Genetic knock-out models 
provided the evidence for anti-depressant-like behavioral alterations after 
the selective switching off of genes encoding TNF or its cognate receptors 
(Simen et al., 2006). These data are in the line with reports about depressive 
syndrome ameliorations under selective blockage of TNF signaling (Krugel 
et al., 2013). TNF is upregulated centrally and systemically in patients 
suffering from major depressive disorder (Misener et al., 2008) and in 
animal models of depressive syndrome (Krugel et al., 2013). Our data are 
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consistent with these reports and we demonstrated a link not only between 
limbic TNF upregulation and enhanced learning to adverse memories but 
also have shown that TNF overexpression has contributed to the 
development of depressive-like traits in depressive syndromes of various 
aetiologies.  
IL-1 is known for its role in induction of sickness behavior, chronic fatigue 
and depression (Misener et al., 2008). There is an emerging concern about 
the role of IL-1 and related signaling pathways in mediation of chronic 
stress effects on an animal emotionality (D'Mello and Swain, 2017). This 
cytokine exerts an important role in the interindividual vulnerability 
mechanisms of a host predisposition to a depressive syndrome in an 
extensive literature (Couch et al., 2013; Fang et al., 2019). Our data from 
both sub-experiments is in the line with these observations that gives us a 
notion about universal mechanisms of involvement of IL-1 in depressive-
like conditions induced by distinct triggers. Notably, overexpression of IL-
1 is a characteristic trait for patients with depression comorbid with PTSD 
(Toft et al., 2019).  
We assessed mRNA expression of COX-1 as it was shown that knock-out 
COX-1 mice are resilient to stress-induced depressive like states (Tanaka et 
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al., 2012), and that PTSD patients displayed upregulated COX-1 in the 
central nervous system (Powers et al., 2019). Repeated swimming sessions 
elevated COX-1 content in the examined limbic structures thus additionally 
emphasizing the profound proinflammatory changes in brain regions 
involved in enhanced learning of adverse memories.  
 
Figure 6. Inflammatory bias in evolution. Adapted from Miller et al., 
2016. Recent theories hypothesize that sickness behavior and conditions 
related to depression, such as social avoidance, serve to preserve energy 
resources required for metabolically expensive tasks such as to escape 
predators, heal wounds or fight infections. Thus, from an evolutionary point 
of view some of the depressive-like traits could serve to enhance chances of 
survival. In the modern world these pro-inflammatory changes are largely 
detrimental when experienced in response to psychosocial stressors. 
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Of particular significance, thiamine and imipramine treatments largely 
ameliorated the effects of stress on depressive-like behaviour, as well as 
stress-mediated GSK-3 upregulation and increased oxidative stress markers 
(Vignisse et al., 2017; Gorlova et al., 2019). My present results confirm our 
previous findings and also demonstrate the anti-inflammatory effect of 
these treatments. 
5.2 The role of GSK-3 isoforms in altered neuroplasticity and oxidative 
stress in depressive syndromes  
An extensive literature search suggests that GSK-3 isoforms can affect 
neuroplasticity and increase production of ROS thus exacerbating 
depressive traits  and suppressing plasticity mechanisms.  
In the ultrasound study observed behavioral changes were accompanied by 
downregulated markers of hippocampal neuroplasticity, such as BDNF and 
its cognate receptor TrkB. The immune system was also affected and we 
revealed activation of microglia shown as an increased population of Iba1 
positive cells and an overexpression of the prominent pro-inflammatory 
cytokines IL-1β, IL-6 and TNF. These changes were paralleled by an 
increased hippocampal content of 3-NT and MDA that reflects oxidative 
stress (Vignisse et al., 2014). Hippocampal overexpression of both isoforms 
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of GSK-3 and functionally related molecules such as FOXO3a and PTEN 
along with downregulation of Akt suggests that interrelation of GSK-3 
cascades, oxidative stress and abnormal neuroplasticity exists. This means 
that GSK-3-mediated cascades are important regulators of depressive 
syndrome as they are involved in many cellular functions. 
We showed that ultrasonic exposure leads to reduction of hippocampal 
population of both Ki67- and DCX-positive cells alongside with a 
downregulation of BDNF/TrkB that suggests diminished neurogenesis and 
neuroplasticity. Our preliminary research showed aberration of serotonergic 
neurotransmission in the limbic structures, especially 5-HT1a and 5-HT2a 
receptors-mediated cell signaling, that are known for their involvement in 
neuronal plasticity mechanisms (Mahar et al., 2014; Morozova et al., 2016). 
Notably, expression of these types of serotonergic receptors can be 
modulated by pro-inflammatory cytokines which were upregulated in our 
model as well (Muller, 2014). In this regard, the changes that were displayed 
in our model can be linked to serotonergic system; of particular 
significance, selective serotonin reuptake inhibitor fluoxetine upregulated 
BDNF level in limbic brain structures in our preliminary study (Morozova 
et al., 2016). 
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Consistent with this result we showed an important role of GSK-3 isoforms 
in our modFST study. As GSK-3 is a crucial factor in the regulation of 
neuroplasticity, aberrant expression of this factor can underlie augmented 
acquisition to negative experiences (Beurel et al., 2015).  It is importantly 
to note that it is the beta isoform that is ubiquitously expressed in the brain 
structures (Graef et al., 1999) and knock-in mutant models that display 
urpregulated content specifically of beta isoform of GSK-3 demonstrate 
vulnerability to depressive syndrome (Beurel et al., 2015). Importantly, lack 
of active GSK-3 prevented long term potentiation in the rodent 
hippocampus. In 2008 Kimure and colleagues revealed that inhibition of 
this kinase prior to context re-exposure but not to conditioning itself impairs 
memory formation, thus beta isoform of GSK-3 is implicated in the 
consolidation phase of learning. Additionally, there is data that indicates an 
association between decreased content of inactive GSK-3 beta in the long-
term negative memories in a model of PTSD (Dahlhoff et al., 2010). The 
role of GSK-3 in regulation of NMDA-dependent mechanisms was also 
addressed (Peineau et al., 2009) which leads us to speculate about an 
important role of this kinase in the synaptic mechanisms, particularly in the 
balance between long term potentiation and long-term depression. 
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Increased production of GSK-3-dependent pro-inflammatory cytokines was 
shown to be closely associated with hypercorticosteronaemia, a condition 
triggered by excessive activation of the HPA axis (Uchoa et al., 2014). 
Increased production of CORT and activation of GSK-3-mediated pro-
inflammatory pathways can provoke oxidative stress and mitochondrial 
changes (Sato et al., 2010), an important vulnerability factor for the 
development of a depressive-like conditions (Oliveira et al., 2017). In our 
modFST model these changes were replicated and we detected increased 
brain content of carbonylated proteins, a marker of irreversible protein 
damage associated with increased content of reactive oxygen species 
(Frijhoff et al., 2015; Gorlova et al., 2019). Oxidative stress was 
accompanied by GSK-3 overexpression and increased CORT production 
that are in the line with the data discussed above. Our results suggest 
overlapping pro-inflammatory mechanisms in these two models of 
depressive syndrome of various aetiologies. 
5.3 Pro-inflammatory changes during stress, depression and 
neuropsychiatric pathology associated with abnormal retention of 
adverse memories 
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Neuropsychiatric pathologies associated with augmented retention of 
negative experiences constitute an important mechanism of depressive 
syndrome development (Gold and Korol, 2012). Depressive syndrome is a 
highly heterogeneous phenomenon and interindividual differences in 
enhanced acquisition of adverse memories can affect efficacy of applied 
antidepressant treatments. Role of neuroinflammatory mechanisms in the 
vulnerability mechanisms to depression has been debated and there is a 
concern that features of neuroinflammation associated with the 
development of a depressive syndrome can underlie higher efficacy of novel 
anti-inflammatory antidepressant treatments as compared to standard 
procedures.  
From clinical data we know that a positive correlation exists between signs  
of inappropriate retention of memories about negative or traumatic 
experiences in patients suffering from PTSD and systemic content of pro-
inflammatory cytokine profile, CRP, INF gamma and COX-1 (Miller et al, 
2018; Toft et al., 2019). Consistent with these studies, similar differences 
were shown for central pro-inflammatory profiles, where brain 
overexpression of IL-6, TNF and other cytokines was associated with drug 
resistance in patients with depression comorbid with PTSD (Costemale-
Lacoste et al., 2016). Of particular importance, GSK-3-dependent 
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functionally related mechanisms have been shown to contribute in the drug 
resistance mechanisms as well (Costemale-Lacoste et al., 2016). 
In our modFST study we aimed to further examine neuroinflammatory 
conditions associated with inappropriate retention of adverse memories and 
thus we have shown that limbic overexpression of IL-1 beta, TNF and COX-
1 are associated with increased floating duration. These data are in the line 
with our reports that functionally related isoforms of GSK-3 are 
overexpressed in two major limbic brain structures, hippocampus and 
prefrontal cortex, and positively correlated with behavioral signs of 
augmented learning of adversity. Together, our data are consistent with the 
notion that both hippocampus and prefrontal cortex are key brain regions 
for animal emotionality and memorizing of environmental adversities in the 
development of PTSD (Jope et al., 2006; Lopresto et al., 2016). 
 Concerning GSK-3-dependend mechanisms of abnormal retention of 
adverse memories, we showed distinct patterns of mRNA expression of 
alpha and beta isoforms of GSK-3. For instance, no significant changes 
were found in the prefrontal cortex for alpha or beta isoforms of GSK-3 nor 
in thiamine-, nor in imipramine-treated groups, while in hippocampus we 
observed changes in beta isoform expression following modFST procedure. 
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Thiamine-dependent changes in hippocampal expression of alpha isoform 
can be explained with known thiamine memory-enhancing properties. 
Overall, our data showed similar anti-stress activity of both treatments on 
alpha and beta limbic expression that can support a notion that alpha 
isoform can serve as a molecular analogue of beta isoform under certain 
conditions. This notion leads us to examine alpha isoform as an additional 
target for the depression treatment. These data support the view that alpha 
isoform can be an important molecular regulator of depressive syndrome 
associated with abnormal retention of adverse memories. 
5.4 Validity of novel models of depression using an ultrasound-induced-
“emotional stress” and modified swim test of enhanced conditioning of 
adverse memories  
Emotional stress is a form of distress resulted from suffering a sudden and 
strong negative experience that is not triggered by any invasive 
manipulation (Fontes et al., 2014). Repeated defeat, death of relatives, and 
maternal separation are among the leading causes of emotional stress 
commonly regarded as a mental stress or psychological stress. Multiple 
factors of organic nature such as pain conditions, infectious diseases, 
neuroendocrine pathologies and inflammation are associated with stress 
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response and can be downstream drivers of depressive symptomology 
(Selye, 1974). 
Here, in the ultrasound stress study, we showed that chronic and 
unpredictable stress based on random alterations of emotionally negative 
ultrasound cues can provoke maladaptive changes that lead to the 
development of a depressive syndrome in rodents. This model lacked any 
physical or organic stressors such as animal immobilization, deprivation of 
food and water or forced swimming. In the present model animal exposition 
to the sound cues was chronic and inescapable and mimicked animal 
vocalization in nature (Brudzynski et al., 2010). When rodents 
communicate at frequencies between 20 and 25 kHz it indicates their 
negative emotional state; when rodents communicate at frequencies 
between 25 and 45 kHz or higher, it indicates their positive or neutral 
emotional state (Kuraoka and Nakamura, 2010).  
As we showed, mice exposed to ultrasound stress had anhedonic states that 
were manifested as decreased sucrose preference and consumption, 
increased despair behavior that was manifested as prolonged time spent 
floating in the modFST, anxiety-like behavior that was manifested as 
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decreased time spent in the central zone of open filed. Animal horizontal 
and vertical activity were affected as well along with aggressive behavior.  
These results further provide evidence that the ultrasound stress model is of 
importance for translational stress-induced depression studies. In recent 
years there was a move toward naturalistic approaches to model depressive 
syndrome that lack any physical or organic components for induction of the 
depressive-like traits (Buwalda et al., 2005; Baram et al., 2012). While 
existing naturalistic models had validity (Pollak et al., 2010), a great deal of 
limitations still exist that narrowed the reliability of these models, which 
were affected with minor changes in the animals’ environment. Employed 
here, the ultrasound stress model is of particular significance as it mimics 
human psychological stress and provokes characteristic behavioral and 
biochemical changes in rodents that are typical for depressive syndrome. 
Despite the fact that augmented memorizing of negative experiences 
constitutes an important element of the pathological alterations associated 
with depressive syndrome, little is known about the mechanisms of this 
phenomenon as multiple limitations still exist to specifically model this 
condition. The modified forced swim test offers a valid and reliable 
approach to discover molecular mechanisms of enhanced cognitive 
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processing associated with depressive syndrome. Our modFST model was 
based on a classical forced swim test (Porsolt, 1977) that is commonly used 
in depression research (Lucki, 1997). This paradigm is used to model an 
inescapable aversive situation where rodents typically demonstrate despair 
behavior that is accompanied by hypothalamic-pituitary-adrenal axis 
activation (Cabib et al., 2012) and release of glucocorticoids. Besides these 
changes, repeated exposure of animals to the aversive context in our 
paradigm was shown to affect pathways that implicate learning and memory 
processes. A series of experiments has been done to specifically address the 
role of context re-exposure and we demonstrated key roles of timing and 
context conditioning for the development of aforementioned behavioral and 
biochemical changes (Strekalova et al., 2016). Notably, a third re-exposure 
to a swimming session before Day 5 showed absence of changes that we 
saw in our established protocol, thus highlighting an important role of 
timing in the development of augmented learning and depressive syndrome. 
In consistency with our results, Bogdanova and colleagues in 2013 have 
revealed that implication of blocators of protein synthesis and biochemical 
memory cascades resulted in moderation of floating behavior.  Thus, our 
paradigm of repeated swimming sessions combines both features of 
depression models and contextual memories approaches and is of a great 
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use to study mechanisms of augmented learning of adverse memories 
associated with the development of a depressive syndrome. 
5.5 Clinical implications of anti-depressant-like activity of thiamine-
related compounds 
Brain thiamine deficiencies can severely impact function of brain structures 
as thiamine is a crucial element for normal brain physiology: such 
deficiencies can provoke profound metabolic aberrations, deficient 
neuroplasticity and oxidative stress (Smidt et al., 1991). Behaviorally, 
thiamine deficiencies can be manifested as increased duration of floating, a 
sign of despair-like behavior in rodents (Nakagawasai et al., 2007). 
Thiamine-related compounds display anti-oxidant and anti-stress effects in 
animal stress research (Bozic et al., 2015). Our data suggest that 14 day- 
long thiamine pre-treatment prevents development of stress-induced 
depressive syndrome as well as overexpression of GSK-3 isoforms further 
support these results (Pavlov et al., 2017). We have chosen the pre-
treatment of imipramine as an internal control to anti-depressant-like 
activity of thiamine as previously these two medications were shown to 
counteract stress-induced signs of behavioral despair and ameliorate brain 
GSK-3 overexpression (Pan et al., 2010; Markova et al., 2017). 
268 
 
Of particular significance are findings that thiamine is able to restore 
hippocampal neuroplasticity and neurogenesis in a model of predation 
stress (Vignisse et al., 2017) presumably via Nrf2 antioxidant response 
element mediated mechanisms (Tapias et al., 2018). Thiamine was efficient 
to prevent brain oxidative stress in our modFST study as well as 
overexpression of beta isoform of GSK-3 thus it can be regarded as a potent 
antioxidant to counteract negative stress induced brain alterations.  
Some of the ameliorated thiamine effects can be due to non-enzymatic 
thiamine activity, presumably extracellular, where thiamine is a known 
molecule for its regulatory functions in the pentose phosphate pathway and 
Krebs cycle  (Bettendorff et al., 2014). Present studies as well as other 
research (Mkrtchyan et al., 2015) demonstrate emerging knowledge of the 
anti-inflammatory properties of the thiamine (Pavlov et al., 2017; Pavlov et 
al., 2019). These effects can be linked to the effects of thiamine on activity 
of GSK-3 beta isoform. GSK-3 is known to phosphorylate Nrf2 that is a 
downregulator of respective genes and antioxidant response. Prevention of 
overexpression of beta isoform of GSK-3 with thiamine can affect 
antioxidant cell system and subsequently ameliorate oxidative stress that we 
saw as decreased levels of protein carbonyls. Importantly, an upregulation 
of expression of proinflammatory cytokines, combined with increase of 
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depressive-like behavioral traits, that were prevented by thiamine 
administration, provide the first evidence that thiamine can affect pro-
inflammatory mechanisms in a model of augmented conditioning to 
environmental adversity. The pro-inflammatory profile of examined limbic 
structures was paralleled with increased oxidative stress, manifested in 
increased content of carbonylated proteins that was counteracted by 
thiamine pretreatment as well. 
 It is established that central upregulation of proinflammatory cytokines 
stimulates glutamatergic microglial and astroglial signaling (Bezzi et al., 
2001; Takeuchi et al., 2006; Fischer et al, 2014) that in turn increases 
production of reactive oxygen species (Dargelos et al., 2010). Reactive 
oxygen species can oxidize proteins leading to protein carbonylation, an 
irreversible process that can be reliably measured. Alleviation of these 
conditions with thiamine supplementation suggests that thiamine exerts the 
capacity to normalize the balance of oxidation processes. Taken together, 
thiamine exerts strong anti-inflammatory and anti-depressant-like 
properties induced by stress. These features indicate that thiamine 
supplementation has the potential to be used in the treatment of depressive 
syndrome and to investigate its underlying mechanisms in the translational 
and clinical research of depression. 
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SUMMARY 
 
In my thesis I aimed to study the role of the glycogen-synthase kinase 3 
(GSK-3) expression, inflammatory mechanisms and associated changes in 
the brain of mice, using two distinct models of depression. These new 
models were the ultrasound stress model of “emotional stress” and the 
model of enhanced contextual learning of adverse memories. In the 
modified forced swim model (modFST), the classic two-day forced swim 
in mice is followed by an additional delayed session on Day 5, where 
increased “despair” behaviour and upregulated GSK-3 are context-
dependent. In the ultrasound stress model of “emotional stress”, mice are 
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exposed to unpredictably presented ultrasound mimicking signals of 
anxiety and distress that are naturally emitted by small rodents. In Chapter 
4 I studied hippocampal gene and protein expression of both GSK-3β and 
GSK-3α, as well as the associated molecules forkhead transcription factor 
O subfamily member 3a (FOXO3a), phosphatase and tensin homolog 
(PTEN) and protein kinase B phosphorylated at serine 473 (AktpSer473) 
in mice exposed to the ultrasound stress model of “emotional stress”. While 
the upregulation of GSK-3β activity in stressed animals was accompanied 
by similar over-expression of hippocampal GSK-3α, no correlation 
between the latter and scores of depressive-like behavior in the forced swim 
test and other  signs of altered emotionality were found suggesting different 
functional roles of two GSK-3 isoforms in stress-induced depressive 
syndrome. We also found decreased densities of Ki67-positive and 
doublecortine-positive cells and downregulated expression of 
neurotrophins, including brain-derived neurotrophic factor (BDNF) and its 
receptor tropomyosin receptor kinase B (TrkB) in the hippocampus, 
suggesting decreased plasticity in the CNS of stressed mice. Stressed mice 
also displayed increased plasma levels of cytokines tumor necrosis factor 
(TNF), interleukin (IL)-1β and IL-6 and hippocampal expression of IL-1β 
and IL-6. Additionally, signs of microglia activation, increased density of 
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ionized calcium binding adaptor molecule 1 (Iba1)-positive cells and 
concentrations of oxidative stress markers 3-nitrotyrosine and 
malondialdehyde were found.  
 In Chapter 2 and Chapter 3 we studied gene expression of GSK3 
isoforms and markers of neuroinflammation in the hippocampus and 
prefrontal cortex of mice exposed to the modFST. We found brain over-
expression of GSK3α , a poorly studied molecule in animal models, with 
distinct expression dynamics from GSK3β after the modFST (Chapter 2). 
Our findings provide the first evidence for the involvement of GSK-3α in 
a depressive-like phenotype in an animal model of depression. In Chapter 
3 we report messenger ribonucleic acid (mRNA) overproduction of pro-
inflammatory cytokines IL-1β and TNF, as well as cyclooxygenase-1 
(COX-1) in the hippocampus and prefrontal cortex of mice subjected to the 
modFST. Overproduction of both IL-1β and TNF positively correlated with 
expression of GSK-3β, but not GSK-3α, and total duration of floating 
correlated with expression of both GSK-3 isoforms in the examined brain 
regions.  In addition, it has been found that mice exposed to the modFST 
demonstrate increased plasma corticosterone concentrations, elevated 
concentrations of protein carbonyl, a marker of oxidative stress and over-
expression of c-Fos in the brain. Most of changes induced by the modFST 
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were reversed by treatments with a low dose of imipramine or thiamine 
(Vitamin B1) that were shown to exert anti-stress and antidepressant 
properties and normalize GSK-3β expression. Together, our results 
obtained in studies with two depression models suggest overlapping 
molecular mechanisms of over-expression of GSK-3 and proinflammatory 
mechanisms along with oxidative stress to underlie distinct aspects of 
depressive syndrome. In addition, we identified GSK-3α as one of potential 
targets of depression treatment and further demonstrated that thiamine 
drugs can have a potential in reducing depressive-like changes associated 
with stress.   
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SAMENVATTING 
De bijdragen van CNS-ontstekingen en glycogen synthase kinase-3 
(GSK-3)-cascades op het negatieve herinneringen geheugen in 
muismodellen van emotionele stress 
 
In mijn proefschrift bestudeerde ik de expressie van de glycogeen-synthase 
kinase 3 (GSK-3), een moleculaire substraat van stress, evenals de 
ontstekingsmechanismen en de bijbehorende veranderingen op moleculair 
en cellulair niveau in de hersenen van muizen, met behulp van twee 
depressiemodellen : het door ultrasonoor geluid geïnduceerd stressmodel 
van "emotionele stress" en de gemodificeerde gedwongen zwemtest 
(modFST).  In het model van "emotionele stress" werd het ultrasone geluid 
willekeurig afgewisseld tussen 20 en 25 kHz wat overeenkomt  met het 
natuurlijk geluid van knaagdieren in een angst en vrees situatie , en 
frequenties tussen 25-45 kHz wat overeenkomt met het geluid dat muizen 
produceren in een "neutrale" emotionele toestand. De muizen, 21-dagen 
blootgesteld aan deze afwisselende frequenties van ultrageluid,  vertoonden 
een depressief beeld. Ten tweede hebben we een aangepaste Porsolt's test 
voor muizen gebruikt, een model van hulpeloos gedrag bij kleine 
knaagdieren, waarbij een extra vertraagde sessie op dag 5 na de initiële 
blootstelling resulteert in een verdere toename van hulpeloos gedrag bij de 
gevoelige dieren maar niet in veerkrachtige individuele muizen. Verhoogde 
hulpeloosheid in deze test wordt beschouwd als een teken van verbeterde 
contextuele conditionering van nadelige herinneringen, een belangrijk 
mechanisme van depressie. De upregulatie van beide isovormen van GSK-
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3 te weten GSK-3β en GSK-3α, werd gevonden in beide muismodellen van 
depressie. Echter, de veranderingen in de expressie van GSK-3β en niet de 
veranderingen in de expressie van GSK-3α in de hersenen, was significant 
gecorreleerd met kernen van depressief gedrag in deze twee modellen. Voor 
het eerst hebben wij de verschillende functionele rollen van de twee GSK-
3 isovormen in het stress-geïnduceerd syndroom aangetoond. De 
ontstekingsbevorderende veranderingen in beide diermodellen waren 
verhoogde plasmaconcentraties en hersenexpressie van tumornecrosefactor 
(TNF), interleukine (IL) -1β en IL-6, evenals cyclooxygenase-1 (COX-1) .  
Ultrasonore stress laat tekenen van verlaagde neuronale plasticiteit zien: de 
densitie aan Ki67-positieve en dubbelcortine-positieve cellen en een 
neerwaarts gereguleerde expressie van neurotrofines, en markers van 
microglia-activering, evenals verhoogde concentraties van oxidatieve 
stressmarkers 3-nitrotyrosine en malondialdehyde. De laatste 
veranderingen werden ook in de modFST gevonden. Dezelfde moleculaire 
en cellulaire veranderingen werden gezien bij de ontwikkeling van 
depressie achtige syndromen van verschillende oorsprong. De meeste 
depressieve uitingen waargenomen in deze twee modellen werden 
tegengegaan door de toediening van antioxidant thiamine (vitamine B1) 
welke ook de expressie van GSK-3β normaliseerde. De overlappende 
veranderingen in de GSK-3-activiteiten en de gerelateerde mechanismen 
dragen beide bij tot het aanleren van negatieve herinneringen en  
"emotionele stress" in de gebruikte modellen van depressie. 
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VALORIZATION   
Relevance for society  
Depression is a heterogeneous group of mental disorders with high 
prevalence. At present, the exact pathophysiological mechanism 
of depression and associated processes of heightened negative memory 
acquisition still remains unclear, while researchers put forward various 
hypotheses to interpret the possible links to this disease, including excessive 
inflammation and deficient neuroplasticity. 
As an outcome from my thesis work, my data will ultimately help to 
understand the molecular basis of depressive disorders of various etiologies to 
enable targeted treatment strategies of them. I pointed out isoforms of 
glycogen synthase kinase 3 (GSK-3), a molecular marker of distress and 
human depression in clinical studies, in two translational depression models 
of various etiologies. Importantly, modFST model replicates enhanced 
contextual conditioning of adversity that enables future studies of the 
mechanisms of certain neurobiological susceptibility mechanisms of 
depressive syndrome that is problematic to model in most of currently used 
rodent paradigms of the disease. As targeting of oxidative stress and 
neuroinflammation-related mechanisms of depression are regarded as a 
promising approach of efficient antidepressant therapy, main pro-
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inflammatory cytokines including tumor necrosis factor (TNF), interleukin-
1β (IL-1β) and interleukin-6 (IL-6) were examined in my work with and 
without thiamine (vitamin B1), a compound with anti-oxidant and anti-
stress properties, and classic antidepressant imipramine treatments. I 
demonstrated that thiamine was effective to counteract elevations of not 
only pro-inflammatory cytokines but also oxidative stress markers in the 
similar manner as imipramine that open new possibilities for thiamine-
based treatment of some depression–related states, as thiamine is a nontoxic 
molecule that lacks side effects. Thus, this thesis is highly valuable as it aimed 
to investigate the contribution of ubiquitous environmental factors to the risk 
of having depressive syndrome, and to determine if thiamine can have 
beneficial impacts on depressive syndrome management. 
 
Target groups  
I consider my target groups to be individuals that are at higher risk of a 
diagnosis of depression, such as war veterans and survivors of car accidents 
and other traumatic experiences as these factors precipitate vulnerability to 
the disease.  
 
Activity / Products  
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As potential outlook of presented work, I anticipate an interest of 
international research groups and pharmaceutical companies to use present 
animal paradigms in translational and academic research to study oxidative 
stress in depression models of various etiologies as well as study 
antidepressant and antioxidant activities of novel drugs in these paradigms. 
Using of thiamine-based compounds for targeted treatment of GSK-3α 
mediated depression can be of additional importance. 
 
Innovation  
My work is innovative in various aspects: I broaden knowledge of two 
mouse depression paradigms that model various aspects of depressive 
syndrome. GSK-3 can be a universal marker of depressive syndrome in 
which the upregulation is accompanied by microglial activation, oxidative 
stress and neuroplasticity disruption. These changes were reversed by pre-
treatments with antidepressants and a prominent anti-oxidant, thiamine, that 
highlights utility of thiamine-based anti-oxidants to prevent development of 
depressive-like traits through GSK-3 overlapping molecular mechanisms. 
Notably, while I have shown that GSK-3 can be a universal marker of 
depressive syndrome of various etiologies, the expression of its isoforms 
GSK-3α and GSK-3β is differentially regulated in both models.  
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Implementation  
I anticipate publishing my results in peer-reviewed international journals, 
presenting them at national and international conferences and further widen 
current knowledge about overlapping molecular mechanisms underlying 
depressive syndrome induced by “emotional stress” and enhanced learning 
of adverse context. 
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